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Abstract 
Wine  has  been  enjoyed  by  individuals  for  centuries.  Epidemiological 
research  has  clearly  demonstrated  that  individuals  who  choose  to  drink  alcohol 
in  moderation  exhibit  improved  cardiovascular  health  and,  on  average,  live 
longer.  While  alcohol  alone  can  help  prevent  coronary  heart  disease  (CHD) 
through  a  number  of  mechanisms,  red  wine  appears  to  offer  protection  above 
and  beyond  that  attributable  to  alcohol  alone.  Red  wine  is  a  rich  source  of 
biologically  active  phytochemicals,  specifically  phenolic  acids  and 
polyphenols,  derived  primarily  from  the  grape  skin,  whose  individual  and 
summated  actions  may  be  able  to  provide  health  benefits. 
Tea,  like  red  wine  is  also  a  rich  source  polyphenols.  Tea  is  also  a  source 
of  bioactive  molecules,  an  important  member  of  the  family  of  antioxidants  and 
a  beverage  which  may  be  able  to  confer  beneficial  health  properties. 
This  project  was  designed  to  determine  the  effect  of  a  wide  range  of 
grape  and  tea  based  extracts  and  green  tea  catechins  on  vascular  tension  in 
vitro,  finiher  determine  the  relationship  between  their  vasodilatory  and 
antioxidant  activities  and  identify  the  major  polyphenols  present  in  green  and 
black  tea. 
Grape  and  tea  based  extracts  were  examined  for  their  vasodilator 
activity  in  vitro  using  standard  organ  bath  pharmacology.  All  extracts  evoked 
biphasic  concentration-dependent  relaxation  in  rabbit  aortic  vessels.  Grape 
based  extracts  were  significantly  better  vasodilators  than  tea  based  extracts. 
Previous  work  by  others  has  shown  that  grape  based  products  induce  vascular 
relaxation  via  nitric  oxide  (NO)  and  endothelium-dependent  mechanisms.  This 
study  demonstrated  that  a  range  of  grape  based  extracts  induced 
vasorelaxation  responses  via  complex  mechanisms  including  endothelium- 
dependent  and  independent  mechanisms  via  vasodilating  prostaglandins  by 
way  of  prostacyclin  and  endothelial  NO  production.  Tea  based  extracts  on  the 
other  hand,  induced  vasorelaxation  via  the  combined  interactions  of 3 
vasodilating  endothelium-dependent  prostaglandins.  The  relationship  between 
the  vasodilation  capacity,  antioxidant  activity,  based  on  the  reduction  of  the 
free  Fremy's  radical  and  ferric  reducing  power,  and  total  phenolic  content  of 
each  extract  was  also  determined.  In  general,  a  significant  inverse  correlation 
was  identified  between  the  vasodilator  abilities  of  the  grape  and  tea  extracts  in 
vitro  and  their  antioxidants  activities. 
This  study  demonstrates  that  grape  and  tea  based  extract  induce 
vasorelaxation  in  isolated  rabbit  aortic  vessels  and  are  effective  antioxidants  in 
vitro,  within  a  concentration  range  that  may  be  reached  in  vivo  by  moderate 
wine  and  tea  consumption.  The  results  presented  here  also  indicate  that 
consumption  of  green  tea  may  have  greater  benefits  than  consumption  of  black 
tea  in  terms  of  their  vasodilatory  activity  and  antioxidant  capacity  in  vitro. 
These  results  do  not  however  take  into  account  metabolism  and  absorption  of 
grape  and  tea  components  in  vivo.  Further  work  is  required  to  elucidate  the 
identification  of  the  vaso-active  components  present  in  theses  extracts  and 
their  possible  effects  in  vivo. 
Green  tea  in  this  study  has  been  shown  to  be  an  antioxidant  and  a 
vasodilator  in  vitro.  In  a  separate  study  the  six  main  catechins,  and  epicatechins 
derivatives  present  in  green  tea  were  examined  for  their  vasodilator  activity  in 
vitro  using  standard  organ  bath  pharmacology.  (+)-Catechin  gallate  (CG)  was 
identified  to  be  the  most  potent  derivative  in  vitro,  that  is  inducing 
vasodilation  at  the  lowest  derivative  concentration  added  to  the  organ  bath, 
and  (-)-epigallocatechin  gallate  (EGCG)  to  be  the  most  effective,  that  is 
inducing  the  highest  maximum  vasodilation  value  of  all  derivatives 
investigated.  (-)-Epicatechin  (EC)  and  catechin  were  found  to  have  no 
significant  effect  on  vascular  tension  in  vitro.  In  all  cases,  vasorelaxation 
occurred  via  the  release  of  NO  and  is  dependent  upon  the  presence  of  intact 
functional  vascular  endothelium.  The  catechins  and  epicatechins  examined  in 
this  study  were  identified  to  be  effective  antioxidants,  a  feature  positively 
correlated  with  their  vasodilatory  activity.  The  total  phenolic  and  total 
catechin  content  of  the  epicatechin  derivatives  was  also  positively  correlated 4 
with  vasodilatory  and  antioxidant  activity.  The  ferric  reducing  ability  (FRAP)- 
derived  antioxidant  activity  of  the  catechin  and  epicatechin  derivatives 
examined  in  this  study  ranged  in  the  order  magnitude  of 
EGCG>EGC>EM:  Catechin>CG>EC. 
Differences  in  the  statistical  results  presented  for  the  vasodilatory  and 
antioxidant  activities  of  the  grape  and  tea  based  extracts  as  compared  to  that  of 
the  green  tea  epicatechin  and  catechin  derivatives,  may  be  due  to  genuine 
differences  in  the  basic  chemical  composition  of  the  compounds  investigated 
as  standard  methodology  was  used  in  both  studies.  The  grape  and  tea  extracts 
investigated  contained  a  range  of  active  components  in  varying  concentrations 
which  may  have  interacted  together  to  produce  cumulative  effects  as 
compared  to  the  purified  epicatechin  and  catechin  standards  of  a  known  and 
predetermined  concentration.  Contamination  of  the  extracts  is  another  factor 
which  may  have  had  an  affect  on  the  results  presented  and  which  could  not  be 
ruled  out. 
A  novel  fractionation  approach  was  also  employed  to  further  determine 
the  identity  of  the  major  polyphenolics  present  in  green  and  black  tea,  based 
on  differences  in  their  polarities.  Tea  catechins,  were  separated  using  a 
preparative  HPLC  system  and  fractionated  in  to  50-60  aliquots.  The 
antioxidant  activity  of  each  fraction  was  determined  using  electron  spin 
resonance  spectroscopy  (ESR)  and  their  ferric  reducing  ability  (FRAP).  The 
total  phenolic  and  catechin  content  of  each  fraction  was  also  determined.  The 
cffect  of  the  green  tea  fractions  on  vascular  tension  in  vitro  was  also 
investigated. 
Green  tea  fractions  with  high  antioxidant  activity  and  high  phenolic  and 
catechin  contents  were  able  to  induce  vasodilation  in  vitro.  Increasing 
antioxidant  activity  was  positively  correlated  with  total  phenolic  and  catechin 
content  of  each  fraction.  The  presence  of  the  main  catechins  and  flavonols 
were  identified  in  the  green  tea  sample  using  HPLC.  The  purine  alkaloid 5 
caffeine  was  identified  in  fraction  27  and  may  account  for  the  poor  vasodilator 
effects  of  this  specific  fraction. 
Black  tea  fractions  were  found  to  be  significantly  lower  in  both 
antioxidant  activity  and  total  phenolic  and  catechin  content  than  the  green  tea 
fractions.  The  presence  of  the  main  catechins  and  flavonols  were  identified  in 
the  black  tea  sample.  Theaflavins  and  thearubigens  were  also  putatively 
identified. 
This  study  demonstrates  that  red  wine  and  tea  have  antioxidant 
capabilities  and  are  able  to  induce  vasorelaxation  in  vascular  endothelium, 
optimising  blood  flow  through  the  cardiovascular  system.  These  results  also 
indicate  that  anthocyanins  present  in  red  wine  account  for  the  vasodilatory 
activity  of  grape  derived  products  and  catechins  are  responsible  for  the  potent 
antioxidant  activity  conferred  by  extracts  of  tea  and  green  tea  derivatives. Table  of  Contents 
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Definitions 
ACh  acetylcholine 
cAMP  cyclic  Adenosine  monophosphate 
cGMP  cyclic  Guanosine  monophoshate 
CCRC  cumulative  concentration  response  curve 
CHD  Coronary  Heart  Disease 
CG  Catechin  gallate 
DNA  deoxyribonucleic  acid 
EC  Epicatechin 
ECG  Epicatechin  gallate 
EGC  Epigallocatechin 
EGCG  Epigallocatechin  gallate 
ESR  Electron  Spin  Resonance 
Fe  (11)  Iron  Sulphate  (FeS04) 
Fe  (111)  Iron  chloride  (FeCl3) 
FRAP  Ferric  reducing  ability  of  plasma 
GAE  Gallic  acid  equivalents 
HDL  High-density  lipoprotein 
HPLC  High  performance  liquid  chromatography 
LDL  Low-density  lipoprotein 
KC1  Potassium  chloride 
L-NAME  Nco-nitro-arginine-methyl-ester 
NO  Nitric  oxide 
nm  nanometers 
MS  Mass  spectroscopy 
m/Z  mass  to  charge  ratio 
PDE  Phosphodiesterase 
PE  phenylephrine 
ROS  reactive  oxygen  species 
Rt  retention  time 
SD  Standard  deviation 
SEM  Standard  error  of  the  mean 
TPTZ  2,4,6  Tri(2-pyr-idyl)-s-triazine 18 
Aims  of  Study 
Wine  and  tea  have  been  part  of  the  diet  for  many  centuries. 
Epidemiological  studies  have  indicated  that  moderate  consumption  of  alcohol, 
especially  consumption  of  red  wine,  and  increased  consumption  of  plant 
derived  foods,  such  as  tea,  may  reduce  the  risk  of  cancers  and  coronary  heart 
disease,  the  main  causes  of  human  mortality.  The  possible  beneficial  health 
effects  of  wine  and  tea  have  mainly  focused  on  their  role  as  antioxidants  and 
their  ability  to  scavenge  free  radicals,  but  other  health  promoting  activities 
have  been  suggested. 
Hypotheses  to  be  investigated: 
1.  the  effects  of  grape  and  tea  based  extracts  on  vascular  tension  in  vitro  will 
be  related  to  their  antioxidant  activity.  The  mechanism  and  pathways  of 
vasorelaxation  will  also  be  determined. 
2.  the  effects  of  green  tea  catechin  and  epicatechin  derivatives  on  vascular 
tension  in  vitro  will  be  related  their  antioxidant  activity.  The  mechanism  of 
vasorelaxation  will  also  be  determined. 
3.  the  antioxidant  and  vasodilator  activity  of  green  and  black  tea  fractions 
will  be  identified  in  samples  of  tea  following  large-scale  preparative 
fractionation.  The  polyphenolics  and  specifically  catechins  will  be 
quantified  within  each  sample. Jennifer  McGinn,  2002  19 
Chapter  1  Introduction 
1.1  Introduction  to  wine 
Wine  has  been  an  important  and  integral  part  of  human  culture  and  diet 
for  more  than  6,000  years  serving  dietary  and  socio-rcligious  functions. 
Grapevine  belongs  to  the  botanical  family  Vitaceae,  which  comprises  12  to  14 
different  genera,  possessing  about  1,000  species,  although  this  exact  number 
remains  under  discussion.  It  is  the  Vitis  and  its  700  species,  especially  Vitis 
vinifera,  that  are  of  particular  interest  to  the  winemaker  (Soleas  et  A,  1997). 
Vitis  vinifera  originated  and  was  cultivated  in  an  area  south  of  the  Black  Sea  in 
Transcaucasis.  The  first  recorded  mention  of  vine  is  found  in  the  Bible  which 
repeatedly  goes  on  to  mention  vineyards,  wine  and  drunkenness  in  following 
passages.  Noah  after  weathering  the  storms  for  40  days  and  nights  left  the  Ark 
and  set  out  to  "become  a  husbandman,  and  he  planted  a  vine:  he  drank  some  of 
the  wine,  and  became  drunk"  (Genesis  IX,  verses  6:  9  -  10:  28)  and  was 
subsequently  "found  by  his  sons  in  a  drunken  stupor".  Not  bad  for  a  drunkard 
who  was  600  years  old  when  the  rains  started  and  lived  for  another  350  years 
after  the  great  flood.  Likewise,  the  Marriage  Feast  at  Cana  (John  2.1),  was  the 
first  miracle  of  the  New  Testament,  when  all  the  wine  was  finished,  Christ 
miraculously  converted  water  to  wine  "keeping  the  best  wine  till  last".  This 
was  all  that  was  needed  to  approve  its  consumption  by  Christians  throughout 
the  world. 
From  its  first  reported  origins,  the  discovery  and  development  of  grape 
growing  and  winemaking  in  the  southern  Caucasus  region,  travelled  south  to 
Palestine,  Syria  and  Egypt.  From  this  base,  wine  consumption,  and  its  socio- 
religious  connections,  distributed  winemaking  throughout  the  Mediterranean 
(Soleas  et  aL,  1997).  Although  not  enjoyed  by  the  general  public  at  this  stage, 
the  royal  priests  made  use  of  its  mystical  and  healing  properties.  Indeed, 
Hippocrates,  the  father  of  medicine,  used  wine  as  an  integral  part  of  his 
remedies. Jennifer  McGinn,  2002  Chapter  1,20 
Due  to  the  extensive  travels  of  the  Romans,  grape  growing  and 
winemaking  spread  swiftly  throughout  Europe.  By  the  18'h  century,  Vitis 
vinifera  was  being  transported  to  Australia  and  New  Zealand,  South  America 
and  South  Africa.  Its  introduction  to  such  countries  was  mainly  due  to  the 
extensive  travels  of  catholic  missionaries  who  required  a  supply  of  wine  for 
their  religious  ceremonies. 
Today  the  production  of  wine  takes  place  on  every  continent,  and  its 
chemical  composition  is  profoundly  influenced  by  enological  techniques,  the 
grape  varieties  from  which  it  originates  and  climatic  and  geographical  factors. 
In  recent  years  wine  has  increased  in  popularity,  due  in  part  to  the  publicity 
about  the  beneficial  effects  on  health.  The  increasing  popularity  of  red  wine 
today,  has  been  attributed  to  the  phenomenon  known  as  the  "French  Paradox", 
the  large-scale  study  of  18  western  countries,  which  highlighted  the  ability  of 
red  wine  in  moderation,  to  confer  protection  against  coronary  heart  disease  (St 
Leger  et  aL,  1979) 
Wine  comes  in  many  forms.  It  may  be  white,  pink  or  red  and  range  from 
light  and  fruity  to  dark  and  robust.  Many  of  the  characteristics  of  individual 
wines  are  due  to  their  phenolic  content.  The  protective  effects  conferred  by  the 
consumption  of  wine,  especially  that  of  red  wine,  has  been  attributed  to  these 
phenolic  compounds 
1.2  Introduction  to  phenolics 
The  majority  of  fruits  and  vegetables  contain  a  large  number  of 
compounds  that  are  without  apparent  nutritive  value  for  humans,  but  which 
have  pronounced  biological  activity.  Flavonoids  are  a  group  of  low  molecular 
weight  C15  polyphenolic  compounds,  of  diverse  chemical  structure  found  in 
fruits,  vegetables,  grains,  roots,  flowers,  tea  and  wine  (Middleton  et  aL,  2000). 
Plants  produce  thousands  of  phenolic  and  polyphenolic  compounds  as 
secondary  metabolites.  They  are  a  family  of  structurally  related  compounds 
which  may  come  from  the  fruit  (both  the  seeds  and  the  skin),  vine  stems, Jennifer  McGinn,  2002  Chapter  1,21 
production  by  yeast  metabolism  and  extraction  from  wood  co'operage. 
Phenolic  compounds  are  characterised  by  having  an  aromatic  ring  with  more 
than  one  hydroxyl  group  attached.  With  more  than  4000  naturally  occurring 
flavonoids  (Harbome,  1993)  and  more  than  8000  phenolic  structures  reported 
to  date,  they  are  widely  distributed  throughout  the  plant  kingdom.  The  nature 
and  distribution  of  phenolics  can  vary  depending  on  the  plant  tissue.  The 
majority  of  the  phenolics  are  synthesized  from  carbohydrates  via  the 
Shikimate  acid  pathway  (Figure  I  and  Table  1)  or  are  derived  from  this 
pathway  in  which  p-coumaric  acid  is  a  key  component  (Duthie  &  Crozier, 
2002).  This  is  the  pathway  responsible  for  the  biosynthesis  of  the  aromatic 
amino  acids.  These  have  been  termed  "essential"  amino  acids  as  the  Shikimate 
pathway  is  limited  to  plants  and  micro-organisms  and  therefore  must  make  up 
part  of  the  mammalian  diet  (Bums  et  aL,  2000).  Flavonoids  are  synthesized  in 
a  series  of  discrete  steps,  each  step  being  catalysed  by  the  appropriate 
oxidative  or  reductive  enzyme.  The  first  flavonoid  intermediate  is  a  chalcone, 
formed  by  chalcone  synthase  (Rice-Evans,  1998).  This  is  immediately 
isomerised  to  the  corresponding  flavanone.  Although  chalcones  and 
flavanones  are  biosynthetic  intermediates,  they  can  also  be  accumulated 
separately  as  end-products  of  the  pathway  (Bravo,  1998;  Harbome,  1999). 
Natural  phenolics  can  range  from  simple  low  molecular  weight,  single 
ringed  aromatic  compounds,  such  as  the  phenolic  acids,  to  the  large  highly 
polymerised  and  complex  tannins  (Bravo,  1998).  They  can  be  classified  by  the 
number  and  arrangement  of  their  carbon  atoms  and  the  level  of  oxidation  of 
their  central  C-ring.  They  occur  primarily  in  the  conjugated  form,  with  one  or 
more  sugar  residues  linked  to  hydroxyl  groups.  The  associated  sugars  can  be 
present  as  monosaccharides,  disaccharides,  or  even  oligosaccharides  (Bravo, 
1998).  Glucose  is  the  most  common  sugar  residue.  They  are  commonly  found 
conjugated  to  other  phenolics,  carbohydrates,  lipids  and  organic  acids. 
The  phenolics  can  be  classified  into  two  groups,  the  flavonoids  and  the 
non-flavonoids. Jennifer  McGinn,  2002  Chapter  1,22 
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Figure  1.  The  Shikirnate  acid,  phenylpropanoid  and  flavonoid  biosynthetic 
pathways 
(See  Table  I  for  abbreviations) Jennifer  McGinn,  2002  Chapter  1,23 
Acronym  Enzyme 
PAL  Phenylalanine  ammonia-lyase 
C411  Cinnamate  4-hydroxylase 
4C3H  4-Coumarate  3-hydroxylase 
CNIT  Caffeate  methyl  transferase 
4CL  4-Coumarate:  CoA  ligase 
ss  Stilbene  synthase 
CHS  Chalcone  synthase 
CHI  Chalcone  isomerase 
IFS  Isoflavone  synthase 
FS  Flavone  synthase 
FN3H  Flavanone  3-hydroxylase 
FLS  Flavonol  synthase 
DFR  Dihydroflavonol  4-reductase 
ANS  Anthocyanidin  4-reductase 
LAR  Leucoanthocyanidin  4-reductase 
Table  1  List  of  enzyme  acronyns  for  the  biosynthetic  pathways Jennifer  McGinn,  20OZ  Chapter  1,24 
1.2.1  Flavonoids 
The  flavonoids  are  an  important  group  of  substances  in  the  diet  which 
occur  naturally  in  fruit,  vegetables,  seeds,  nuts  and  flowers  (Cook  &  Samann, 
1996),  principally  as  sugar  conjugates.  The  term  flavonoid  encompasses  the 
flavones,  flavonols,  flavan-3-ols,  flavanones,  isoflavones,  and  anthocyanins 
(Figure  2). 
The  structural  basis  underlying  all  substances  of  flavonoid  character  is 
the  flavane  nucleus  or  2-phenyl-benzo-y-pyrane,  representing  a  system  of  2 
benzene  rings  (A  &  B)  mutually  combined  by  the  mediation  of  the  oxygen 
containing  pyrane  C-ring.  They  have  the  common  skeleton  of 
diphenylpropanes  (C6-C3-C6).  which  occur  in  a  wide  range  of  plants.  The  basic 
flavonoid  structure  is  derived  from  two  sources.  The  B-ring  and  part  of  the  C- 
ring  are  derived  from  the  Shikimate  pathway,  the  biosynthetic  route  for 
aromatic  arnino  acids,  while  the  A-ring  is  formed  from  the  condensation  and 
cyclisation  of  3  acetate  units  from  malonyl  Co-A  (Harborne,  1999)  (see  Figure 
1).  The  antioxidant  activities  of  flavonoids  and  their  metabolites  depend  on 
their  chemical  structure  and  orientation  of  the  various  substitution  patterns  in 
the  two  benzene  rings  (Bravo,  1998).  Due  to  this  feature  allowing  extensive 
substitution  within  the  3  rings  a  large  number  of  flavonoids  can  be  found  in 
nature.  There  are  numerous  structural  variations  within  the  major  flavonoid 
classes  which  depend  on  the  level  of  hydrogenation,  methylation, 
hydroxylation  and  sulphation  of  the  molecules  (Adhere  &  O'Brien,  2002). 
1.2.1.1  Flavonols 
The  flavonols  are  of  particular  importance  in  this  review  because  of  their 
potentially  protective  role  in  carcinogenesis  and  coronary  heart  disease. 
Flavonols  are  commonly  found  in  foods.  Vegetables,  fruits  and  beverages, 
such  as  tea  and  red  wine  (Table  2),  are  the  main  dietary  sources  of  flavonols, 
primarily  as  glycosides  of  quercetin,  kaempferol  and  myricetin  (Crozier  et  aL, 
1997a). Jennifer  McGinn,  2002 
Table  2  Flavonol  content  of  selected  beverages 
Beverage  Flavonol  content* 
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Loose  green  tea 
Japanese  32.8  ±  0.4 
Loose  black  tea 
Safeway  21.0  ±  0.3 
Typhoo  39.1  ±  0.9 
Red  wines 
Cabernet  Sauvignon,  Chile  58.4  ±  4.0 
Pinot  Noir,  California  30.2  ±  0.6 
Merlot,  Chile  25.2  ±  1.2 
Beaujolais,  France  9.9  ±  0.9 
White  wines 
Reisling,  Australia  1.7  ±  0.2 
Bordeau  Blanc,  France  n.  d. 
Dry  White,  South  Africa  n.  d. 
All  data  expressed  as  mg  L  -1  total  flavonols  ±  s.  e.  m,  n--3,  n.  d.,  not 
Detected.  Adapted  from  Crozier  et  aL,  2000 Jennifer  McGinn,  2002  Chapter  1,26 
The  variability  within  the  flavonols  is  extensive,  with  over  380  flavonol 
glycosides  and  more  than  200  different  quercetin  and  kaempferol  glycosides 
being  described  to  date  (Bravo,  1998).  Conjugation  occurs  most  commonly  at 
the  3  position  of  the  C-ring  although  substitutions  at  the  7,4',  3'  and  5'  also 
occur  (Harborne,  1993).  Flavonols  occur  in  an  extensive  array  of  derivatives 
with  extra  hydroxylation  and/or  methylation.  Their  glycosides  have  been 
found  in  practically  all  types  of  plants  but  are  the  major  components  in  fruits 
(Herrmann,  1988). 
The  formation  of  flavonol  glycosides  normally  depends  on  light.  In 
general,  the  highest  concentrations  of  these  compounds  occur  in  the  leaves, 
while  only  trace  amount  are  found  in  the  parts  of  the  plant  below  the  soil 
surface  (Herrmann,  1976,1988;  Hertog,  1994).  The  common  onion  is  the 
well-known  exception  to  the  rule.  It  appears  that  in  general,  UV  light  is  the 
predominant  factor  in  determining  the  flavonol  content  of  the  plant.  However, 
growing  plants  in  glasshouses  reduces  the  flavonol  content,  particularly  in  the 
outer  leaves,  as  has  been  shown  for  kale,  brussel  sprouts  and  lettuces  as  they 
are  out  of  direct  contact  with  UV  light  (Hertog,  1994).  The  concentrations  of 
flavonols  and  flavones,  like  those  of  all  secondary  plant  metabolites,  vary 
within  certain  limits  and  are  dependant  upon  a  number  of  factors,  such  as  the 
growing  conditions,  degree  of  ripeness  and  the  size  and  variety  of  the  fruit 
(Herrmann,  1976). 
1.2.1.2  Flavones 
Flavones  differ  from  flavonols  only  in  the  absence  of  hydroxylation  at 
the  3-position  in  the  C-ring  (Rice-Evans,  1998)  (Figure  2).  The  most  common 
flavones  are  apigenin  and  luteolin  which  are  mainly  found  in  vegetables,  such 
as  celery,  sweet  red  pepper,  citrus  fruits  and  herbs.  The  flavone,  luteolin, 
corresponds  in  the  hydroxylation  pattern  to  the  flavonol  quercetin.  Chemically 
flavones  are  also  classified  as  3-hydroxyflavones  (Herrmann,  1976). Jennifer  McGinn,  2002 
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Figure  2  The  generic  structure  of  flavonoids Jennifer  McGinn,  2002 
1.2.1.3  Flavan-3-ols 
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This  is  the  most  complex  subclass  of  flavonoids  ranging  from  the  simple 
(+)-catechin  and  its  isomer  (-)-epicatechin,  to  the  oligomeric  and  polymeric 
proanthocyanins,  also  known  as  condensed  tannins  (Balentine  et  aL,  1997).  In 
addition  to  forming  complexes  with  other  flavan-3-ols,  they  also  undergo 
esterification  with  gallic  acid  to  form  catechin  gallates,  and  hydroxylation 
reactions  to  form  gallocatechins  (Robb  &  Brown,  2001).  Proanthocyanins  are 
a  subclass  of  flavan-3-ols  which  are  universally  present  in  woody  plants  and 
are  normally  present  in  the  non-glycosidic  form.  Flavan-3-ols  are  involved  in 
the  taste  and  texture  of  food  and  confer  a  bitter  and  astringent  taste  to  red  wine 
and  tea  (Balentine  et  aL,  1997).  Catechins  and  epicatechins  are  discussed  in 
more  detail  in  section  1.12.1. 
1.2.1.4  Flavanones 
The  flavanones  are  the  first  flavonoid  products  of  the  biosynthetic 
pathway.  Two  main  structural  features  characterise  the  flavanones,  the 
absence  of  the  C2-C3  double  bond,  and  the  presence  of  a  chiral  centre  at  C2. 
In  naturally  occurring  flavanones,  the  C2  phenyl  group  is  orientated 
downwards,  in  the  (x-configuration  (Bohm,  1998).  The  flavanones  group  is 
highly  reactive  and  they  have  been  reported  to  undergo  hydroxylation, 
glycosylation  and  0-methylation.  The  most  common  flavanones,  naringenin 
and  hesperidin,  and  their  glycosides,  are  abundant  in  citrus  fruits  and  juices, 
for  example  in  grapefruits,  oranges  (125  -  150  mg/L  of  juice)  (Scalbert  & 
Williamson,  2000)  and  lemons,  where  they  contribute  to  the  bitter  flavour,  and 
in  prunes,  liquorice  and  peppermint.  In  citrus  fruits,  flavanones  are  usually 
found  conjugated  to  rutinosides,  that  have  no  taste  (Scalbert  &  Williamson, 
2000). Jennifer  McGinn,  2002 
1.2.1.5  Anthocyanins 
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Anthocyanins  are  widely  distributed  throughout  the  plant  kingdom  and 
are  responsible  for  most  floral,  fruit  and  leaf  colours  in  nature,  apart  from  the 
green  chlorophyll  and  yellow  carotenoids  (Rice-Evans,  1999).  In  nature  they 
are  responsible  for  blue,  pink,  red  and  purple  colours.  They  play  an  important 
role  in  attracting  insects  to  flowers  for  pollination  but  are  also  involved  in 
protecting  the  plant  against  UV  light.  Anthocyanins  consist  of  an 
anthocyanidin  bound  to  one  or  more  sugar  moieties,  with  a  sugar  always 
present  at  C3  and  frequently  on  carbons  5,7,3'  and  5'  (Rice-Evans,  1998). 
The  term  anthocyanin  refers  to  the  glycosides  of  anthocyanidin,  for  example 
pelargonidin,  malvidin  and  cyanidin  (Bravo,  1998).  In  addition  to 
glycosylation,  common  linkages  with  aromatic  acids  and  methyl  ester 
derivatives  also  occur.  Anthocyanins  also  readily  form  loose,  hydrogen- 
bonded  complexes  with  flavones  and  metal  ions,  acting  as  co-pigments  which 
help  to  stabilise  pigments  in  the  hostile  acidic  environment  of  the  plant  cell 
sap  (Rice-Evans,  1998).  Anthocyanin  colour  is  pH  dependent  with 
anthocyanins  usually  red  at  acid  pH's  becoming  colourless  then  shifting  to 
blue  as  the  pH  increases.  Fruit  anthocyanin  content  usually  increases  as  the 
fruit  matures  (Peterson  &  Dwyer,  1998).  Anthocyanins  are  present  in  cherries, 
strawberries,  grapes,  red  currents,  raspberries  and  plums. 
1.2.1.6  Isoflavonoids 
Isoflavonoids  are  a  distinct  class  of  flavonoids  best  known  for  their 
estrongenic  activity  and  their  suggested  role  in  the  prevention  of  breast  cancer 
and  osteoporosis  (Scalbert  &  Williamson,  2000).  Structurally  they  differ  from 
the  common  flavonoid  in  the  orientation  of  the  B  ring.  They  are  characterised 
by  having  the  B  ring  attached  at  the  C3  of  the  phenylchromane  structure. 
Isoflavonoids  are  derived  from  the  biosynthetic  pathway  and  can  be  converted 
into  a  wide  variety  of  different  isoflavonoids,  the  isoflavanones,  isoflavones 
and  isoflavonols  (Harbome,  1993). Jennifer  McGinn,  2002  Chapter  1,30 
The  best  known  isoflavonoids  are  daidzein  and  genistein.  They  are 
found  predominately  in  legumes.  Soybeans  are  the  major  source  of  daidzein 
(-I  mg/g  dry  bean),  while  genisten  is  found  in  black  beans,  green  split  peas 
and  sprouts  (Peterson  &  Dwyer,  1998).  As  with  the  rest  of  the  flavonoid 
family  they  also  undergo  hydroxylation  and  methylation  reactions. 
1.2.2  Non-flavonoid  phenolics 
The  main  non-flavonoid  phenolics  are  derivatives  of  benzoic  and 
cinnarnic  acids  and  their  respective  aldehydes  (Soleas  et  aL,  1997).  Along  with 
the  other  phenylpropanes  they  are  synthesized  by  the  phenylpropanoid 
pathway  (Figure  1).  These  non-flavonoid  phenolics  are  structurally  simpler 
and  are  stored  within  the  cell  vacuoles  of  the  grape.  They  are  easily  extracted 
on  crushing  and  commonly  occur  esterified  to  sugars,  organic  acids,  or  various 
alcohols.  They  are  susceptible  to  substitution  of  the  aromatic  ring  and  also  to 
oxidative  modifications,  thereby  giving  rise  to  a  large  number  of  related 
compounds  (Singleton,  1995). 
1.2.3  Function  &  distribution  in  plants 
Phenolics  and  polyphenolics  are  essential  to  the  plant's  physiology. 
Several  functions  of  compounds  in  plants  have  been  proposed  or 
demonstrated.  Plants  have  evolved  to  produce  flavonoids  to  protect  against 
damage  by  UV-B  light,  fungal  parasites,  herbivores,  pathogens  and  oxidative 
cell  injury.  They  are  also  plant  hormone  secretion  controllers  and  enzyme 
action  inhibitors  (Markham,  1989;  Harborne,  1993).  Flavonoids  also  produce 
stimuli  to  assist  in  pollination  and  are  involved  in  the  regulation  of  pollen  tube 
growth  in  the  stigma,  and  are  able  to  produce  stimuli  to  help  guide  insects  to 
their  food  source  (Cook  &  Samman,  1996).  In  foods,  phenolics  may  play 
important  roles  as  natural  colorants  and  in  their  flavouring  of  compounds. 
They  have  been  reported  to  exhibit  a  wide  range  of  clinically  relevant 
biological  effects,  which  will  be  discussed  in  more  detail  in  this  chapter. Jennifer  McGinn,  2002  Chapter  1,31 
1.2.4  Dietary  intake  of  flavonoids 
The  structural  diversity  of  polyphenols  makes  the  estimation  of  their 
content  in  food  difficult  due  to  the  wide  variation  in  phenolic  content  of 
certain  common  foods  in  the  diet.  Until  recently  our  knowledge  of  flavonoid 
intakes  was  limited  to  the  data  of  KOhnau,  1976,  who  estimated  the  total 
flavonoid  intake  in  the  USA  to  be  approximately  1000  mg/day  (expressed  as 
glycosides)  or  650  mg/day  (expressed  as  aglycones)  consisting  of  primarily  of 
flavonols,  flavanones  and  flavones.  These  values  have  been  widely  quoted  in 
the  literature,  however  they  are  based  on  food  analysis  techniques  now 
considered  inappropriate  and  inaccurate  leaving  the  estimated  dietary  intake  of 
phenolics  open  to  interpretation.  A  range  of  methods  have  been  used  to 
quantify  the  phenolics  present  in  the  diet  but  few  studies  have  examined  more 
than  one  food  group.  In  a  more  recent  study  of  Dutch  people,  using  data  from 
the  Dutch  National  Food  Consumption  Survey,  the  average  dietary  flavonoid 
intake  was  estimated  to  be  approximately  23  mg/day,  as  expressed  as 
aglycones  (Hertog  et  A,  1992),  with  tea  and  onions  being  the  major  sources  at 
48%  and  29%  of  total  intake  respectively.  In  fact,  the  Dutch  investigators 
measured  not  flavonoids  but  selected  flavonols  and  flavoncs.  These  intakes  of 
flavonoid  intake  arc,  therefore,  almost  certainly  a  severe  underestimate.  Red 
wine  and  apples  arc  the  other  main  dietary  sources  of  phenolics  in  the  diet. 
Calculated  flavonol/flavone  intakes  from  other  studies  have  ranged  from  3 
mg/day  in  Finland  to  65  mg/day  in  Japan  (Duthie  et  aL,  2000)  (Table  3).  In 
general,  dietary  intakes  of  flavonols  and  flavoncs  arc  quantitatively  similar  to 
those  of  many  well  recogniscd  micro-nutrients,  such  as  vitamins  E  and  C,  and 
the  overall  flavonoid  intake  may  be  well  in  excess  of  the  traditional  vitamins 
(Duthie  &  Crozier,  2002).  It  should  be  recognised  however  that  there  is 
substantial  potential  for  error  and  bias  in  the  methods  employed  to  estimated 
dietary  intake.  These  are  based  on  subjects'  memories,  competence  and 
honesty.  Under-reporting  is  common  and  the  methods  do  not  provide  details 
on  the  varieties  of  plant  foods  which  may  have  widely  varying  nutrient 
contents. Jennifer  McGinn,  2002  Chapter  1,32 
Table  3  Estimated  flavonol  and  flavone  intake  of  different  countries 
Country  flavonol  &  flavone  intake 
(mg/day  mean  value) 
The  Netherlands  3-33 
Finland  3-6 
USA  13 
Greece  16 
Italy  27 
Japan  16  -65 
Scotland  17 
Wales  26 
Adapted  from  Duthie  &  Duthie,  2000 
1.3  Bioavailability  of  polyphenols 
An  understanding  of  the  absorption  and  bioavailability  of  phenolic 
compounds  is  critical  before  biological  activity  and  nutritional  potential  value 
can  be  estimated.  In  general,  the  absorption,  distribution,  metabolism  and 
excretion  of  dietary  phenolics  in  humans  is  poorly  understood. 
The  rate  and  extent  of  intestinal  absorption  and  metabolism  of  food 
phenolics  are  determined  by  their  chemical  structure,  which  depends  on 
several  factors  including  the  degree  of  glycosylation  and  polymerisation, 
conjugation  with  other  phenolics,  solubility  and  their  basic  structure,  whether 
benzene  or  flavone  derivative  (Bravo,  1998).  Glycosylation  influences  the 
chemical,  physical  and  biological  properties  of  the  polyphenol,  all  factors 
which  influence  its  bioavailability  in  vivo. 
Indirect  evidence  of  their  absorption  through  the  gut  barrier  has  focused 
on  the  increase  in  the  antioxidant  capacity  of  the  plasma  after  the  consumption 
of  polyphenol  rich  food.  This  increase  in  the  antioxidant  capacity  of  plasma 
has  been  shown  following  repeated  consumption  of  tea  (Serafini  et  aL,  1996; 
van  het  Hof  et  aL,  1999)  and  whiskey  (Duthie  et  aL,  1998)  and  red  wine 
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hand,  direct  evidence  on  the  bioavailability  of  a  small  number  of  polyphenols 
has  been  obtained  by  measuring  their  concentrations  in  plasma  and  urine  of 
human  volunteers  following  consumption  of  pure  compounds  and  polyphenol 
rich  extracts  and  beverages,  such  as  onions  (Hollman  et  aL,  1995,1996;  Aziz 
et  A,  1998),  red  wine  (Donovan  et  A,  1999;  Caccetta  et  aL,  2000),  and  green 
and  black  tea  (He  &  Kies,  1994;  Kivitis  et  aL,  1997)  and  flavonol  rich  diets 
(Noroozi  et  A,  2000),  with  evidence  suggesting  that  flavonol  conjugates  are 
absorbed  to  a  greater  extent  than  the  parent  aglycone.  However,  increases  in 
the  concentrations  of  polyphenols  and  associated  metabolites  in  plasma  and 
urine  do  not  inevitably  mean  that  they  have  significant  effects  in  vivo  (Duthie 
&  Crozier,  2002).  While  many  aspects  of  phenolic  and  flavonoid  absorption 
and  metabolism  remain  unknown  at  present,  there  is  adequate  evidence  to 
suggest  that  a  number  of  these  compounds  will  be  absorbed  in  sufficiently 
high  concentrations  to  have  physiological  effects. 
1.4  From  grape  to  glass 
A  number  of  factors  have  been  shown  to  affect  the  level  of  phenolics  in 
grapes  and  their  corresponding  wines  (McDonald  et  Al  1998).  Processing  and 
vinification  are  the  series  of  unit  operations  leading  from  the  initial  crushing  of 
the  grape  to  the  bottling  of  the  finished  wine. 
1.4.1  Vifficulture 
Grape  variety  is  the  first  important  stage  in  the  production  of  wine. 
Phenolics  and  polyphenols  are  derived  from  the  skin  of  the  grape  where  they 
function  as  LJV  protectors.  Thick  skinned  grape  have  the  potential  to  release 
more  polyphenols  than  thin  skinned  grapes.  Today,  wines  are  produced  from 
numerous  grape  varieties  of  grapes,  including  Cabernet  Sauvignon,  Merlot, 
Pinot  Noir,  Rondinella,  Sangiovese,  Grenache,  Tempranillo  and  Carignan 
(Soleas  et  aL,  1997).  The  type  of  grape  used  is  crucial  to  the  characteristics 
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Sunlight  is  the  most  important  climatic  factor  affecting  grape 
development  (Soleas  et  aL,  1997).  High  sunlight  encourages  the  synthesis  and 
accumulation  of  polyphenols.  Grapes  grown  in  the  shade  been  shown  to  have 
a  7-fold  lower  flavonol  content  than  those  grown  in  direct  sunlight  (Price 
, 
et 
A,  1995).  Changes  also  occur  in  anthocyanin  composition  during  ripening 
which  are  significant  to  the  overall  wine  colour  stability. 
Temperature  has  a  pronounced  effect  on  anthocyanin  synthesis  and 
stability  in  grapes,  and  influences  enzyme  function  and  cell  membrane 
permeability  (Soleas  et  aL,  1997).  Warm  conditions  also  increase  sugar 
accumulation  and  amino  acid  content  of  the  maturating  grape.  High  nitrogen 
levels  have  been  shown  to  suppress  anthocyanin  production  levels  with  high 
potassium  levels  affecting  grape  pH  thereby  altering  the  stability  of  colour. 
Over  irrigation  can  double  fruit  yield  and  increase  fruit  size,  however  it  can 
also  reduce  sugar  content  and  increase  acidity  (Soleas  et  aL,  1997). 
1.4.2  trinification 
Red  wine  is  today  produced  on  every  continent.  Its  chemical 
composition  is  profoundly  influenced  by  enological,  techniques  employed  by 
the  winery,  the  country  in  which  it  originates  and  climatic  and  geographical 
factors  influencing  its  development  (McDonald  et  A,  1998). 
Immediately  after  the  harvest  of  the  grapes  from  the  vine,  the  stems, 
leaves  and  grape  stalks  are  removed.  The  gapes  are  then  crushed  to  avoid 
microbial  contamination  and  better  control  of  enzymatic  oxidation.  The  fruit  is 
then  passed  through  a  set  of  rollers,  the  juice  (must),  pulp,  seeds  and  skins  are 
collected  in  vats  ready  for  maceration  and  alcoholic  fermentation  which  allows 
the  rupture  and  release  of  enzymes  from  grape  cells  bound  in  the  skin,  flesh 
and  seeds  (Soleas  et  aL,  1997).  In  red  wine  production,  the  style  of  the  wine 
can  be  altered  dramatically  by  the  duration  and  conditions  of  maceration  and 
fermentation.  It  can  be  quick,  lasting  only  24  hours  to  produce  a  light  rose 
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colouration  and  low  tannin  levels.  Wines  for  long  aging  are  usually  fennented 
for  up  to  21  days,  which  may  decrease  free  anthocyanin  content  but  enhance 
colour  stability  and  aging  potential  (Soleas  et  A,  1997). 
Following  maceration  and  fermentation,  wines  are  pressed  and  heated  to 
improve  the  colour  of  the  wine.  The  temperature  used  depends  on  the  variety 
of  the  grape  and  strength  of  the  wine.  The  wine  is  then  fined  prior  to  blending. 
Fining  agents  (fine  clays,  silica  gels,  albumin)  are  then  added  to  the  wine  to 
remove  or  reduce  any  large  particles  leaving  the  wine  clear  (Soleas  et  aL, 
1997).  This  process  helps  remove  tannins  and  proteins  and  help  prevent  the 
formation  of  sediment  in  the  bottle.  Formation  of  sediment  is  usually  the  sign 
of  a  high  tannin  content  and  a  high  quality  wine.  The  wines  are  then  matured 
in  stainless  steel  vats,  or  in  the  case  of  higher  quality  vintages  in  oak  barrels, 
for  varying  periods  before  being  filtered  and  bottled. 
1.5  Grape  &  wine  phenolics 
Red  wine  is  a  complex  fluid  containing  grape,  yeast  and  oak  derived 
products,  which  may  influence  the  aroma  and  texture  of  the  wine.  The  major 
contributors  to  taste,  aroma  and  texture  are  those  compounds  found  in  higher 
quantities,  such  as  water,  ethanol,  sugars,  organic  acids,  glycerol  and  tannins 
(Soleas  et  aL,  1997).  Wine  contains  8-  15%  ethanol  (v/v)  (German,  2000). 
Although  red  wine  contains  wood  and  yeast  derived  phenolics,  the  greater 
amount  of  phenolics  are  derived  from  the  grape.  Red  wines  are  produced  from 
the  seeds,  flesh  and  skins  of  black  grapes  and  arc  therefore  an  extremely  rich 
source  of  phenolics  (Singleton,  1982).  Red  wines,  in  contrast  to  white  wines 
which  contain  few  components  derived  from  the  skin  and  seeds  of  grapes, 
contain  significant  amounts  of  free  and  conjugated  grape-skin  derived  phenols, 
principally  quercetin  and  myricetin  (Table  4),  as  a  consequence  of  the 
different  variety  of  grapes  used,  climatic  and  cultural  conditions  and 
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Table  4  Typical  composition  of  wines  (%  weight) 
Component  Red  wine  White  wine 
Water  87  87 
Ethanol  10  10 
Other  volatiles  0.04  0.04 
Sugars  0.05  0.05 
Pectins  0.3  0.3 
Glycerol  1.1  1.1 
Acids  0.6  0.7 
Phenols  0.2  0.01 
Amino  acids  0.25  0.25 
Lipids  0.02  0.01 
(Adapted  from  Singleton,  1982) 
The  most  common  flavonoids  in  red  wine  are  the  flavonols,  flavan-3-ols 
and  the  anthocyanins,  (Figure  3)  with  smaller  amounts  of  free  leuco- 
anthocyanins  (flavan-3,4-diols)  also  occurring  (Kinsella  et  aL,  1993).  The 
flavonols  and  anthocyanins  are  derived  from  the  grape  skin  and  the  flavan-3- 
ols,  primarily  from  the  seed  and  stems.  Flavonoids  may  occur  in  the  free  form 
or  polymerised  to  other  flavonoids,  sugars,  non-flavonoids  or  to  a  combination 
of  these  compounds  (Bravo,  1998).  In  red  wine,  flavonoids  commonly 
constitute  more  than  85%  of  the  total  phenol  content  (Soleas  et  aL,  1997), 
compared  to  less  than  20%  in  white  wines. 
Wines  contain  grape-skin  derived  flavonols,  quercetin,  myricetin, 
kaempferol  and  isorhamnetin  (Bums  et  aL,  2000).  Flavonols  are  found  mainly 
as  sugar  conjugates  which  aids  their  solubility  and  subsequent  transport  and 
storage  within  a  tissue,  but  up  to  50%  of  the  flavonols  present  in  red  wines  can 
be  in  the  free  form,  due  to  the  enzymatic  hydrolysis  of  the  conjugates  during 
fermentation  releasing  the  glycone.  In  grapes  and  wine  they  occur  as  0- 
glucosides  and  glucuronides,  typically  bound  to  glucose  or  rhamnose.  The 
total  overall  flavonol  content  of  red  wines  can  range  from  4.5  to  42  mg/L 
(McDonald  et  aL,  1998).  Flavan-3-ols  or  catechins  are  found  in  high 
concentrations  in  the  grape  seeds  and  grape  stem  tissue.  However,  the  grape 
skins  are  the  primary  source  of  catechins  due  to  the  ease  of  transfer  of Jennifer  McGinn,  2002 
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Figure  3  Structure  of  the  major  phenolics  present  in  red  wine Jennifer  McGinn,  2002  Chapter  1,38 
phenolics  from  skins  into  wines  during  manufacturing.  Catechins  are  also 
found  as  gallate  esters  or  as  oligomers  and  polymers  also  known  as  condensed 
tannins.  Additional  hydroxylation  of  the  catechin  structure  leads  to  the 
formation  of  gallocatechins.  Both  the  gallate  esters  and  gallocatechins  are 
found  in  very  low  levels  in  grapes,  which  decrease  further  during  ripening  and 
wine  maturation  (Singleton,  1982). 
Anthocyanins  are  responsible  for  the  colouring  of  black  grapes  and  red 
wine.  They  are  absent  in  white  wine  due  to  a  synthetic  blockage  in  the 
Shikimate  pathway  (Soleas  et  aL,  1997)  and  due  to  the  process  of  removing 
the  skin  of  the  grapes  during  the  manufacturing  of  white  wine.  The  amount 
and  concentration  of  anthocyanins  in  red  grapes  depends  on  the  variety  of 
grape,  climate,  grape  maturity  and  geographical  factors  (McDonald  et  aL, 
1998).  The  anthocyanins  reported  in  red  grapes  are  primarily  malvidin  and  the 
3-0-glucosides  of  cyanidin,  peonidin,  delphinidin  and  petunidin  (Bums  et  aL, 
2000).  During  the  aging  of  red  wine  the  levels  of  anthocyanins  decline  as  they 
undergo  condensation  reactions  being  converted  to  more  stable,  darker 
oligomeric  and  polymeric  pigments. 
The  major  non-flavonoid  phenolics  found  in  red  wine  are  the 
hydroxybenzoic  acid  derivates  and  phenolic  acids  (Figure  3),  especially  gallic 
acid  and  its  ellagic  acid  dimer,  hydroxycinnarnates  and  stilbenes,  all  which 
have  similar  biosynthetic  origins  (Soleas  et  aL,  1997).  The 
hydroxycinnamates,  caffeic  acid  and  ferulic  acid,  are  stored  in  the  cell 
vacuoles  of  the  grape  flesh  and  are  easily  extracted  during  the  manufacture  of 
both  white  and  red  wine.  They  are  usually  found  in  wines  esterified  to  sugars, 
organic  acids  and  various  alcohols.  Gallic  acid  is  present  in  the  flesh  of  both 
white  and  black  grapes  and  is  therefore  a  constituent  of  both  white  and  red 
wines,  although  it  is  present  in  a  5-  to  10-fold  higher  concentrations  in  red 
wine  (Frankel  et  aL,  1995).  The  stilbene,  trans-resveratrol  (3,5,4'- 
trihydroxystilbene)  is  also  present  in  red  wine.  Over  30  stilbene  and  stilbene 
glycosides  are  known  to  occur  in  a  restricted  distribution  in  the  plant  kingdom 
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functioning  as  a  phytoalexin  in  grapes  where  it  accumulates  in  the  skin  in 
response  to  response  to  fungal  infection  (Kopp,  1998).  Within  the  cells  of 
grape  skins  resveratrol  is  principally  found  conjugated  to  glucose  and  is 
known  as  trans-resveratrol-3-0-p-glucoside  (Soleas  et  aL,  1997b).  The 
presence  of  the  cis  isomer  of  both  free  and  conjugated  resveratrol  has  also 
been  reported  in  red  wine.  Although  present  in  red  wine,  trans-resveratrol  is 
found  in  lower  levels  than  many  other  phenolics  (Soleas  et  aL,  1997b). 
The  concentration  of  phenolics  in  wine  increases  during  skin 
fermentation  and  consequently  begins  to  fall  as  the  phenols  bond  and 
precipitate  with  proteins  and  yeast  cell  remnants,  not  removed  during 
filtration.  In  the  making  of  red  wine,  with  prolonged  extraction,  the  fermented 
grape  juice  can  contain  up  to  40%  of  the  phenolics  originally  present  in  the 
grapes  (Duthie  &  Crozier,  2002).  During  fining  and  maturation  of  the  wine, 
the  phenol  content  continues  to  decrease,  with  the  ageing  of  the  wine  having  a 
further  dramatic  effect  on  the  final  phenolic  content  (Soleas  et  A,  1997).  Both 
these  enological  techniques  and  climatic  and  geographical  factors  therefore 
not  only  influence  the  taste,  fragrance  and  texture  of  the  wine  but  also  the 
phenolic  content  which  may  in  the  long-term  lead  to  benefits  in  health. 
1.6  Alcohol  &  health 
Alcohol  has  been  consumed  through  the  ages  because  of  its  perceived 
benefits  as  a  social  lubricant  and  for  relaxation,  mood  alteration  and  sensory 
pleasure  (Friedman  &  Klatsky,  1993),  but  long-term  consumption  of  large 
amounts  of  alcohol  is  harmful,  and  may  lead  to  addiction,  aggressive 
behaviour  and  suicide.  Today  there  is  much  controversy  surrounding  the  use 
of  alcohol  in  society.  The  public  health  issue  of  limiting  alcohol  use  is  not 
questioned. 
The  ever-increasing  human  and  economic  cost  of  coronary  heart  disease 
(CHD)  has  promoted  extensive  investigation  into  the  associated  risk  factors 
such  as  diet,  exercise,  lifestyle  and  alcohol  consumption.  Epidemiological Jennifer  McGinn,  2002  Chapter  1.40 
studies  have  consistently  shown  an  apparent  protective  association  between 
light  to  moderate  alcohol  consumption,  and  the  incidence  of  atherosclerosis 
CHD,  but  the  interpretation  of  these  findings  remain  a  subject  of  much  debate. 
In  the  last  decade,  a  number  of  large  scale  epidemiological  studies  have 
indicated  that  moderate  alcohol  consumption  is  associated  with  a  reduced  risk 
of  coronary  heart  disease  (CHD)  and  overall  mortality  (Jackson  et  aL,  1991; 
Rimm  et  aL,  1991;  Cullen  et  aL,  1993;  Woodward  &  Tunstall-Pedoe,  1995; 
McElduff  &  Dobson,  1997;  Thun  et  aL,  1997),  while  a  very  small  majority 
others  have  shown  little  or  no  association  (Kaufman  et  aL,  1985).  Evidence 
has  been  provided  by  socio-economic  studies  as  well  as  retrospective  or 
prospective  observation  studies.  It  is  widely  accepted  that  it  is  difficult  to 
collect  accurate  data  on  alcohol  consumption.  The  methods  of  assessing 
alcohol  intake  vary  widely  in  different  studies  (Marmot  &  Brunner,  1991). 
Methods  for  analysing  alcohol  intake  and  CHD  and  mortality  include  standard 
qualitative  questionnaires  of  the  frequency,  quantity  and  type  of  alcohol 
consumed,  smoking,  medical  history  and  lifestyle,  7-day  alcohol  and  food 
recall  questionnaires  and  24  hour  recall  studies.  These  studies  are  therefore 
open  to  potential  substantial  bias  and  error  in  the  methods  employed  to 
estimate  alcohol  consumption.  Under-reporting  of  alcohol  intake  is  common 
and  is  based  on  subject's  honesty,  competence  and  memories.  The  evidence 
suggests  that  ingestion  of  two  alcoholic  drinks  per  day  (15-20  g/day)  is 
associated  with  reduced  mortality  and  maybe  protective  against  coronary  heart 
disease.  The  consumption  of  more  than  four  drinks  per  day  (>34  g/day)  may 
be  associated  with  an  increase  in  overall  mortality  risk  (Mannot  et  aL,  1981). 
Analysis  of  the  relationship  between  reported  alcohol  consumption  and 
subsequent  mortality  persists  after  the  removal  of  the  confounding  factors, 
age,  cigarette  smoking,  blood  pressure,  plasma  cholesterol  and  grade  of 
employment  (Marmot  et  aL,  1981)  and  social  class  (Shaper  et  aL,  1988). 
The  well-known  U-shaped  curve  of  mortality  indicates  that  moderate 
alcohol  intake  may  confer  protection  against  cardiovascular  disease  in  general 
and  particularly  against  heart  attacks  (Sharper  et  A,  1988).  This  curve Jennifer  McGinn,  2002  Chapter  1,41 
describes  the  relationship  between  alcohol  consumption  and  risk  of  death  from 
all  cause  mortality.  Heavy  drinkers  are  seen  to  have  an  increased  risk  of  death 
compared  with  moderate  drinkers,  but  moderate  drinkers  to  have  a  lower 
mortality  than  that  of  abstainers  (non-drinkers)  (Sharper  et  aL,  1988). 
However  the  classification  of  abstainers  and  non-drinkers  includes  those  who 
have  stopped  drinking  due  to  ill  health  and  therefore  have  an  increased  rate  of 
disease,  those  who  may  die  soon  and  those  who  are  at  higher  risk  of  mortality 
due  to  other  reasons  (Klatsky,  2001).  Either  of  these  groups  may  account  for 
the  higher  risk  among  non-drinkers  and  therefore  give  the  CHD  and  alcohol 
mortality  curve  its  distinctive  shape.  The  higher  risk  of  CHD  in  non-drinkers 
could  also  be  due  to  inaccurate  alcohol  histories  if  drinkers  at  high  risk  declare 
themselves  to  be  non-drinkers  or  life  long  abstainers  (Mannot  &  Brunner, 
1991).  In  the  relationship  between  alcohol  consumption  and  total  mortality,  a 
number  of  potential  confounders  could  influence  the  shape  of  the  curve.  These 
include  the  characteristics  and  potential  misclassification  of  the  study 
population,  misclassification  of  alcohol  intake  and  the  level  of  alcohol 
consumption  associated  with  the  lowest  risk  of  mortality  for  the  study 
population  (Mannot  &  Brunner,  1991).  Alcohol  is  believed  to  confer 
protection  against  CHD  through  a  number  of  mechanisms  working  in  synergy. 
These  cardio-protective  mechanisms  include  the  ability  to  inhibit  lipid 
peroxidation  and  increase  the  levels  of  "protective"  high  density  lipoprotein 
cholesterol  (HDL),  to  reduce  platelet  aggregation,  to  decrease  the  permeability 
and  increase  the  stability  of  capillaries  and  to  interact  with  the  pathway  that 
generates  nitric  oxide  (NO)  from  vascular  endothelium. 
A  reduction  in  risk  of  coronary  heart  disease  has  been  attributed 
separately  to  beer  (Yano  et  aL,  1977),  to  spirits  (Hennekens  et  aL,  1979),  and 
to  most  notably  wine  (Rosenberg  et  aL,  1981;  Rimm  et  A,  1996;  Gronback, 
1997;  Criqui,  1998).  Protective  effects  have  also  been  ascribed  to  ethanol  itself 
rather  than  other  substances  found  in  each  type  of  drink.  However,  a  weak 
inverse  relationships  between  red  wine  and  CHD  mortality  may  indicate  that 
with  its  abundant  content  of  polyphenols  and  phenolic  acids  red  wine  confers 
additional  health  benefits,  over  and  above  ethanol  and  other  alcoholic  drinks. Jennifer  McGinn,  2002  Chapter  1,42 
1.7  Physiological  activity  of  grape  polyphenols 
1.7.1  Antioxidants:  mechanism  of  action 
Oxygen  is  essential  to  maintain  life,  but  it  can  also  have  adverse  effects 
if  the  number  of  highly  reactive  oxygen  containing  radicals  exceeds  the  needs 
of  the  cell  or  are  not  trapped  adequately  (Halliwell,  1997).  Metabolic  activities 
produce  free  radicals,  unstable  molecules  able  to  react  with  electron  donors  to 
equilibrate  its  charge  (Rice-Evans,  2001).  This  reaction  is  essential  for  the 
synthesis  of  nucleic  acids,  hormones  and  proteins.  Free  radicals  are  also 
produced  to  intercept  cell  invaders  like  microbes  and  viruses. 
The  oxidation/antioxidation  balance  is  highly  regulated.  Oxidation  is  the 
transfer  of  electrons  from  one  atom  to  another  and  represents  an  essential  part 
of  aerobic  life  and  metabolism.  Oxidative  stress  induced  by  an  overproduction 
of  reactive  oxygen  species  (ROS)  and  leads  to  the  disruption  of  cellular 
functions  (Halliwell,  1997).  Reactive  oxygen  species  or  free  radicals  include 
the  hydroxyl  radical  (OH),  superoxide  radical  (02'-),  peroxyl  radical  (ROO-) 
and  nitric  oxide  (NO)  (Pietta,  2001).  These  ROS  are  produced  from 
endogenous  sources,  such  as  electron  transport  chains,  peroxisomes  and  the 
cytochrome  P-450  system  (Wiseman  et  aL.  1997).  ROS  can  reactive  together 
with  other  molecules  to  form  more  or  less  reactive  molecules.  Free  radicals 
can  also  be  generated  by  the  external  action  of  toxic  substances,  ozone,  UV 
radiation,  cigarette  smoke  or  intensive  exercise  (Dufresne  &  Farnworth,  2001). 
ROS  have  different  functions  in  vivo  (Pietta,  2000).  They  are  identified 
to  be  involved  in  energy  production,  phagocytosis,  regulation  of  cell  growth 
and  the  synthesis  of  biologically  important  compounds  (Halliwell,  1997). 
However,  ROS  may  be  damaging,  altering  lipids  in  cell  membranes, 
decreasing  their  capacity  to  protect  cell  contents,  proteins  in  tissues  and 
enzymes,  carbohydrates  and  DNA,  inducing  oxidations  which  cause 
membrane  damage,  protein  and  enzyme  modifications  and  DNA  damage 
(Pietta,  2000).  This  oxidative  damage  is  considered  to  play  a  causative  role  in Jennifer  McGinn,  2002  Chapter  1,43 
aging  and  degenerative  diseases  (Halliwell  &  Gutterridge,  1998).  The 
oxidation  of  nucleic  acids  bases  in  DNA  induces  mutations  and  heightens  the 
risk  of  cancer  occurrence.  Although  cells  possess  enzymatic  and  cellular 
protection  against  ROS,  antioxidants  from  nutrients  obtained  from  the  diet, 
both  vitamin  and  mineral,  contribute  highly  to  the  overall  protection  of  cell 
integrity  and  immune  function  (Pietta,  2000). 
Humans  have  evolved  antioxidant  systems  to  protect  against  free 
radicals.  There  are  a  number  of  antioxidant  defence  mechanisms  that  can 
decrease  the  adverse  effects  of  ROS.  These  mechanisms  produced  in  the  body 
and  obtained  from  the  diet  are  able  to  either  suppress  free  radical  formation 
and  chain  initiation  or  to  scavenge  free  radical  and  chain  propagation  (Pietta, 
2000).  These  include  the  binding  of  metal  ions  needed  for  catalysis  of  ROS 
generation,  the  scavenging  of  ROS  and  their  precursors,  the  up-regulation  of 
endogenous  antioxidant  enzymes  and  the  repair  of  oxidative  damage  to 
biological  molecules  (Morton  et  al,  2000).  Some  antioxidants  react  readily 
with  free  radicals,  quenching  them  before  they  can  react  with  other  cell 
components  (free  radical  scavenging).  Antioxidant  defence  mechanisms  also 
include  the  enzymes,  superoxide  dismutase,  which  removes  superoxide 
radicals,  gluthathione  peroxidase,  which  converts  hydrogen  peroxide  to  water, 
and  catalase,  which  breaks  down  hydrogen  peroxide  (Morton  et  al.,  2000). 
These  defence  mechanisms  are  complementary  to  each  other  since  they  act 
against  different  species  at  different  cellular  components  (Pietta,  2000). 
1.7.2  Red  wine  as  an  antioxidant 
Polyphenols  are  multifunctional  and  can  act  as  reducing  agents, 
hydrogen  donating  antioxidants,  singlet  oxygen  quenchers  (Rice-Evans  et  aL, 
1996)  and  chelators  of  metal  ions,  preventing  metal-catalysed  formation  of 
initiating  radical  species.  The  efficiency  of  polyphenols  as  antioxidants 
depends  greatly  on  their  chemical  structure.  For  a  polyphenol  to  be  classed  as 
an  antioxidant,  two  basic  conditions  must  be  met.  Firstly,  when  present  in  low 
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delay,  retard  or  prevent  the  autoxidation  or  free  radical-mediated  oxidation  of 
the  substrate  (Salah  et  A,  1995).  Secondly,  the  free  radical  formed  after 
scavenging  must  be  stable,  either  through  intramolecular  hydrogen  bonding  or 
by  further  oxidation  (Shahidi  &  Wanasundara,  1992).  The  position  and 
number  of  free  hydroxyl  groups  (OH)  in  flavonoids  are  responsible  for  their 
antioxidant  activity.  In  general,  optimal  antioxidant  activity  is  associated  with 
multiple  phenol  groups,  especially  at  3'  and  4'  positions,  a  carbonyl  group  at 
C4,  and  a  free  C2  and  C3  double  bond.  If  the  Y-011  group  is  bound 
glycosidically  or  is  absent,  the  antioxidant  activity  is  weakened  (Herrmann, 
1976).  The  antioxidant  effect  increases  with  the  number  of  hydroxyl  groups  in 
rings  A  and  B  (Kiihnau,  1976). 
The  focus  on  phenolics  is  largely  due  to  the  finding  that  the  antioxidant 
properties  of  these  non-alcoholic  compounds  may  delay  the  onset  of 
atherogenesis  and  CHD,  by  reducing  chemically  and  enzymatically  mediated 
peroxidative  reactions  and  being  able  to  down-regulate  thrombotic  tendencies. 
Although  there  is  conflicting  evidence,  the  majority  of  studies  have  shown  that 
the  consumption  of  red  wine  inhibits  low-density  lipoprotein  (LDL)  oxidation 
in  vitro  (Frankel  et  al.,  1993;  Kanner  et  al.,  1994;  Kerry  &  Abbey,  1997)  and 
in  vivo  (Furhman  et  al.,  1995;  Day  et  al.,  1997;  Nigdikar  et  al.,  1998).  It  also 
promotes  an  overall  increase  in  plasma  levels  of  apoliprotein  A-I  and  high- 
density  lipoprotein  cholesterol  (HDL)  which  is  an  important  anti-atherogenic 
factor,  which  inhibits  the  uptake  of  LDL  and  is  involved  in  the  normal 
clearance  of  cholesterol  from  the  tissues.  The  antioxidant  activity  of  red  wines 
has  been  attributed  to  its  phenolic  components,  as  research  has  shown  that 
wines  devoid  of  phenolics  do  not  inhibit  LDL  oxidation  in  vitro  (Maxwell  et 
aL,  1994). 
It  has  also  been  shown  that  red  wine  ingestion  increases  human  serum 
antioxidant  capacity  and  activity  (Maxwell  et  aL,  1994;  Day  et  A,  1997). 
Whitehead  et  aL,  (1995),  reported  that  after  the  ingestion  of  300mL  of  red 
wine,  the  mean  serum  antioxidant  capacity  is  increased  by  18%  after  1  hour 
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and  7%  increases  respectively.  Alcohol-free  red  wine  has  also  been  shown  to 
display  a  stronger  in  vitro  antioxidant  capacity  than  alcohol-free  white  wine, 
reaching  peak  levels  between  30  and  90  minutes  and  remaining  above  basal 
levels  even  after  2-4  hours.  The  only  consistent  difference  between  red  and 
white  wines  being  the  phenolic  content,  which  was  20  times  higher  in  red  wine 
(Serafini  et  aL,  1998).  It  is  therefore  evident  that  the  changes  in  plasma 
antioxidant  capacity  may  be  entirely  attributable  to  the  phenolic  fraction  of  the 
wine.  Based  on  the  calculations  of  Panganga  et  aL,  (1999),  the  antioxidant 
activity  in  a  glass  of  red  wine  (150  mL)  is  equivalent  to  the  antioxidant 
activity  of  12  glasses  of  white  wine,  2  cups  of  tea,  500  mL  of  beer  and  7 
glasses  of  orange  juice. 
A  recent  comparison  of  the  effects  of  consumption  of  100  mL  of  an  aged 
malt  whisky  with  that  of  the  100  mL  of  red  wine  by  9  fasted  volunteers, 
indicated  that  both  beverages  increased  plasma  antioxidant  capacity  (Duthie  et 
A,  1998).  Blood  and  urine  samples  were  obtained  up  to  4  hours  following 
consumption.  The  increase  was  greater  with  red  wine  consumption,  but  despite 
the  Mold  greater  concentration  of  phenolics  in  the  wine,  both  beverages 
produced  similar  increases  in  the  total  plasma  phenolic  content,  suggesting 
that  a  proportionally  greater  amount  of  phenolics  were  absorbed  from  the 
whisky  than  from  the  red  wine.  This  effect  could  be  ascribed  to  the  greater 
alcohol  content  of  the  whisky  aiding  phenolic  absorption,  suggesting  a 
separate  and  specific  role  for  the  alcoholic  fraction  of  wine  (Duthie  et  aL, 
1998). 
1.7.3  Red  wine  &  platelet  function 
Other  potential  mechanisms  contributing  to  the  cardio-protective  effects 
of  moderate  alcohol  consumption,  and  more  specifically  red  wine 
consumption,  include  alterations  in  blood  platelet  function,  coagulation  and 
fibrinolysis.  Alcohol  appears  to  affect  several  factors  involved  in  maintaining 
the  balance  between  clot  formation  to  protect  against  bleeding  and  clot 
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implicated  as  a  risk  factor  in  the  development  of  CHD  (Rotondo  &  de 
Gaetano,  2000). 
Alcohol  consumption  has  been  associated  with  increased  levels  of  tissue 
plasminogen  activator  (tPA),  the  clot-dissolving  enzyme  and  lower  levels  of 
fibrinogen,  anti-thrombin  III  and  anti-atherogenic  fraction  apoAl  (Renaud  & 
Ruf,  1996).  The  reduce  susceptibility  of  platelets  to  aggregation  has  been 
reported  after  alcohol  consumption.  The  anti-aggregation  action  of  daily 
alcohol  consumption  was  the  mechanism  originally  proposed  to  account  for 
the  low  incidence  of  CHD  mortality  in  French  populations  (Renuad  &  de 
Lorgeril,  1992)  prior  to  the  involvement  of  LDL  oxidation  and  subsequent 
increases  in  HDL,  which  are  thought  to  account  for  only  50%  of  the  protective 
effect  of  red  wine  consumption  and  reduced  CHD.  The  remaining  50%  being 
attributed  to  the  effects  of  alcohol  on  platelet  function  (Renaud  &  Ruf,  1996). 
Polyphenols  from  grapes  and  those  present  in  red  wine  contains 
compounds  that  may  slow  the  process  of  platelet  aggregation.  The  platelets  of 
both  dogs  and  monkeys  exhibited  significantly  reduced  ability  to  aggregate 
after  being  fed  grape  juice,  whereas  the  same  volumes  of  orange  and 
grapefruit  juice  had  no  effect  (Osman  et  aL,  1998).  Similarly,  rats  fed  red  wine 
or  red  wine  phenolics  showed  increased  bleeding  times  in  vivo  and  in  vitro  and 
decreased  platelet  aggregation  as  compared  to  rats  fed  either  white  wine  or 
ethyl  alcohol  (Wollyn  et  aL,  1999).  Likewise  in  vitro  incubation  and  oral 
supplementation  in  healthy  human  subjects  with  purple  gape  juice  and 
selected  derived  flavonoids  have  also  shown  to  decrease  platelet  aggregation, 
increase  platelet-derived  NO  release  and  decrease  superoxide  production 
(Freedman  et  A,  2001).  The  administration  of  red  wine  and  gape  juice  in 
stenosed  dog  coronary  arteries  was  found  to  inhibit  in  vivo  platelet  activity  and 
thrombosis  when  administered  both  intravenously  (1.6  mg/mL,  13%  alcohol  in 
200  mL  saline)  and  intragastrically  (4  mL/Kg)  (Demrow  et  aL,  1995)  using  the 
Folts  coronary  thrombosis  model  of  platelet  aggregation  (Antiplatelet 
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of  the  red  wine  and  grape  juice  to  the  bloodstream  where  they  were  able  to 
remove  the  effects  of  metabolism  and  absorption  of  the  red  wine  and  grape 
products.  The  results  therefore  cannot  be  regarded  as  being  completely 
relevant  to  standard  feeding  studies.  Administration  of  white  wine  at  the  same 
concentrations  had  no  effect  on  platelet  activity,  suggesting  that  there  are 
compounds  present  in  grape  juice  and  red  wines  which  are  not  present  in  white 
wine,  which  are  anti-thrombotic  and  platelet  inhibitory.  Both  grape  juice  and 
red  wine  components  were  also  effective  as  anti-thrombotic  and  antiplatelet 
agents  when  administered  directly  to  the  stomach  of  the  dog,  indicating  that 
the  active  ingredients  are  absorbed  and  transported  to  the  bloodstream 
(Demrow  et  aL,  1995). 
The  mechanism  by  which  polyphenols,  from  red  wine  and  grape  juice, 
exert  these  actions  appear  to  be  multiple  and  poorly  understood.  Polyphenols 
have  been  shown  to  inhibit  the  production  of  thromboxane  A2  (TXA2),  which 
is  formed  in  platelet  by  means  of  the  cyclo-oxygenase  (COX)  pathway  and  is  a 
powerful  proaggregatory  agent  and  vasoconstrictor  of  smooth  muscle  cells 
(Vanhoutte,  1989)  (Figure  4).  On  the  other  hand,  nitric  oxide  (NO)  activates 
guanylyl  cyclase  in  platelets,  increasing  the  levels  of  the  intracellular 
messenger,  cGMP.  This  increases  platelet  aggregation  inhibition,  by  a 
reduction  in  the  intracellular  free  calcium  (Ca2)  concentration.  Prostacyclin 
(PG12)  causes  the  same  effect  through  adenylyl  cyclase  activation,  which 
increases  intracellular  levels  of  cAMP,  which  as  before  lowers  the  platelet 
intracellular  calcium  levels  and  decreases  in  vivo  platelet  activity  (Vanhoutte, 
1989;  Marin  &  Rodriguez-Martinez,  1995)  (Figure  4).  Increases  in 
intracellular  calcium  concentration  from  extracellular  sources  and  the 
mobilisation  of  intracellular  stores,  is  the  crucial  step  for  the  activation  of  the 
cyclo-oxygenase  pathway  and  endothelial  nitric  oxide  synthase  (eNOS) 
(Martin  et  aL,  2002). 
The  structural  feature  required  for  polyphenols  to  inhibit  platelet 
aggregation  are  similar  to  those  associated  with  their  antioxidant  function. Jennifer  McGinn,  2002 
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Figure  4  The  mechanism  of  platelet  aggregation  inhibition  by  red  wine 
Polyphenols  stimulate  increases  in  the  [(Ca  2+)i,  concentration  which  leads  to 
activation  of  eNOS  and  the  cyclo-oxgenase  pathway. 
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They  include  a  double  bond  between  C2  and  C3,  a  3'-OH  group  and  a 
carbonyl  group  on  C4  (Rotondo  &  de  Gaetano,  2000). 
1.7.4  Vasorelaxation  &  cardiovascular  protection 
The  relaxation  of  the  arterial  smooth  muscle  produced  by  some  wines 
and  grape  products  appears  to  involve  the  endothelium-derived  relaxing  factor 
(EDRF),  which  was  first  described  by  Furchgott  &  Zawadzki  in  1980.  The 
EDRF  involved  in  the  relaxation  produced  by  plant  derived  products  was 
subsequently  determined  to  be  nitric  oxide  (NO)  or  a  NO  derivative  (Palmer  et 
A,  1987). 
NO  has  been  implicated  in  a  wide  range  of  physiological  roles  in  the 
cardiovascular  system.  Endothelial  NO  plays  an  important  role  in  regulating 
vascular  tone  and  myocardial  contractility,  maintaining  endothelial  integrity, 
inhibiting  platelet  aggregation  and  maintaining  normal  functioning  of  the 
cardiovascular  system  (Loscalzo  &  Welch,  1995).  Dysregulation  of  NO 
production  may  play  a  role  in  the  pathogenesis  of  several  cardiovascular 
disorders.  Therefore,  enhancement  of  NO  production  may  be  useful  in 
preventing  or  blocking  the  progression  of  atherosclerosis,  CHD  and  other 
diseases  in  which  there  is  endothelium  dependant  relaxation  impairment,  such 
as  hypertension  and  diabetes  mellitus  (Stoclet  et  aL,  1997;  Rakhit  &  Marber, 
2001). 
The  vascular  endothelial  cell  is  able  to  produce  and  release  several 
mediators  that  act  at  different  sites  on  the  adjacent  smooth  muscle  cell  to 
modulate  local  vascular  tone  (Ziegler  et  aL,  1995).  The  release  of  these 
mediators  is  influenced  by  several  factors  and  multiple  homeostatic 
mechanisms,  determine  the  overall  balance  between  endothelial-derived 
vasoconstricting  and  vasodilating  influences.  NO  is  produced  by  the 
endothelial  cell  during  the  conversion  of  L-Arginine  to  L-Citrulline,  a  reaction 
catalysed  by  the  enzyme  by  nitric  oxide  synthase  (NOS)  (Ziegler  et  aL,  1995). 
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controls  and  mediates  local  vascular  tone.  Nitric  oxide  also  plays  a  major  role 
in  determining  the  resting  vascular  tone  of  coronary  resistance  vessels, 
regulates  basal  pulmonary  vascular  resistance  and  is  responsible  for  the 
autoregulation  of  blood  flow  in  several  organ  systems  including  the  brain, 
heart  and  kidney  (Loscalzo  &  Welch,  1995).  Vascular  endothelial  cells  also 
produce  NO  in  response  to  physiological  stimuli,  including  changes  in  oxygen 
tension,  shear  stress,  thrombin  and  the  platelet  products,  ADP  and  serotonin 
(Stoclet  et  aL,  1997).  Nitric  oxide  therefore  plays  a  major  role  in  protection  of 
the  cardiovascular  system  but  excessive  nitric  oxide  production  may  by 
deleterious  and  may  cause  vascular  collapse  (Stoclet  et  aL,  1997).  Large  tissue 
nitric  oxide  concentrations  may  be  cyctotoxic.  The  breakdown  and 
bioavailability  of  nitric  oxide  can  be  reduced  and  removed  by  its  reaction  with 
superoxide  anion  (02)  yielding  peroxynitrite  and  peroxynitrous  acid,  instable 
molecules  which  are  potent  oxidants  (Benito  et  aL,  2002). 
After  formation,  NO  rapidly  diffuses  from  its  site  of  synthesis,  in  the 
endothelial  cell,  to  neighbouring  smooth  muscle  cells  where  it  "activates"  its 
target  enzyme,  soluble  guanylate  cyclase  (GC),  resulting  in  an  increased 
smooth  muscle  cell  concentration  of  cGMP.  Generated  cGMP  then  initiates  a 
cascade  of  intracellular  events  which  stimulates  protein  kinase  G  (PKG),  via 
phosphorylation,  which  results  in  the  vasodilation  of  the  smooth  muscle  cell 
(Ziegler  et  A,  1995)  (Figure  5).  cGMP  is  continually  hydrolyzed  and 
inactivated  within  the  smooth  muscle  cell  by  phosphodiesterase  (PDE) 
enzymes.  Therefore  the  continued  release  of  NO  and  production  of  cGMP  is 
important  in  maintaining  basal  tone  in  vascular  beds  (Marin  &  Rodriguez- 
Martinez,  1995).  In  response  to  endothelial-dependent  vasodilators,  the  basal 
production  of  NO  is  increased  significantly  (Ziegler  et  aL,  1995). 
1.7.5  Red  wine  &  vasorelaxation 
In  addition  to  the  proposed  effects  of  regular  moderate  wine 
consumption  on  blood  lipid  changes  and  platelet  function,  a  small  number  of 
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may  affect  blood  vessel  function.  This  may  be  a  third  potential  explanation  for 
the  French  Paradox. 
The  vascular  endothelium  lies  at  the  interface  between  the  circulating 
blood  cells  and  the  vascular  smooth  muscle  cells,  responding  to  vaso-active 
stimuli,  blood  flow  and  stress  (Stoclet  et  aL,  1997).  Wine  as  an  ethanol- 
containing  beverage,  is  well  known  to  affect  blood  flow  in  the  vascular  system 
(Fitzpatrick  et  A,  1993).  However,  the  non-alcoholic  phenolics  present  in  red 
wine  affect  vascular  blood  flow  and  endothelial  function  to  a  greater  extent 
than  alcohol  alone  indicating  that  the  beneficial  effects  are  independent  of  the 
ethanol  component  (Fitzpatrick  et  aL,  1995). 
The  active  components  responsible  for  this  vasorelaxing  activity  of  wine 
and  grape  products  are  believed  to  be  derived  from  the  skin  of  the  grape 
(Fitzpatrick  et  aL,  1993).  Therefore  the  findings  that  red  wines  are  better 
vasorelaxants  than  white  wines  may  be  attributable  to  the  fact  that  the  grape 
skins  are  removed  before  fermentation  in  the  production  of  white  wines,  but 
left  intact  in  red  wine  production  allowing  a  longer  time  period  for  the 
extraction  of  the  vaso-active  grape  skin  components  into  the  wine  must 
(Soleas  et  aL,  1997). 
The  ability  of  red  wine  polyphenols  to  induce  NO-mediated  responses 
was  first  reported  by  Fitzpatrick  et  al,  (1993)  who  studied  the  vasorelaxant 
effects  of  wine  and  grape-derived  polyphenols  in  isolated  rat  aortic  rings. 
Studies  have  showed  that  certain  wines,  grape  juices  and  grape  skin  extracts 
were  able  to  relax  precontracted  smooth  muscle  of  intact  aortic  rings,  an  effect 
which  was  dependent  upon  the  presence  of  intact  endothelium.  The  extracts 
also  increased  smooth  muscle  cell  concentrations  of  cGMP,  both  relaxation 
and  increases  in  cGMP  levels  were  reversed  by  inhibitors  of  NO  synthase, 
indicating  that  relaxation  was  mediated  by  the  NO/cGMP  pathway  (Fitzpatrick 
et  A,  1995,  Andriambeloson  et  A,  1997,  Cishek  et  A,  1997). Jennifer  McGinn,  2002 
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Recent  studies  have  shown  that  the  endothelium-dependent 
vasorelaxation  of  the  rat  aorta  by  red  wine  polyphenols  is  mediated  by  an 
increase  in  the  NO  aortic  content,  with  the  NO  increase  due  to  an  enhancement 
of  NO  synthesis  rather  than  increased  protection  against  breakdown  by 
superoxide  radicals  (02)  (Andriambeloson  et  aL,  1997b,  Benito  et  aL,  2002). 
It  was  also  noted  that  despite  their  comparable  antioxidant  activity  in  red  wine, 
leucocyanidol  (flavan-3,4-ol)  but  not  the  structurally  closely  related  catechin 
(flavan-3-ol)  relaxed  the  endothelium.  suggesting  that  the  antioxidant 
properties  of  polyphenols  are  not  involved  in  their  vasodilatory  effects 
(Andriambeloson  et  aL,  1998).  Therefore  some  components  of  red  wine 
contribute  to  the  prevention  and  treatment  of  cardiovascular  diseases  by 
increasing  NO  levels  in  the  vascular  system  without  increasing  02'  production, 
and  the  subsequent  formation  of  peroxynitrite-derived  pro-oxidants  (Benito  et 
aL,  2002). 
It  is  well  established  that  increases  in  intracellular  C2+  concentrations 
[(Ca2)i]  within  the  endothelial  cell  is  critical  step  for  the  activation  of 
endothelial  NO-synthase  leading  to  the  production  of  NO  and  the  subsequent 
endothelium-dependent  vasorelaxation  (Andriambeloson  et  aL,  1999,  Martin 
et  aL,  2002).  Therefore  the  increases  in  [(Ca2)i]  can  be  due  to  either  an  influx 
of  extracellular  C2+,  to  a  release  of  Ca2+  from  intracellular  stores  or  both. 
Vasorelaxation  was  abolished  after  removal  of  cxtracellular  Ca2+  from  the 
medium  and  the  presence  of  a  Ca2+-entry  blockcr,  indicating  that  C2+  influx 
from  extracellular  stores  via  voltage-independent  channels  is  the  critical  step 
involved  in  vasodilation  with  red  wine  and  grape  products  (Stoclet  et  aL, 
1999,  Martin  et  A,  2002).  Phospholipase  C  (PLC)  and  Tyrosinc  Kinase  (TK) 
arc  both  thought  to  be  implicated  in  this  Ca2+  signalling  (Martin  et  al.,  2002) 
with  red  wine  and  grape  products.  It  has  also  been  suggested  that  the 
inhibitory  effect  of  polyphenols  on  PDE's  involved  in  the  breakdown  of 
vasodilatory  cyclic  nucleotides  may  be  implicated  in  the  endothelium- 
independent  component  of  the  vasorelaxation  induced  by  red  wine  and  grape 
products,  but  this  has  not  yet  be  substantiated  (Andriambeloson  et  aL,  1999). Jennifer  McGinn,  2002  Chapter  1,54 
Red  wine  phenolics  have  also  been  shown  to  significantly  lower  blood 
pressure  in  stroke-prone  spontaneously  hypertensive  rats  (SHRSP)  (Mizutani 
et  aL,  1999).  The  phenolics  were  also  shown  to  improve  the  aortic 
biomechanical  properties,  improving  aortic  elasticity  and  fragility  following  a 
diet  rich  in  wine  polyphenols  for  8  weeks. 
Studies  to  identify  and  isolate  the  compounds  present  in  wine  and  grape 
products  that  are  responsible  for  their  effects  on  endothelial  function  and  their 
mechanisms  of  action  remain  controversial.  Purified  flavonoids;  have  been 
shown  to  induce  NO-mediated  vasorelaxation  in  pulmonary  arteries.  Luteolin, 
apigenin,  myricetin,  kaempferol,  quercetin  and  isorhamnetin  all  induced 
significant  relaxation  in  the  preconstricted  pulmonary  vessels  (MacLean  et  aL, 
1997).  Similarly,  the  polyphenolic  anthocyanins  and  oligomeric  condensed 
tannins  have  also  shown  to  induced  relaxation  to  levels  comparable  to  the 
original  red  wine  from  which  they  were  extracted  (Andriambeloson  et  aL, 
1997).  Epicatechins;  derived  from  grape  seed  extracts  have  also  been  shown  to 
have  an  effect  on  vascular  tension  in  vitro  but  are  considerably  less  active  than 
the  structurally  related  proanthocyanidins  (Fitzpatrick  et  aL,  2000)  isolated 
from  the  same  extract. 
1.7.6  Plant  products  &  vasorelaxation 
The  previous  section  has  shown  that  red  wine  and  grape-derived 
products  are  all  potent  vasodilators  but  it  has  also  been  shown  that  a  wide 
range  of  fruits,  vegetables  and  nuts,  herbs  and  spices  also  have  an  effect  on 
vascular  tension  in  vitro  (Fitzpatrick  et  aL,  1995)  as  shown  in  Table  5. 
Several  fruits  and  vegetable  were  found  to  be  potent  vasodilators  in 
endothelial  intact  aortic  vessels  inducing  more  than  50%  relaxation  (Table  5). 
Extracts  of  fruit  such  as  the  skin  of  the  red  apple,  the  skin  and  pulp  of  the  plum 
and  cranberries  were  also  found  to  be  strong  relaxing  agents.  The  range  of 
vegetables  examined  were  found  to  induce  less  vasodilation  than  the  fruit 
selection.  The  skin  of  the  peanut  (the  papery  outer  layer)  was  identified  to  be Jennifer  McGinn,  2002  Chapter  1,55 
an  effective  dilator  in  vitro  as  were  the  spices,  cinnamon  and  garlic.  Some  of 
the  extracts  (strawberry,  tomato,  black  pepper)  had  very  little  or  no  effect  on 
vascular  tension,  while  others  (potato  and  banana)  induced  a  vasoconstriction 
of  the  PE-contracted  aortic  vessels.  It  is  surprising  that  the  strawberry  and  the 
red  cabbage  which  are  rich  in  anthocyanins  like  red  grapes  did  not  induce 
significant  vasorelaxation  (Fitzpatrick  et  aL,  1995). 
Table  5  Vasorelaxation  induced  by  selected  fruits  &  vegetables 
Extract  %  relaxation  induced 
Fruits: 
Cranberries  87  ±6 
Red  apples  (skin)  92  ±I 
Red  apples  (pulp)  81  ±  15 
Plum  (skin)  88  ±4 
Plum  (pulp)  92  ±2 
Tomato  (skin)  10  ±2 
Tomato  (pulp)  5±2 
Strawberry  0 
Banana  -21  ±  8* 
Vegetables: 
Potato  -52  ±  7* 
Cabbage  (green)  26  ±3 
Cabbage  (red)  43  ±5 
Aubergine  (skin)  77  ±6 
Broccoli  49  ±  12 
Nuts,  herbs  &  spices: 
Peanut  (skin)  97  ±3 
Peanut  (meal)  60  ±  10 
Pepper  (red)  18  ±5 
Pepper  (white)  17  ±2 
Pepper  (black)  0 
Cinnamon  98  ±2 
Garlic  65  ±8 
*Extract  caused  a  vasoconstriction  of  the  aortic  vessel 
Adapted  from  Fitzpatrick  et  aL,  1995 
Cocoa  is  also  a  rich  source  of  polyphenols,  particularly  catechins  and 
procyanidins.  It  has  been  shown  to  be  an  effective  antioxidant  in  vitro  systems 
(Vinson  et  aL,  1999)  being  more  potent  and  having  a  higher  polyphenol Jennifer  McGinn,  2002  Chapter  1,56 
content  than  a  wide  range  of  fruits  and  vegetables  with  a  40  mg  serving  of 
milk  chocolate  containing  394  mg  of  polyphenol  antioxidants  as  compared  to 
a  serving  of  red  wine  which  contains  431  mg/250  mL  (Vinson,  1998). 
However  it  remains  to  be  shown  whether  chocolates  can  act  as  antioxidants 
following  ingestion  since  fat  is  a  well  known  pro-oxidant  in  vivo  (Wollgast  & 
Anklam,  2000).  Further  studies  have  also  shown  that  cocoa  polymeric 
procyanidins  induce  endothelium-dependent  vasorelaxation  in  rabbit  aortic 
vessels  in  vitro  (Karim  et  aL,  2000)  inducing  up  to  50%  vessel  vasodilation. 
Relaxation  was  mediated  via  the  release  of  NO  and  increases  in  aortic  cGMP 
content  (Karim  et  aL,  2000). 
1.8  Role  of  grape  phenolics  in  health  promotion 
1.8.1  Wine  &  coronary  heart  disease 
The  onset  of  cardiovascular  disease  depends  on  numerous  factors  that 
can  be  modulated  by  components  in  the  diet.  It  has  been  estimated  that  up  to 
20%  (Weisburger,  2000)  of  all  coronary  heart  disease  is  attributable  to  dietary 
factors. 
In  CHD,  atherosclerotic  plaques  protrude  from  the  inner  surface  of  the 
arteries,  narrow  the  lumen  and  reduce  blood  flow  through  the  vital  organs 
(Stanley  &  Mazier,  1999).  At  the  first  stage,  LDL  deposits  at  lesions  sites  on 
the  arterial  wall  and  is  subjected  to  oxidation  when  antioxidant  protectors, 
such  as  polyphenols  or  vitamins  are  depleted.  Subsequently,  oxidation  of  LDL 
induces  modification  in  lipoproteins,  stimulates  inflammatory  reactions, 
causes  monocytes  and  monocyte-derived  macrophages  to  accumulate  large 
amounts  of  oxidised  LDL  and  forms  lipid-laden  foam  cells  and  atherosclerotic 
plaques  by  merging  (Tijburg  et  al.,  1997)  (Figure  6).  The  intake  of  saturated 
fats,  smoking,  excessive  alcohol  and  little  or  no  physical  activity  accelerate 
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Epidemiological  studies  have  led  to  the  identification  of  key  dietary 
components  that  are  etiological  factors  in  the  pathogenesis  of  CHD.  However 
the  true  identification  of  these  components  lies  with  large-scale  controlled 
prospective  intervention  trials,  the  strength  of  which  is  dependent  upon  the 
number  of  people  involved  and  the  duration  of  study  follow-up.  The  effect  of 
traditional  vitamins  and  other  dietary  antioxidants  on  atherosclerosis  remain 
controversial. 
Inverse  associations  with  the  risk  of  stroke  have  been  observed  for 
flavonols  and  flavones  (Keli  et  aL,  1996)  and  carotenoids  in  the'Health 
Professionals  Follow-up  Study  (Ascherio  et  aL,  1999).  However  no 
association  between  dietary  antioxidants  and  risk  of  stroke  was  reported  in  the 
American  Western  Electric  Study  (Daviglus  et  aL,  1997).  In  the  large-scale 
intervention  ATBC  trial  of  26,000  male  smokers  in  Finland,  a  protective 
association  between  the  consumption  of  fruits  and  vegetables  and  risk  of 
stroke  was  confirmed  (Hirvonen  et  aL,  2000).  Neither  flavonols,  flavones  or 
vitamin  C  intakes  were  related  to  a  reduced  risk  of  stroke.  Vitamin  E  intakes 
were  also  not  related  to  a  reduced  risk  of  CHD  (Virtamo  et  aL,  1998)  as 
assessed  by  dietary  supplementation  and  dietary  food  recall  questionaires. 
However  high  dietary  0-carotene  intakes  were  inversely  associated  with  risk 
for  cerebral  infarction  in  male  smokers  (Hirvonen  et  aL,  2000).  Likewise,  the 
Linxian  China  Study  is  a  primary  prevention  trial  of  29,000  people  testing 
dietary  supplementation  with  four  combinations  of  vitamins/micronutrients  on 
overall  mortality  and  cancer  mortality.  On  analysis  of  heart  disease,  all 
combinations  did  not  find  evidence  for  reduced  relative  risk  of  cardiovascular 
mortality  (Blot  et  aL,  1993).  Methods  for  assessing  and  estimating  dietary 
intakes  in  such  intervention  trials  have  included  the  use  of  dietary  assessment 
models  such  as  self-administered  baseline  food  frequency  and  history 
questionnaires,  24  hour  dietary  recall  interviews  and  4  day  food  diaries, 
replacement  of  normal  dietary  intake  with  study  diet  over  the  specified  study 
period,  personalised  dietary  information  and  dietary  surveys  to  ensure 
adhesion  and  compliance  to  experimental  diets  and  the  dietary 
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are  therefore  open  to  potential  error  and  bias  due  to  the  methods  employed  and 
use  of  dietary  intake  information  obtained  from  subjects. 
Studies  conducted  in  vitro  and  in  vivo  in  animal  models  and  with 
humans  suggest  that  red  wine  and  its  active  components  may  play  a  protective 
role  in  the  development  and  progression  of  CHD. 
In  1979,  St  Leger  et  al.,  were  the  first  to  describe  an  association  between 
CHD  mortality  and  wine  consumption  in  a  large-scale  epidemiological  study. 
The  findings  of  the  MONICA  study  (World  Health  Organisation,  1989)  a 
worldwide  monitoring  system  of  cardiovascular  diseases  using  data  from  IS 
western  countries  using  43  centres,  highlighted  a  positive  association  between 
death  from  CHD  and  saturated  fat  intake  while  a  negative  correlation  was 
identified  when  wine  consumption  was  taken  into  account  (Renaud  &  De 
Logeril,  1992).  Supporting  evidence  for  this  association  came  from  the 
observation  that  the  incidence  of  CHD  mortality  in  France  is  significantly 
lower  (one  third  of  the  average)  than  that  of  other  industrialised.  countries  with 
similar  high  dietary  fat  intakes  (14-15%  of  energy)  such  as  the  UK  and  the 
USA.  This  phenomenon  has  been  referred  to  as  the  "French  Paradox"  (Renaud 
&  De  Logeril,  1992).  It  should  however  be  recognised  as  stated  before  that 
due  to  the  use  of  dietary  intake  and  alcohol  consumption  information  obtained 
from  subjects  in  this  study  there  is  substantial  potential  for  bias  and  error  in 
the  methods  employed  for  the  recall  of  information  which  may  have  affected 
the  overall  study  results. 
Studies  have  indicated  that  consumption  of  alcohol  at  the  level  of  intake 
in  France  (20-30  g/day)  can  reduce  the  risk  of  CHD  by  at  least  40%  (German, 
2000).  It  was  also  noted  that  other  risk  factors  for  CHD  such  as  blood 
pressure,  body  mass  index  and  cigarette  smoking  were  no  different  from  that 
of  other  industrialised  countries.  This  phenomenon  is  believed  to  be  due  to  the 
high  consumption  of  wine  together  with  the  healthy  "Mediterranean-style" 
diet,  rich  in  vegetables  and  olive  oil,  consumed  by  the  French  (Renaud  &  De 
Logeril,  1992).  Epidemiological  studies  which  have  studied  this  relationship  in Jennifer  McGinn,  2002  Chapter  1,59 
specific  populations  have  indicated  that  wine  may  be  more  potent  than  other 
alcoholic  beverages  in  reducing  the  incidence  of  CHD  as  determined  by 
mortality  data,  food  disappearance  rates  and  alcohol  data  from  21  developed 
countries  between  1964  and  1988  (Criqui  &  Ringel,  1994).  Another  possibility 
for  this  relationship  may  be  that  wine  is  drunk  in  a  healthier  fashion  than  that 
of  other  alcoholic  beverages.  The  tradition  of  drinking  wine  with  meals  may 
have  a  favourable  effect  on  post-prandial  hyperlipidaernia  (Criqui  &  Ringel, 
1994).  Drinking  with  meals  may  also  reduce  some  of  the  toxic  effects  of  high 
alcohol  consumption  because  of  reduced  absorption. 
The  phenolic  components  of  red  wine  derived  from  the  grape  skin,  have 
been  identified  as  the  primary  factors  responsible  for  this  protective  role 
against  CHD,  exerting  their  effect  as  antioxidants,  free  radical  scavengers  and 
protectors  of  blood  vessel  function.  In  particular,  the  ability  of  red  wine  to 
inhibit  the  oxidation  of  LDL  in  vitro  has  been  suggested  as  the  mechanistic 
explanation  for  the  association  relating  red  wine  to  a  lowered  risk  of  CHD 
(Frankel  et  aL,  1993,  Tiessedre  et  aL,  1996,  Nigdikar  et  aL,  1998).  Other 
proposed  mechanisms  include  the  ability  of  red  wine  to  inhibit  platelet 
aggregation  (Demrow  et  aL,  1995,  Pace-Asciak  et  aL,  1995)  and  induce 
endothelium-dependent  vasorelaxation  via  the  release  of  NO  (Fitzpatrick  et 
aL,  1993,1994;  Andriambeloson  et  aL,  1999)  in  vascular  tissue  as  previously 
discussed. 
1.8.2  Wine  &  cancer 
The  relationship  between  moderate  red  wine  intake  and  cancer  risk  are 
less  clear  and  epidemiological  studies  give  variable  results.  It  is  widely 
accepted  that  up  to  one-third  of  all  human  cancer  cases  could  be  related  to 
some  dietary  component  in  the  Western  world  (Doll  &  Peto,  1981).  Dietary 
factors  are  now  considered  responsible  for  40  -  60%  of  all  cancer  incidence 
and  for  35%  of  cancer  deaths  (National  Research  Council,  1989). Jennifer  McGinn,  2002 
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Large-scale  intervention  trials  investigating  the  effects  of  flavonols, 
flavones,  vitamins  and  micronutrients  on  cancer  incidence  and  mortality  have 
also  been  carried  out.  Intake  of  flavonols  and  flavones  were  inversely  related 
to  incidence  and  risk  of  lung  cancer  but  not  to  prostate,  colorectal  and  stomach 
cancers  in  the  ATBC  (The  Alpha  Tocopherol  Beta  Carotene)  study  of  27,000 
male  heavy  smokers  in  Finland  aged  50-69  years  (Hirvonen  et  aL,  2001).  Data 
was  collected  from  validated  dietary  questionnaires  and  diaries.  On  the  other 
hand  3  large  scale  studies,  ATBC,  CARET  (Beta-Carotene  and  Retinol 
Efficacy  Trial)  and  the  Health  Professionals  Study  concluded  that  dietary 
supplementation  with  0-carotene  provided  no  protection  against  lung  cancer 
(Pryor  et  aL,  2000),  with  the  ATBC  study  identifying  a  higher  risk  of  lung 
cancer  for  those  in  the  P-carotene  intervention  group  as  compared  to  those  in 
the  control  group  (The  ATBC  Study  Group,  1994).  Likewise,  long-term 
supplementation  with  alpha-tocopherol  and  0-carotene  provided  no 
preventative  effect  on  urinary  track  cancers  (Virtamo  et  aL,  2000)  but  did 
lower  the  risk  of  occurrence  of  prostate  cancer  (Heinonen  et  aL,  1998)  in  the 
ATBS  Study.  The  Linxian  Cancer  Study  in  China,  supplementation  with 
combinations  of  vitamins  and  micronutrients,  especially  vitamins  C  and  E  and 
selenium,  reduced  total  mortality  mainly  due  to  significant  a  significant 
reduction  in  cancer  rates,  especially  stomach  cancer  and  oesophageal  cancer 
(Blot  et  aL,  1993). 
Alcohol  containing  drinks  have  now  been  identified  as  factors  that 
increase  the  risk  of  several  forms  of  cancer  (IARC,  1988).  At  high  intakes, 
alcoholic  drinks  are  highly  associated  with  increased  cancer  risk  especially 
cancers  of  the  larynx,  liver,  breast  and  oesophagus  but  this  relationship  is 
weak  for  red  wine  (Barra  et  A,  1990).  However  other  studies  have  highlighted 
a  protective  and  beneficial  effects  of  drinking  wine,  white  and  red,  in  reducing 
cancer  risk.  Klatsky  et  aL,  (1989)  found  no  relationship  between  moderate 
consumption  of  wine  and  colorectal  cancer  incidence,  similarly  Gronbaek  et 
aL,  (1998)  found  that  moderate  wine  intake  did  not  increase  the  risk  of  upper 
digestive  tract  cancer,  whereas  moderate  intake  of  beer  or  spirits  did  increase 
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cancer  was  associated  with  a  high  consumption  of  beer  and  spirits  whereas 
wine  may  be  proteclive.  Overall,  population  studies  show  that  moderate 
consumption  of  wine,  especially  red  wine  is  associated  with  cancer  incidence 
less  often  than  for  consumption  of  similar  quantities  of  other  alcohol- 
containing  beverages.  The  inconclusive  nature  of  the  epidemiological  studies 
may  reflect  in  part,  potential  biases  in  recall  and  the  difficulty  of  separating  the 
effects  of  red  wine  from  those  of  alcohol. 
The  mechanisms  by  which  red  wine  may  protect  against  cancers  are  yet 
undetermined  but  some  studies  in  vitro,  now  support  a  role  for  wine  in 
protecting  against  cancer.  The  red  wine  polyphenol,  trans-resveratrol  has  been 
indicated  to  have  anti-carcinogenic  effects  in  cancer  cell  lines  being  able  to 
induce  dose-dependent  inhibition  of  proliferation  and  DNS  synthesis.  Red 
wine  concentrate  with  the  alcohol  removed,  has  dose-dependent  anti- 
proliferative  effects  on  breast  cancer  cell  lines  (Damianaki  et  aL,  2000)  and 
consumption  of  dehydrated  dealcoholised  red  wine  delays  the  onset  on 
tumours  in  transgenic  mice  that  subsequently  develop  visible  tumours  without 
carcinogen  pre-treatment  (Clifford  et  aL,  1996). 
1.9  Absorption  &  bloavailability  of  red  wine 
polyphenols 
Absorption  from  the  diet  is  a  prerequisite  for  a  possible  causal 
relationship  between  the  intake  of  polyphenols  from  red  wine  and  prevention 
from  CHD.  However  information  on  the  extent  of  absorption,  bioavailability 
in  the  body  and  the  metabolic  fate  of  ingested  polyphenols  is  limited  and  often 
controversial. 
Very  few  studies  have  provided  an  estimate  of  the  extent  of  polyphenol 
absorption  from  wine  in  humans.  The  ingestion  of  a  glass  of  red  wine  results 
in  rapid  and  transient  increase  in  total  phenol  content  of  the  plasma  (Serafini  et 
aL,  1998).  Ingestion  of  white  wine  did  not  alter  plasma  polyphenol  level.  As Jennifer  McGinn,  2002  Chapter  1,63 
of  yet  it  is  unclear  which  of  the  many  polyphenols  present  in  red  wine  are  the 
most  bioavailable.  Although  there  is  an  increasing  body  of  evidence 
supporting  the  view  that  flavonol  conjugates  are  preferentially  absorbed  and 
that  the  nature  of  conjugation  is  important  (Hollman  et  aL,  1995,  Aziz  et  aL, 
1998).  Following  the  consumption  of  red  wine  the  presence  of  catechin 
metabolites,  predominately  as  sulphate  conjugates  and  conjugates  containing 
both  glucuronide  and  sulphate  residues  were  identified  in  human  plasma 
(Donovan  et  aL,  1999),  however  the  overall  levels  identified  were 
comparatively  low  compared  to  the  catechin  levels  of  the  wine  itself. 
Cyanidin-3-0-glucoside,  an  anthocyanin  present  in  red  wine  has  also  been 
identified  in  the  plasma  of  orally  dosed  rats  (Tsuda  et  aL,  1999)  and  was  found 
with  its  methylated  metabolites  to  accumulate  in  the  kidney. 
1.10  Introduction  to  tea 
1.10.1  The  History  of  Tea 
According  to  Chinese  mythology  in  2737  BC,  the  Chinese  emperor  Shen 
Nung,  the  scholar  and  herbalist  was  sitting  beneath  a  tree  while  his  servant 
boiled  drinking  water.  A  leaf  from  the  wild  tree  dropped  into  the  water  and 
Shen  Nung  decided  to  try  the  brew.  The  resulting  drink  was  said  to  be  both 
healthy  and  refreshing,  Shen  Nung  noted  in  his  Pen  ts'ao,  or  medical  book,  "It 
is  good  for  tumours  and  abscesses  that  come  about  the  head,  or  for  aliments  of 
the  bladder.  It  gladdens  and  cheers  the  heart"  (Liao  et  aL,  2001). 
From  the  earliest  times  tea  was  renowned  for  its  properties  as  a  healthy 
refreshing  drink.  By  the  time  of  the  Song  Dynasty  (960  ý-  1271  AD)  the  major 
tea  plantations  in  China  extended  southeast,  and  people  were  offering  tea  as 
tribute  in  place  of  grain  and  money.  After  the  Ming  Dynasty  (1368  -  1644 
AD),  tea  became  the  national  drink  of  China  (Liao  et  aL,  2001).  Tea  became  a 
necessity  of  life  equal  to  fuel,  rice,  oil  and  salt.  People  were  said  to  go  without Jennifer  McGinn,  2002  Chapter  1,64 
rice  for  3  days  but  would  not  go  without  tea  for  a  single  day  (Yamanishi, 
1995). 
1.10.1.1  The  history  of  tea  in  Britain 
The  early  beginnings  of  tea  in  Britain  are  obscure.  The  East  India 
Company  under  the  charter  granted  by  Elizabeth  I  to  the  directors  had  the 
monopoly  of  importing  goods  from  outside  Europe  and  recorded  ships 
reaching  Britain  in  1637,  but  no  recording  of  tea  dealings  with  Chinese 
merchants  appears  until  1644.  Sailors  bringing  packets  of  tea  as  presents  and 
stories  its  health  benefits  led  to  its  introduction  into  London  coffee  houses. 
The  merchant,  Thomas  Garraway,  was  among  the  first  to  trade  tea  in  Britain. 
People  flocked  to  his  coffee  shop  in  London's  Exchange  Alley  to  try  a  drink 
that  was  said  to  among  other  things  to  "help  the  headache,  clean  the  kidneys 
and  clear  the  sight".  He  offered  it  in  dry  and  liquid  form,  holding  his  first 
public  sale  in  1657.  Tea  rapidly  gained  in  popularity  and  by  1700  was  on  sale 
in  more  than  500  coffee  houses  in  London.  By  the  middle  of  the  18'h  century, 
tea  had  become  the  drink  of  the  masses  and  had  become  Britain's  most 
popular  beverage  (www.  tea.  co.  uk). 
1.11  From  plantation  to  cup 
At  one  time  two  species  of  tea  plants,  Camellia  sinensis  (northern  China 
form)  and  Camellia  assamica  (southern  China  form)  were  recognised  by 
botanists.  However  these  plants  are  now  considered  different  strains  of 
Camellia  sinensis,  members  of  the  Theaceae  family  (Liao  et  al.,  2001).  As  a 
member  of  the  Camellia  family,  tea  is  a  perennial  evergreen  tropical  plant 
which  yields  crops  through  out  the  year  in  tropical  regions  and  for  6  to  8 
months  in  subtropical  regions.  Free  growing  tea  plants  have  shiny  green 
pointed  leaves  similar  to  that  of  privet  leaves,  white  flowers  with  yellow 
anther  resembling  the  wild  rose  and  the  tea  fruit  containing  3  seeds 
(Yamanishi,  1995).  In  its  wild  state,  tea  grows  best  in  regions  which  enjoy  a 
warm,  humid  climate  with  a  rainfall  measuring  at  least  100  cm  a  year.  Ideally Jennifer  McGinn,  2002  Chapter  1,65 
it  likes  a  deep,  light,  acidic  and  well-drained  soil.  Given  these  ideal  conditions, 
tea  will  grow  in  areas  from  sea-level  up  to  altitudes  as  high  as  2,100  meters 
above  sea-level.  Tea  is  also  grown  across  a  wide  range  of  latitudes,  from  45*N 
(Russia)  to  30*S  (South  Africa),  and  from  150'E  (New  Guinea)  to  60'W 
(Argentina).  Tea  varies  in  flavour  and  characteristics  according  to  the  type  of 
soil,  altitude,  latitude  and  climate  conditions  of  the  area  in  which  it's  grown 
(Yamanishi,  1995). 
1.11.1  Manufacturing  of  tea 
Tea  manufacturing  includes  different  technological  processes  (Table  6). 
Tea  production  technology  is  aimed  at  modifying  the  chemical  composition  of 
the  raw  material,  the  fresh  tea  leaf,  in  order  to  produce  new  tastes  and  aroma 
compounds  responsible  for  the  taste,  colour  and  aroma  of  the  manufactured  tea 
that  are  so  highly  valued  by  the  consumer  (Bokuchava  &  Skobeleva,  1980). 
Classification  of  processed  tea  is  well  established  and  is  based  on  quality  and 
processing.  There  are  6  main  types  of  tea  produced:  green,  yellow,  dark, 
white,  oolong  and  black,  with  green,  black  and  oolong  teas  being  the  main  tea 
types  consumed  today.  This  division  is  based  on  the  degree  of  fermentation 
and  oxidation  of  the  polyphenols  present  in  the  tea  leaves. 
1.11.1.1  Tea  Leaf  Plucking 
Once  the  correct  tea  leaf  age  and  size  has  been  achieved,  the  tea  leaf  is 
gathered  in  mainly  by  hand.  Due  to  this,  tea  is  regarded  to  be  the  most  labour- 
consuming  crop.  The  tea  leaf  must  be  gathered  as  fast  as  possible  as  the 
slightest  delay  may  destroy  tender  flushes  and  decrease  the  harvest 
(Bokuchava  &  Skobeleva,  1980). 
1.11.1.2  Withering 
Withering  is  the  first  important  step  in  tea  manufacturing.  The  withering 
step  is  carried  out  to  biochemically  and  physically  prepare  the  freshly  plucked Jennifer  McGinn,  2002  Chapter  1,66 
tea  leaves  for  ftirther  processing  procedures.  The  leaf  is  spread  on  trays  and 
left  to  wither  in  air  at  25-30"C.  The  freshly  plucked  tea  leaf  contains  about  75- 
80%  water  and  the  withered  leaf  contains  62  to  64%  (Liao  et  aL,  2001). 
Withering  also  induces  changes  in  the  overall  catechin  content  and  the  protein 
and  amino  acid  composition  (Bokuchava  &  Skobeleva,  1980).  The  withering 
process  involves  both  physical  and  chemical  changes  which  exert  a  significant 
effect  on  the  subsequent  technological  processes  of  rolling  and  fermentation 
and  as  a  result  on  the  quality  of  the  manufactured  tea. 
1.11.1.3  Rolling  &  Crushing 
The  second  important  step  in  tea  manufacture  is  the  rolling  and 
subsequent  crushing  of  the  tea  leaf  The  main  purpose  of  the  rolling  step  is 
complete  maceration  of  tea  leaf  tissues  to  induce  fermentation.  The  rolling 
step  proceeds  slowly,  providing  a  gradual  excretion  of  tea  leafjuices. 
1.11.1.4  Fermentation 
The  most  important  stage  in  the  manufacture  of  black  tea  is 
fermentation.  The  biochemical  changes  developed  in  the  withering  stage 
proceed  at  a  rapid  rate  during  fermentation.  These  changes  result  in  profound 
changes  in  tea  leaf  constituents  contributing  to  the  formation  of  the  new  taste 
and  aroma  responsible  for  the  character  of  black  tea.  Following  rolling  and 
crushing,  the  tea  leaves  are  laid  out  in  a  cool  humid  atmosphere  for  3-4  hours 
to  ferment  or  oxidise.  Fermentation  is  mediated  by  oxidative  enzymes  present 
in  the  tea  leaf,  mainly  polyphenol  oxidases  (Bokuchava  &  Skobeleva,  1980). 
During  fermentation  the  rolled  leaves  lose  their  green  colour  acquiring  a 
coppery-red  colour,  due  to  the  strong  oxidative  reactions  occurring.  During 
fermentation  the  catechins  present  in  the  fresh  tea  leaf  are  rapidly  converted  to 
the  characteristic  theaflavins  and  thearubigens  of  black  tea,  the  ratio  of  which 
are  responsible  for  the  strength  of  the  tea  brew  (Liao  et  al.,  2001). Jennifer  McGinn,  2002 
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Following  fermentation  the  tea  leaf  immediately  undergoes  firing  at  high 
temperature  of  90  to  95"C  reducing  tea  moisture  content  to  34%  (Bokuchava 
&  Skobeleva,  1980).  The  main  purpose  of  firing  is  to  stop  fermentation  at  the 
very  moment  when  the  amount  of  valuable  substances  accumulated  in  the  tea 
leaf  is  highest.  During  firing  the  tea  undergoes  physical  and  chemical  changes, 
which  depend  on  firing  temperature  and  rate  of  air  flow. 
1.11.1.6  Cleaning,  sorting  &  packing 
The  dried  tea  is  sifted  to  prepare  the  final  product.  The  tea  is  sorted  into 
grades  or  leaf  particle  size  by  being  passed  through  a  series  of  wire  mesh  sifts 
of  varying  size  into  containers  before  being  weighed  and  packed  into  chests  or 
tea  sacks.  Tea  storage  is  followed  by  chemical  changes  in  the  content  of 
essential  oils,  tannins  and  other  soluble  constituents  which  all  gradually 
decrease  which  deteriorates  the  taste  and  aroma  of  the  finish  tea  product 
(Bokuchava  &  Skobeleva,  1980). 
1.11.2  World  tea  production 
Tea  like  red  wine  is  a  rich  source  of  polyphenols.  Although  native  to 
south  east  Asia,  tea  is  now  cultivated  in  more  than  25  countries  worldwide 
(Table  7)  with  the  major  commercial  producers  being  India,  Japan,  Africa,  Sri 
Lanka,  China  and  Indonesia  (Tea  Council,  2000).  It  is  generally  accepted  that 
next  to  water,  that  tea  is  the  most  consumed  beverage  worldwide,  with  a  per 
capita  consumption  of  120  mL  per  day  (Ahmad  &  Mukhtar,  1999).  World  tea 
production  and  consumption  levels  are  presently  the  highest  levels  achieved  in 
the  last  decade  and  rising.  To  date  about  3  billion  Kg  (Graph  1)  are  produced 
per  year  (Tea  Council,  2000)  with  78%  of  tea  produced  accounting  for  black 
tea,  20%  as  green  tea  and  2%  as  oolong  tea  (Yang  &  Landau,  2000). 
Approximately  90%  of  the  tea  consumed  in  Britain  is  known  as  the  popular 
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TabIe  6  Summary  of  the  processes  involved  in  the  manufacture  of  tea 
Process  Method 
Plucking  the  new  growth  is  picked,  usually  by  hand 
Withering  the  leaf  is  allowed  to  dry  slowly  and  the  leaf  becomes 
more  pliable 
Rolling  the  softened  leaf  is  rolled,  resulting  in  a  large  and  wiry 
end  product 
Crushing  the  leaf  is  crushed,  shredded  and  rolled,  resulting  in  a 
granular  end  product 
Fermentation  the  green  leaf  oxidises,  changing  in  both  colour  and 
flavour 
Firing  the  tea  is  dried  at  high  temperature  to  stop  fermentation 
and  reduce  moisture  (<3%) 
Cleaning  the  coarse  stalk  and  large  leaf  is  removed  from  the  dried 
tea 
Sorting  the  leaf  is  passed  through  a  series  of  meshes  to  produce 
standard  grades 
Packing  the  graded  tea  in  bulked  in  silos  and  packed  into  paper 
sacks 
Table  7  Tea  production  around  the  world 
Country  %  production  of 
world  exports 
India 
SriLanka 
Africa 
Kenya 
Malawi 
Tanzania 
Zimbabwe 
China 
Indonesia 
Non-Tea  Council  Members 
Australia 
Turkey 
Japan 
SouthAmerica 
14% 
21% 
25% 
18% 
8% 
34% 
Adapted  from  the  Tea  Council,  2000 a) 
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1.11.3  Tea  types 
70 
There  are  three  main  categories  of  tea  consumed  in  the  world  today 
(Table  8)  which  are  manufactured  due  to  differences  in  the  aforementioned  tea 
processing  procedures  and  which  give  rise  to  the  characteristic  colour,  flavour 
and  aroma  of  each  specific  tea  type.  They  are: 
1.11.3.1  Green  Tea 
Green  tea  is  a  very  valuable  food  product  which  is  widely  consumed 
throughout  the  world  but  predominately  in  China  and  Japan.  With  respect  to 
the  world  tea  market,  green  tea  is  inferior  only  to  black  tea  (Liao  et  aL,  2001). 
The  manufacture  of  green  tea  based  is  on  the  steaming  and  withering  of  the 
fresh  tea  leaf  In  green  tea  manufacture  the  development  of  oxidative 
processes  is  regarded  as  an  adverse  factor,  the  fresher  the  tea  leaf  the  better  the 
tea  produced  (Yamanishi,  1995).  Therefore,  enzymic  activity  is  arrested  by 
high  temperatures,  at  an  early  stage  in  production  and  replaced  with  thermal 
treatment  of  the  raw  tea,  applied  as  sweating  or  roasting  to  make  the  tea  tender 
for  rolling. 
The  raw  tea  in  the  production  of  green  tea  is initially  steamed  to  induce 
leaf  withering  at  temperatures  up  to  95-100'C.  The  leaves  are  then  dried  to 
remove  excess  moisture,  at  temperatures  from  100  to  11  OC,  before  rolling  to 
crush  the  leaf  blades  and  stalks  (Bokuchava  &  Skobeleva,  1980).  The  tea  is 
then  sifted  and  cooled  before  firing  to  reduce  the  overall  residual  moisture 
content  to  3  to  5%  and  to  produce  a  finished  dry,  olive-green  in  colour,  stable 
product  of  high  quality  (Bokuchava  &  Skobeleva,  1980)  (Figure  7). 
1.11.3.2  Black  tea 
Black  tea  is  the  most  commonly  consumed  type  of  tea  in  the  market 
today  accounting  for  up  to  80%  of  all  tea  produced  and  consumed Jennifer  McGinn,  2002  Chapter  1,71 
predominately  consumed  in  western  countries,  and  is  one  of  the  most  widely 
consumed  beverages  in  the  world  (Liao  et  al.,  2001). 
In  the  manufacture  of  black  tea,  the  fresh  tea  leaves  are  allowed  to 
initially  wither  to  about  55%  of  their  original  leaf  weight  altering  the  chemical 
and  physical  composition  of  the  raw  tea  leaf  and  to  prepare  them  for  rolling 
and  crushing  and  the  onset  of  fermentation  (Bokuchava  &  Skobeleva,  1980). 
Inadequate  withering  at  this  initial  stage  results  in  an  inferior  quality  of  tea. 
The  leaves  are  then  rolled  and  crushed  to  induce  the  gradual  excretion  of  tea 
leaf  cell  juices  and  to  initiate  fermentation.  In  black  tea  manufacture,  rolling  is 
in  essence  the  first  stage  of  fermentation  usually  requiring  about  2-3  hours, 
with  the  second  stage  of  extensive  fermentation  and  leaf  oxidation  continuing 
thereafter  via  the  release  of  polyphenol  (o-diphenol)  oxidase  from  the  leaf 
endoplasmic  reticulum  (Bokuchava  &  Skobeleva,  1980).  Fermentation  is  the 
major  technological  process  in  the  manufacture  of  black  tea  and  is  based  on 
these  oxidative  transformations  which  are  responsible  for  formation  of  black 
tea  aroma,  flavour  and  colour.  Following  fermentation,  the  leaf  is  fired, 
moisture  content  is  evaporated  and  the  leaf  turns  a  dark  brown  to  black  (Figure 
7). 
Oolong  tea 
Oolong  tea  (or  red  tea)  is  mainly  produced  in  China  and  Taiwan.  The 
first  stage  in  oolong  tea  manufacture  is  withering  followed  by  mild  rolling  and 
brief  partial  fermentation.  The  latter  is  halted  when  the  leaf  tips  and  edges 
become  reddish  brown  and  a  specific  aroma  appears.  The  tea  leaves  are  then 
fired  to  reduce  the  moisture  content  to  4  to  5%  (Bokuchava  &  Skobeleva, 
1980,  Yamanishi,  1995)  (Figure  7).  Oolong  tea  is  a  semi-green  or  semi- 
fermented  tea  with  a  chemical  composition  between  that  of  green  and  black 
teas. Jennifer  McGinn,  2002  Chapter  1,72 
Oolong  tea  has  a  pleasant,  mild  but  at  the  same  time  has  an  astringent 
taste  and  strong  stable  aroma  which  is  best  drunk  without  milk  (Liao  ef  aL, 
2001). 
Table  8  Main  varities  of  tea  avaliable  and  country  of  origin 
Green  Oolong  Black 
Genmaicha  (Japan)  Ti  Kuan  Yin  (China)  Assam  (India) 
Spider  Leg  (Japan)  Formosa  Oolong  (Taiwan)  Ceylon  (Sri  Lanka) 
Gyokuro  (Japan)  Pu-erh  (Cpaulhina)  Darjeeling  (India) 
Sencha(Japan)  Yunnan  (China) 
Gunpowder  (China)  Keemun  (China) 
Longjing  (China)  Sikkim  (India) 
Baozhong  (China) 
Adapted  from  Duthie  &  Crozier,  2002 
1.11.4  Herbal  &  Fruit  teas 
Fruit  and  herbal  teas  are  not  made  of  tea  leaves  but  are  an  infusion  of 
fruit  and  herbs.  Fruit  teas  are  a  blend  of  ingredients  with  one  or  more 
predominant  fruit  flavours.  Such  teas  may  contain  up  to  eight  or  nine  different 
ingredients  each  with  their  own  role  to  play  in  the  flavour  of  the  infusion.  Fruit 
teas  are  noted  for  their  refreshing  and  delicious  taste  and  are  a  modem 
alternative  to  tea  and  coffee.  Herb  teas  are  the  leaves,  seeds  and  flowers  of  a 
particular  herb,  harvested  and  dried  into  a  tea  with  a  fresh  clean  taste.  These 
teas  are  traditionally  believed  to  have  properties  to  treat  specific  medical 
conditions  especially  those  which  are  related  to  stress  or  the  digestive  system 
(www.  tea.  co.  uk).  Examples  of  such  teas  include  Camomile,  renowned  for  its 
soothing  and  calming  properties,  Echinacea  to  maintain  a  healthy  immune 
system,  Ginseng  for  its  stimulating  and  energising  benefits  and  Peppermint 
renowned  for  its  distinctive  flavour  and  stimulating  effect  on  the  digestive 
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Fruit  and  herb  teas  are  generally  caffeine  free,  usually  contain  less  than 
5  calories  per  cup  and  have  no  added  sugar  and  make  a  refreshing  alternative 
to  other  hot  beverages. 
In  addition  there  are  a  number  of  scented  teas  also  available  today  such 
as,  Earl  Grey  (black  tea  with  oil  of  bergamot),  Lady  Grey  (black  tea  with 
orange,  lemon  peel  and  oil  of  bergamot),  Lapsang  Souchong  (black  tea 
scented  with  smoke)  and  Jasmine  (green  tea  scented  with  Jasmine  flowers) 
(Duthie  &  Crozier,  2002). 
1.11.5  Tea  composition 
On  average  British  people  drink  about  3.5  cups  of  tea  a  day  (National 
Drinks  Survey,  1996),  with  it  being  stated  that  "increasing  this  average 
consumption  by  just  one  cup  a  day  may  yield  significant  health  benefits  on  a 
population  basis,  not  at  least  due  because  of  its  contribution  to  fluid  intake". 
Tea  taken  on  its  own  has  no  calories  however  as  most  people  take  it  with 
milk,  tea  is  a  valuable  provider  of  the  nutritional  content  of  milk,  which  can 
account  for  up  to  16%  of  the  recommended  daily  amount  of  calcium  and 
significant  amounts  of  folic  acid,  riboflavin  (B2)  and  vitamin  B6  (pyridoxine) 
(Liao  et  A,  2001)  (Table  9). 
Tea  is  also  a  rich  source  of  manganese,  essential  for  bone  growth  and 
the  body's  development,  potassium  which  is  vital  for  maintaining  fluid  levels 
in  the  body,  zinc  which  is  essential  for  growth  and  development  and  fluoride, 
0.5  -  0.8  mg  per  day  (Liao  et  al.,  2001)  for  protection  against  tooth  decay  and 
gum  disease.  The  tea  drunk  today  may  also  be  less  rich  in  micro-nutrients  than 
in  previous  decades  as  tea  infusion  times  have  decreased  dramatically  from  5- 
6  mins  to  about  40  -60  seconds  decreasing  the  overall  nutrient  content  of  the 
brew  (Duthie  &  Crozier,  2002). Jennifer  McGinn,  2002  Chapter  1,75 
TabIe  9  Nutrients  value  of  tea 
Amount  provided  by  650mL  of  tea*  with  semi-skimmed  milk 
Parameter  Contribution 
Energy  200  U  (48  Kcal) 
Protein  3.41  g 
Carbohydrate  4.77  g 
Fat  1.36  g 
Minerals: 
Calcium  109  mg 
Potassium  300  mg 
Zinc  0.68  mg 
Vitamins: 
Thiamine  (B  1)  70  mg 
Riboflavin  (B2)  270  mg 
Vitamin  B6  70  mg 
Folate  20  mg 
*  Average  daily  consumption  of  tea  is  3.43  cups/day  (650  mL)  (National 
Drinks  Survey,  1996). 
1.11.5.1  Caffeine  content 
Tea  contains  caffeine,  a  naturally  occurring  purine  alkaloid  (Duthie  & 
Crozier,  2002).  Apart  from  tea,  caffeine  can  also  be  found  in  chocolate,  soft 
drinks,  coffee,  cold  remedies  and  pain  relievers.  Caffeine  is  a  powerful 
stimulant  which  can  increase  concentration,  accuracy,  sensitivity  to  taste  and 
smell  and  which  overall  benefits  performance.  Extensive  studies  have  failed  to 
show  that  caffeine,  in  moderation  has  any  deleterious  effects  on  blood 
cholesterol  levels,  the  cardiovascular  circulation  or  that  it  may  give  rise  to  the 
formation  of  cancers  and  heart  disease  (Liao  et  aL,  2001). 
Table  10  disPlays  the  difference  in  caffeine  content  of  a  wide  range  of 
regularly  consumed  drinks.  The  amount  of  caffeine  in  a  cup  of  tea  depends  on 
the  plant  variety  and  how  long  you  let  the  tea  brew  infuse.  On  average  a  200 
mL  cup  of  tea  contains  about  40  mg  of  caffeine,  about  half  the  amount Jennifer  McGinn,  2002  Chapter  1,76 
contained  in  an  average  cup  of  coffee  (www.  tea.  co.  uk)  and  which  accounts  for 
an  average  daily  intake  of  0.15  g  of  caffeine  (Duthie  &  Crozier,  2002). 
Table  10  Typical  caffeine  content  of  selected  beverages 
Beverage  Caffeine  content 
(per  200  mL  cup) 
I  cup  ground  roasted  coffee  115  mg 
I  cup  instant  coffee  65  mg 
I  can  regular  cola  50  mg 
I  cup  tea-leaf  or  bag  40  mg 
I  cup  instant  tea  30  mg 
(Adapted  from  www.  tea.  co.  uk) 
1.12  Chemical  composition  of  tea 
Green  tea  leaves  are  very  unique  in  that  they  are  very rich  in  catechins, 
caffeine  and  the  amino  acid,  theanine.  These  constituents  are  soluble  in  hot 
water  and  impart  flavour  and  taste  to  green  tea  beverages  (Balentine  et  aL, 
1997).  As  discussed  before,  the  amounts  of  these  compounds  in  tea  beverages 
varies  considerably  depending  on  the  manufacturing  process,  the  strain  of  tea 
plant,  climatic  and  geographical  factors  (Balentine  et  aL,  1997). 
1.12.1  Catechins 
Tea  leaves  contain  in  amounts  equivalent  to  30  -  40%  of  the  overall  dry 
weight  of  the  tea  (Balentine  et  aL,  1997),  a  range  of  polyphenols  particularly 
the  flavan-3-ols  (+)-catechin  and  (-)-epicatechin  (EQ  and  their  gallate  and 
galloyl  derivatives;  epicatechin  gallate  (ECG),  epigallocatechin  (EGC), 
epigallocatechin  gallate  (EGCG)  and  catechin  gallate  (CG)  (Figure  8).  The 
type  and  proportion  of  catechins  present  in  the  tea  leaf  varies  with  the  season, Jennifer  McGinn,  2002 
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climate  and  horticultural  practices  (Bokuchava  &  Skobeleva,  1980). 
More  than  80  to  90%  of  green  tea  polyphenols  are  catechins  (Liao  et  A, 
2001).  Catechins  (3,3,4',  5,7-pentahydroxyflavan)  contain  a  hydroxypyranone 
ring  system  attached  to  a  hydroxylated  phenyl  ring,  the  latter  of  which  is 
referred  to  as  the  "B"  ring  (Balentine  et  aL,  1997).  Two  chemical 
configurations  within  the  catechin  family  are  possible,  but  the  majority  of  the 
catechin  mass  is  in  the  so-called  "epi-catechin"  form.  When  there  is  the 
presence  of  3  tri-hydroxyl  (OH)  groups  present  on  the  B  ring,  compounds  are 
known  as  gallo-catechins.  The  term  "gallo"  comes  from  its  analogy  to  gallic 
acid,  1,2,3  trihydroxy  benzoic  acid  (Robb  &  Brown,  2001).  The  addition  of  a 
gallic  acid  group  on  the  pyran  "C"  ring  leads  to  compounds  being  known  as 
catechin  gallates.  It  is  thought  that  gallocatechin  gallate  (GCG)  and  catechin 
gallate  (CG)  are  not  indigenous  to  the  tea  plant,  but  are  the  product  of  a 
epimerisation  reaction  with  EGCG  caused  by  the  high  temperatures  of  the 
firing  process  during  manufacturing  (Robb  &  Brown,  2001).  EGCG  is  the 
most  abundant  catechin  found  in  green  tea  and  accounts  for  25  to  40%  of  the 
total  catechin  content.  In  tea  leaves,  EC  is  synthesized  from  flavanone  and 
acetyl-Co  A,  while  gallic  acid  is  synthesized  from  shikimic  acid  (Figure  1) 
(Liao  et  aL,  200  1). 
The  biological  function  of  catechins  in  tea  plants  is  not  clear  and  why 
the  tea  leaves  accumulate  high  concentrations  of  catechins  in  their  leaves  is  yet 
to  be  determined  (Liao  et  aL,  2001).  The  occurrence  of  lower  catechin  levels 
in  shaded  leaves  as  compared  to  apical  leaves  may  indicate  that  they  may  be 
used  to  protect  the  plant  from  UV  damage  and  excessive  sunlight.  The  bitter 
taste  that  catechins  confer  on  the  tea  beverage  may  function  as  an  anti- 
microbial  protection  and  the  antioxidant  properties  of  catechins  may  also  act 
as  a  deterrent  and  protect  the  tea  bush  against  insects,  infection  and 
environmental  damage  (Cook  &  Samman,  1996). Jennifer  McGinn,  2002 
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Catechins  undergo  many  chemical  reactions  both  in  the  processing  of 
different  tea  types  and  in  the  preparation  of  the  tea  beverage  itself. 
During  the  fermentation  process  of  the  manufacturing  of  black  tea, 
ungallated  catechins  undergo  condensation  reactions  with  gallated  catechins 
(Balentine  at  aL,  1997).  This  reaction  is initiated  by  polyphenol  oxidase.  The 
products  of  such  reactions  are  called  theaflavins  (Table  11). 
Table  11  Theaflavin  reactants  and  products 
Catechin  reactant  Gallocatechin  reactant  Theaflavin  product 
(-)-epicatechin 
(-)-epicatechin 
(-)-epicatechin  gallate 
(-)-epicatechin  gallate 
(-)-epigallocatechin 
(-)-epigallocatechin  gallate 
(-)-epigallocatechin 
(-)-epigallocatechin  gallate 
Adapted  from  Robb  &  Brown,  2001 
theaflavin 
theaflavin-3-gallate 
theaflavin-3'-gallate 
theaflavin-3,3'-digallate 
Theaflavins,  which  are  characterised  by  a  benzotropolone  ring  system 
(Figure  9)  contribute  to  the  overall  astringency  and  brightness  of  black  tea 
(Robb  &  Brown,  2001).  Common  to  black  tea  are  4  main  theaflavins  (Table 
11,  Figure  10)  that  vary  in  degree  of  gallation  and  several  minor  theaflavins, 
including  isotheaflavin  and  neotheaflavin.  The  total  theaflavin  content  of  black 
tea  leaves  does  not  usually  exceed  2%  and  can  be  as  low  as  0.3%  (Balentine  et 
aL,  1997).  Theaflavins  undergo  further  condensation  to  form  undefined  water- 
soluble  thearubigens  (Figure  9).  During  fermentation  the  fresh  tea  leaf 
catechins  can  be  reduced  by  as  much  as  85%,  only  10%  of  which  are 
accounted  for  as  theaflavins  with  the  balance  of  catechins  forming  the 
indistinct  thearubigens  (Balentine  et  aL,  1997). Jennifer  McGinn,  2002 
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1.12.3  Other  components 
Tea  also  contains  the  flavonols,  quercetin,  kaempferol  and  rutin  and  the 
phenolic  acids,  caffeic,  quinic  and  gallic  acids  (Dufresne  &  Fransworth,  2001). 
Both  green  and  black  tea  infusions  have  been  shown  to  contain  conjugated 
quercetin,  kaempferol  and  myricetin  with  the  total  flavonol  content  ranging 
from  21.0  to  32.8  mg/L  (Table  2)  (Crozier  et  al.,  2000).  Tea  is  also  a  good 
source  of  methylxanthines  primarily  in  the  form  of  caffeine  and  the  amino  acid 
theanine,  accounting  for  about  50%  of  the  total  amino  acid  content  and  which 
imparts  a  pleasantly  sweet  taste.  Theanine  is  degraded  to  glutamic  acid  and 
has  been  shown  to  be  able  to  reduce  blood  pressure  and  to  have  a  relaxation 
effect  in  humans  (Yokozawa  el  al.,  1998).  The  aromatic  flavour  of  tea  has 
been  attributed  to  a  number  of  alcohols  (amyl  alcohol,  pentenols),  theaspirane 
and  hexenoate  derivatives  and  sulphur  compounds.  Some  of  these  compounds 
are  present  in  green  tea  as  glycosides,  are  known  aroma  precursors  which  are 
enzymatically  hydrolysed  during  fermentation  to  alter  tea  aroma  and  flavour 
(Guo  el  al.,  1995).  Green  tea  also  has  about  600  mg  of  vitamin  C  and  80  mg  of 
vitamin  E  per  100  g  of  freshly  dried  leaves  (Liao  el  al.,  2001). 
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1.13  Physiological  activity  of  tea  catechins 
1.13.1  Tea  as  an  antioxidant 
Oxidative  darnage  by  free  oxygen  radicals  is  known  to  be  one  of  the 
prevalent  mechanisms  in  the  development  of  chronic  diseases  such  as  CHD 
and  cancers.  The  mechanisms  of  action  of  antioxidants  are  discussed  in  detail 
in  section  1.7.1. 
Evaluation  of  the  antioxidant  potential  of  tea  and  tea  catechins  based  on 
chemical  and  biological  in  vitro  systems  and  redox  potentials  indicate  that  tea 
catechins  are  effective  antioxidants  and  free  radical  scavengers  and  in  some 
cases  display  up  to  5  times  the  antioxidant  activity  of  vitamin  E  and  vitamin  C 
(Wiseman  et  A,  1997).  Similar  levels  of  antioxidant  activity  are  reported  for 
the  theaflavins  and  the  fact  that  the  overall  antioxidant  capacity  of  infusions  of 
black  tea  are  similar  to  green  tea  suggest  that  thearubigens  are  equally  as 
effective  as  antioxidants  as  catechins  (Balentine  et  aL,  1997).  A  recent  study 
has  shown  that  the  theaflavins  present  in  black  tea  possess  at  least  the  same 
antioxidant  potency  as  catechins  present  in  green  tea  (Kwok  et  aL,  2001).  The 
conversion  of  catechins  to  theaflavins  during  fermentation  in  the 
manufacturing  of  black  tea  does  not  appear  to  significantly  alter  their  free 
radical  scavenging  ability  (Kwok  et  aL,  2001). 
The  scavenging  activity  of  different  tea  and  tea  catechin  molecules  is 
related  to  the  number  of  o-dihydroxy  and  o-hydroxyketo  groups,  C2  -C3 
double  bonds,  solubility,  concentration,  the  accessibility  of  the  active  group  to 
the  oxidant  and  the  stability  of  the  reaction  product  (Wiseman  et  aL,  1997). 
The  addition  of  glycosidic  groups  to  the  flavonoid  molecule  reduces  the 
antioxidant  activity.  Structurally  catechins  therefore  have  the  potential  to 
donate  electrons  and  subsequently  delocalise  and  stabilise  unpaired  electrons. 
Gardner  et  al  (1998)  identified  EGCG  to  be  clearly  the  most  effective 
antioxidant  in  several  chemical  systems  followed  by  ECG.  The  gallic  acid 
ester  moiety  at  the  3-position  on  the  C-ring  of  the  catechin  is  an  important Jennifer  McGinn,  2002  Chapter  1,83 
determinant  of  antioxidant  potential  as  substitution  of  this  group  by  hydroxyl 
in  EGCG  or  ECG  to  form  EGC  or  EC  respectively,  markedly  decreases  the 
overall  antioxidant  activity  (Gardner  et  A,  1998). 
Studies  dealing  investigating  the  in  vivo  increase  of  antioxidant  effects 
are  limited  at  present  and  results  conflicting.  Green  and  black  tea  both 
represent  an  excellent  source  of  antioxidant  polyphenols,  green  tea  being 
about  five  times  more  potent  than  black  tea  (Serafini  et  aL,  1996)  with  the 
antioxidant  activity  of  tea  being  directly  proportional  to  its  total  polyphenolic 
content.  Green  tea  was  found  to  be  20  25%  more  effective  at  radical 
quenching  than  black  tea  in  both  water  and  lipid  soluble  media  (Gardner  et  aL, 
1998).  Total  antioxidant  capacity  of  plasma  was  seen  to  be  significantly 
increased  (7%)  after  60  mins  and  6.2%  after  120  mins  at  baseline  values 
following  consumption  of  300  mL  of  green  tea  and  up  to  12%  following 
consumption  of  450  mL  of  tea  after  60  mins  and  12.7%  after  120  mins  (Sung 
et  aL,  2000).  Total  increase  in  plasma  antioxidant  concentration  was  tea 
dosage  dependent.  However  Serafini  et  al  (1996)  reported  that  after 
consuming  300  mL  of  green  tea  total  radical  antioxidant  capacity,  using  the 
TRAP  assay,  showed  the  highest  increment  of  40%  at  30  mins  after  ingestion 
and  decreased  thereafter  reaching  baseline  values  at  80  mins  following 
ingestion,  different  results  to  the  previous  study.  Using  the  FRAP  assay, 
Benzie  et  al  (1999)  reported  a  4%  increase  in  antioxidant  power  40  mins  after 
consuming  400  mL  of  green  tea,  returning  -to  basal  levels  after  2  hours. 
Ingestion  of  300  mL  of  red  wine  was  seen  to  show  a  similar  antioxidant  effect 
to  450  mL  of  green  tea  (Whitehead  et  aL,  1995).  The  green  tea  epicatechins, 
EGCG,  EGC  and  EC,  the  main  polyphenols  with  an  antioxidant  effect, 
reported  a  maximum  plasma  concentration  time  of  1.5  to  2.5  hours  after 
consumption  (Yang  et  aL,  1998). 
On  the  other  hand,  while  catcchins  are  effective  antioxidants  that  act  as 
radical  scavengers  and  maybe  able  to  protect  cell  components  from  free 
radical  damage,  these  antioxidants  can  also  be  pro-oxidants  under  certain 
conditions  and  can  generate  hydroxyl  radicals  especially  in  the  presence  of Jennifer  McGinn,  2002  Chapter  1,84 
iron  (Fell  or  Fel),  silver  (Aý)  or  copper  (Cull)  (Liao  et  A,  2001).  In  the 
presence  of  these  metal  ions  and  under  aerobic  conditions,  tea  catechins  (EC, 
EGC  and  EGCG)  can  generate  radicals  that  can  cleave  DNA,  chromatin  and 
can  accelerate  the  peroxidation  of  unsaturated  fatty  acids. 
1.13.2  Tea  &  vasorelaxation 
In  addition  to  the  proposed  effects  of  moderate  tea  consumption  on 
general  health  through  its  role  as  a  potent  antioxidant,  a  small  number  of 
animal  studies  from  one  group  have  shown  that  tea  and  tea  catechins  may  also 
affect  blood  vessel  function  (Huang  et  aL,  1998,1999).  The  role  of 
vasorelaxation  in  the  protection  of  the  cardiovascular  system  is  discussed  in 
detail  in  section  1.7.4.  The  vasodilator  effect  and  pathways  of  action  of  black 
tea  have  not  been  investigated  to  date. 
Green  tea  epicatechins  derivatives  isolated  and  purified  from  jasmine 
green  tea  were  seen  to  induced  vasorelaxation  in  isolated  rat  mesenteric  artery 
rings  with  intact  endothelium.  following  preconstricted  with  various 
pharmacological  vasoconstrictors  (Huang  et  aL,  1998)  including 
phenylephrine  (PE),  glibenclamide,  the  ATP-sensitive  K+  channel  blocker  and 
charybdotoxin,  the  C2+-activated  W  channel  blocker.  EGCG  was  identified  to 
be  the  most  potent  vasodilator  with  all  epicatechins  inducing  vasorelaxation 
with  similar  potencies,  in  a  concentration-dependent  manner  following 
preconstriction  with  PE.  All  epicatechins  reduced  the  maximal  contraction 
induced  by  PE.  Relaxation  induced  by  green  tea  epicatechins  was  unaffected 
by  glibenclamide  and  charybdotoxin  ruling  out  the  involvement  of  ATP- 
sensitive  and  Ca2+-activated  W  channels  in  vasorelaxation  induced  by  these 
compounds  (Huang  et  aL,  1998).  The  vasodilator  activity  of  green  tea 
epicatechins  occurred  via  endothelium-dependent  and  -independent 
mechanisms  and  has  been  attributed  to  the  release  of  NO,  the  inhibition  of 
calcium  influx  and  activation  on  NO  (Huang  et  aL,  1999). Jennifer  McGinn,  2002  Chapter  1,85 
Although  evidence  at  present  is  scarce,  these  studies  provide  novel 
evidence  for  the  possible  mechanisms  involved  in  the  relaxation  of  vascular 
tissue  by  green  tea  epicatechin  components. 
1.13.3  Tea  as  an  anti-carcinogen 
Many  mechanisms  have  been  proposed  concerning  the  inhibitory  action 
of  tea  and  tea  catechins  against  carcinogenesis.  The  anti-carcinogenic 
properties  of  green  tea  polyphenols  are  likely  a  result  of  the  inhibition  of 
biochemical  markers  of  turnour  initiation  and  promotion,  induction  of 
apoptosis  and  inhibition  of  cell  replication  rates  retarding  the  growth  and 
development  of  turnours.  Other  main  mechanisms  include  the  antioxidative 
effect  of  tea  catechins,  the  direct  interaction  between  the  reactive  mutagens 
and  the  nucleophilic  tea  catechin  and  the  inhibition  of  the  bioactivation  of 
promutagens  (Liao  et  aL,  2001).  Catechins  can  act  at  the  level  of  cancer 
initiation  by  preventing  chemically  induced  mutagenesis  which  is  achieved  by 
the  inhibition  of  the  mutagen  bioactivation  process  or  enhancement  of  the 
deactivation  of  reactive  mutagens  by  enzymes  like  glutathione-S-transferase, 
glutathione  peroxidase  and  catalase  (Yang  &  Wang,  1993).  Catechins  can  also 
influence  the  post-initiation  process  by  suppressing  cell  proliferation  (Liao  et 
aL,  2001). 
Many  studies  have  demonstrated  the  inhibition  of  cancer  activation  by 
tea  and  tea  polyphenols  in  vitro,  but  such  activities  have  only  been  observed  in 
a  very  small  number  of  studies  in  vivo.  The  anti-proliferative  effects  of  tea 
polyphenols  have  been  demonstrated  in  the  NNK-induced  lung  tumourgenesis 
model  in  mice.  When  green  or  black  tea  polyphenols  were  given  to  mice  24 
hours  after  a  dose  of  NNK,  bronchiolar  hyperproliferation  was  significantly 
inhibited  (Fujiki  et  aL,  1992).  Similarly,  treatment  with  black  tea  also 
inhibited  cell  proliferation  in  NNK-induced  turnours  in  mice  (Yang  et  aL, 
2000).  Inhibition  of  cell  transformations  and  cell  growth  by  purified  catechins 
and  theaflavins;  have  also  been  reported.  These  have  been  attributed  to  the 
inhibition  of  MAP-kinase  activity  and  phosphorylation.  In  addition  tea Jennifer  McGinn,  2002  Chapter  1,86 
polyphenols  have  been  shown  to  inhibit  the  binding  of  epidermal  growth 
factor  to  its  receptor  (Liao  et  aL,  2001).  Purified  tea  polyphenols,  especially 
EGCG  can  also  inhibit  apoptosis  in  cancer  cells  (Mukhtar  &  Ahmad,  2000)  is 
able  to  arrest  the  cell  cycle  in  human  epidermal  cancer  cells  and  may  be  able 
inhibit  the  process  of  turnour  formation  by  blocking  cellular  signal 
transduction  pathways.  Additional  studies  are  needed  to  clarify  the 
mechanisms  of  tea  and  tea  polyphenols  in  cancer  prevention. 
1.14  Tea  &  coronary  heart  disease 
When  the  complex  nature  of  CHD  is  considered,  tea  and  tea  catechins 
may  play  a  protective  role  via  a  number  of  different  mechanisms,  previously 
discussed  working  in  synergy.  The  aetiology  of  cardiovascular  disease  is 
discussed  in  detail  in  section  1.8.1. 
Although  a  small  number  of  epidemiological  studies  have  not  provided 
clear-cut  evidence  for  a  link  between  tea  consumption  and  cardiovascular 
disease  (van  het  Hof  et  aL,  1997,1999;  Hollman  et  aL,  1999),  the  majority  of 
studies  have  shown  that  tea  consumption  is  associated  with  a  lower  risk  of 
cardiovascular  disease  (Klatsky  et  aL,  1990;  Stensvold  et  aL,  1992;  Hertog  et 
aL,  1993;  Knekt  et  aL,  1996).  However  from  such  a  wide  range  of  studies  it  is 
not  possible  to  establish  whether  the  relationship  between  tea  intake  and 
disease  risk  is  causal  or  chance. 
Tea  consumption  is  difficult  to  measure  or  estimate  from  questionnaires. 
Such  methods  employed  to  estimate  total  dietary  intake  and  tea  consumption 
are  open  to  substantial  potential  error  and  bias  and  the  effect  of  confounding 
factors.  Methods  employed  in  estimating  tea  consumption  include  various 
dietary  assessment  models  including  24  hour  dietary  recall,  completion  of 
food  diaries  and  self  or  investigator  administered  diet  history  frequency 
questionaires.  Various  factors  may  affect  the  recall  of  dietary  information 
including  subjects  honesty,  competence  and  memories.  In  terms  of  tea 
consumption  and  CHD  various  factors  may  affect  exposure.  These  include Jennifer  McGinn,  2002  Chapter  1,87 
frequency  of  consumption,  duration  of  tea  leaf  extraction  on  brewing,  the 
addition  of  milk,  type  of  tea  and  size  of  cup.  Many  questionnaires  used  are 
general  dietary  intake  surveys  and  are  not  designed  to  specifically  quantify  tea 
consumption  and  do  not  investigate  potential  confounding  factors  such  as 
social  class  or  ethnic  group. 
A  large-scale  epidemiological  study  carried  out  in  Norway,  compared 
the  cholesterol  levels  and  blood  pressures  of  9,856  men  and  10,233  women, 
without  a  history  of  cardiovascular  disease  or  diabetes  (Stensvold  et  aL,  1992). 
This  study  found  that  both  factors  were  lower  and  inversely  related  to 
increasing  tea  consumption,  when  individuals  were  consuming  less  than  one 
cup  per  day  as  compared  to  individuals  consuming  more  than  one  cup  or  more 
than  five  cups  per  day  (Stensvold  et  aL,  1992).  Likewise  in  the  recent 
prospective  Rotterdam  study  of  over  3,000  men  and  women  aged  over  55 
years,  a  significant  inverse  relationship  between  tea  intake  and  radio- 
graphically  quantified  atherosclerosis  was  identified  (Geleinjnse  et  al.,  1999). 
The  Boston  Area  Health  Study  of  340  subjects  and  age,  sex  and  community 
matched  controls  also  found  that  subjects  who  drank  one  or  more  cups  of 
black  tea  a  day  had  approximately  half  the  risk  of  a  heart  attack  as  those  who 
did  not  drink  tea  at  all  (Sesso  et  al.,  1999). 
Welsh  men,  however  in  the  Caerphilly  Study  had  a  positive  association 
between  black  tea  consumption  and  CHD  (Hertog  et  A,  1997)  determined 
using  a  semi-quantitative  food  frequency  questionaire.  It  was  thought  that  the 
addition  of  milk  to  the  tea  may  have  however  abolished  the  antioxidant 
potential  of  the  tea,  but  subsequent  human  studies  on  this  topic,  have  shown 
that  the  addition  of  milk  to  the  tea  does  not  affect  plasma  antioxidant  level  or 
urinary  excretion  of  catechins  (Serafini  et  aL,  1996,  van  het  Hof  et  aL,  1999). 
The  effects  on  tea  on  the  cardiovascular  system  have  also  been  reported 
in  experimental  studies  with  animals.  Green  tea  significantly  reduces  serum 
and  liver  cholesterol  levels  and  liver  weight  by  lowering  lipid  deposition  in 
hypocholesterolemic  diet-induced  rats  (Yokozawa  et  aL,  1998).  Likewise  rats Jennifer  McGinn,  2002  Chapter  1.88 
fed  with  2.5%  green  tea  leaves  in  the  diet  over  a  long  period  of  time  were 
found  to  have  a  reduction  in  blood  triglycerides  and  total  cholesterol  content. 
Green  and  black  tea  fed  at  lower  levels  also  improved  plasma  lipid  profiles 
and  reduced  LDL  and  vLDL  (very  low-density  lipoprotein)  oxidation  in 
hamsters  fed  a  normal  of  high  cholesterol  diet  (Vinson  et  aL,  1998). 
Oxidation  of  LDL  is  recognised  as  an  important  step  leading  to 
atherosclerosis  and  there  are  several  reports  indicating  that  tea  and  tea 
catechins  inhibit  the  oxidation  of  LDL  in  vitro  (Wiseman  et  aL,  1997).  Studies 
testing  the  antioxidant  effect  of  tea  polyphenols  on  LDL  and  vLDL  oxidation 
all  indicate  that  EGCG  is  the  most  potent  inhibitor  of  lipid  peroxidation  and 
has  a  lipoprotein  bound  antioxidant  activity  greater  than  that  of  vitamin  C, 
tocopherol  and  P-carotene  (Vinson  et  A,  1995).  Black  tea  extract  has  also 
been  shown  to  increase  the  resistance  of  LDL  to  oxidation  in  a  concentration 
dependent  manner.  Green  tea  catechins,  have  also  been  shown  to  suppress  of 
inhibit  the  proliferation  of  smooth  muscle  cells  in  bovine  aortic  vessels  which 
produce  connective  tissue  leading  to  luminal  narrowing  and  atherosclerosis 
(Yokozawa  et  A,  1995).  Similarly  in  human  aortic  vessels,  tea  extracts, 
catechin  and  epicatechin  all  exhibit  a  dose-dependent  inhibition  of  the 
formation  of  early  lipid  peroxidation  products  (Pearson  et  A,  1998).  Such 
effects  may  be  due  to  the  direct  scavenging  of  the  oxidising  species  by  the 
polyphenols  or  may  results  from  the  polyphenol-mediated  regeneration  or 
protection  of  vitamin  E  in  LDL. 
Consumption  of  tea  and  tea  catechins  may  also  have  other  possible 
beneficial  effects  in  the  prevention  of  CHD  by  other  mechanisms  aside  from 
its  antioxidant  capabilities.  The  vasodilatory  effects  as  discussed  previously, 
of  tea  extracts  and  epicatechins,  may  enhance  optimal  blood  flow  by  affecting 
the  enhancement  of  NO  release  from  endothelial  cells,  the  accumulation  of 
cyclic  3',  5'-guanosine  monophosphate  (cGMP)  and  inhibition  of  calcium 
influx  into  the  smooth  muscle  cell  (Huang  et  aL,  1999).  At  present  the 
suggested  vasodilatory  effects  of  tea  catechins  in  protecting  vascular  function 
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adhesion  and  aggregation  by  inhibiting  the  cyclo-oxygenase  pathway  and 
reducing  cyclic  3',  5'-adenosine  monophosphate  (cAMP)  response  of  platelets 
to  prostaglandin  12  (Gryglewski  et  aL,  1987,  Tijburg  et  aL,  1997).  Caffeine  in 
tea  may  also  reduce  blood  coagulation  by  inhibiting  thrombin-stimulated 
thromboxane  formation  (Duthie  &  Crozier,  2002). 
1.14.1  Tea  &  cancer 
Initiation,  promotion  and  progression  in  cancer  development  are 
modulated  by  many  factors  relating  to  the  diet,  metabolism  and  environmental 
factors  (Dufresne  &  Farnworth,  2001).  Accumulation  of  reactive  oxygen 
species  (ROS)  in  cells  and  resultant  changes  and  modifications  in  DNA 
structure,  enzymatic  activity  and  cell  defence  mechanisms  all  influence  the 
development  of  cancer  pathogenesis  (Yang  et  aL,  2000). 
The  experimental  and  epidemiological  data  from  a  wide  range  of  studies 
have  provided  evidence  that  polyphenolic  antioxidants  present  in  green  tea 
may  be  able  to  confer  protection  against  cancer  initiation  and  its  subsequent 
progression  and  development  (reviews  by  Kohlmeier  et  aL,  1997;  Bushman, 
1998).  The  majority  of  studies  demonstrating  cancer  cherno-preventative 
effects  have  been  conducted  using  green  tea,  where  as  only  a  limited  number 
have  assessed  the  effects  of  black  tea. 
In  a  study  in  China,  green  tea  drinkers  who  consumed  more  than  two 
cups  of  tea  per  day  were  found  to  have  the  risk  of  esophageal  cancer  reduced 
by  50%  (Gao  et  aL,  1994)  especially  in  non-smokers  and  non-alcohol  drinkers 
as  assessed  by  food  frequency  and  lifestyle  questionaires.  Another  large  study, 
also  from  China,  which  controlled  for  confounding  factors  found  that  green  tea 
drinkers  had  a  40-50%  reduction  in  stomach  cancer  incidence  (Yu  et  aL, 
1995).  Similarly  studies  from  northern  Italy  have  suggested  a  protective  effect 
of  tea  against  oral,  pharyngeal  and  laryngeal  cancers.  Japanese  women 
consuming  more  than  10  cups  of  tea  daily  have  been  shown  to  have  a  lower 
risk  for  cancer,  at  all  sites,  with  increased  tea  consumption  being  associated Jennifer  McGinn,  2002  Chapter  1,90 
with  a  lower  risk  of  breast  cancer  development  and  recurrence  (Nakachi  et  aL, 
1998).  Likewise,  a  prospective  cohort  study  of  postmenopausal  women  in 
Iowa,  USA,  consumption  of  black  tea  has  been  shown  to  be  associated  with  a 
lower  risk  of  digestive  and  urinary  tract  cancers  (Zheng  et  al.,  1996).  Data  was 
collected  from  validated  food  questionnaires  and  diaries.  In  contrast,  in  the 
Netherlands  Cohort  study  on  diet  and  cancer,  consumption  of  black  tea  was 
not  found  to  affect  the  risk of  developing  stomach,  colorectal,  lung  and  breast 
cancers  (Goldbohm  et  al.,  1996).  Similarly,  a  recent  study  carried  out  in 
middle-aged  Finnish  men  indicated  a  positive  association  between  increased 
tea  consumption  and  colon  cancer  risk  (Hartman  et  al.,  1998). 
However  in  contrast  to  the  epidemiological  studies,  animal  studies  have 
demonstrated  the  inhibition  of  carcinogenesis  by  tea  and  tea  catechins.  Studies 
have  shown  that  oral  consumption  or  topical  application  of  green  tea  and/or  its 
polyphenolic  components  provide  protection  against  chemically-induced  or 
ultraviolet  radiation-induced  skin  carcinogenesis  in  the  mouse  model  (Mukhtar 
et  aL.  1994).  In  other  animal  model  systems,  the  polyphenols  isolated  from 
green  tea  have  been  shown  to  provide  protection  against  chemically-induced 
carcinogenesis  in  lung,  fore-stomach,  pancreas,  breast,  colon  and  oesophagus 
(Kohlmeier  et  aL,  1997).  Recent  studies  have  also  suggested  that  much  of  the 
chemo-preventive  effects  of  green  tea  are  mediated  by  its  major  polyphenolic 
constituent,  EGCG.  Although  it  is  important  to  note  that  the  other 
polyphenolics  present  in  green  tea  also  contribute  to  this  effect  (Liao  et  aL, 
2001). 
There  are  currently  a  number  of  different  mechanisms  suggested  by 
which  tea  and  tea  catechins  may  influence  the  three  stages  of  cancer 
development.  These  include  the  direct  and  indirect  antioxidant  protection  of 
DNA  by  neutralising  the  pro-carcinogen  by  their  strong  oxygen  scavenging 
activity  before  cell  injury  occurs  (Vinson  et  aL,  1995)  by  the  modulation  of 
enzyme  systems,  such  as  cytochrome  P450  complexes  which  metabolise 
carcinogens  or  pro-carcinogens  to  genotoxins  and  by  the  modulation  of 
malignant  transformations,  apoptosis  and  gene  expression  (Duthie  et  aL, Jennifer  McGinn,  2002  Chapter  1,91 
2000).  Phenolics  from  green  tea  can  also  prevent  the  in  vitro  formation  of 
nitrosamines,  a  group  of  carcinogens  also  found  in  tobacco  (Gordon,  1996). 
Tea  polyphenols  can  also  inhibit  the  formation  of  heterocyclic  amines  from 
cooked  meat  and  fish  which  are  genotoxic  carcinogens  and  are  associated  with 
cancer  of  the  breast,  colon  and  pancreas  (Liao  et  aL,  2001). 
1.15  Absorption  &  metabolism  of  tea  catechins 
Knowledge  of  the  absorption  and  metabolism  of  catechins  are  crucial  to 
the  understanding  of  whether  these  compounds  or  their  metabolites  have  the 
potential  to  exert  the  biological  activity  in  vivo. 
The  bioavailability  of  polyphenolic  compounds  and  their  distribution 
throughout  the  body  following  administration,  either  orally  or  locally,  have 
been  investigated  using  sensitive  methods  to  analyse  the  metabolites  in 
biological  fluids  and  tissues.  Consumption  of  a  single  dose  of  green  tea  results 
in  a  small  but  significant  increase  in  plasma  concentrations  of  total  catechins 
(van  het  Hof  et  aL,  1999)  peaking  at  about  2  hours  following  consumption. 
The  effect  is  less  for  black  tea.  This  may  be  due  to  the  presence  of  the  high 
molecular  weigh  theaflavins  and  thearubigens  in  black  tea  (van  het  Hof  et  aL, 
1999).  As  stated  before,  the  addition  of  milk,  at  the  typical  LJK  level  of  10- 
15%  volume  does  not  appear  to  affect  the  absorption  of  catechins  from  tea. 
Much  larger  amounts  of  milk  may  impair  absorption  but  evidence  is  limited 
(Serafini  et  aL,  1996).  Likewise,  almost  50%  of  orally  administered  radio- 
labelled  catechin  was  excreted  in  the  form  of  urinary  metabolites,  indicating 
that  catechins  and  their  gut  flora  metabolites  are  well-absorbed  (Das  et  aL, 
1971)  with  plasma  concentrations  of  catechins  peaking  between  1.5  to  2.6 
hours  on  all  subjects  and  declining  to  undetectable  levels  after  24  hours. 
Although  the  concentrations  of  catechins  in  the  plasma  are  low,  the  total 
amount  of  catechins  present  in  the  total  blood  volume  at  any  time  is  only  a 
minute  proportion  of  the  total  amount  consumed  (van  het  Hof  et  aL,  1998). 
Tea  catechins;  appear  in  the  urine  soon  after  consumption,  but  the  total  amount Jennifer  McGinn,  2002  Chapter  1,92 
excreted  in  the  urine  again  only  represents  a  very  small  proportion  of  the  total 
present  in  a  cup  of  tea  (He  &  Kies,  1994). 
The  tea  epicatechins,  EGCG,  EGC,  ECG  and  EC  have  all  been 
identified  in  the  portal  vein  of  rats  following  the  oral  administration  of  a  single 
dose  of  isolated  green  tea  catechins  indicating  that  these  compounds  can  cross 
intestinal  membranes  (Hollman  et  aL,  1997).  The  limited  number  of 
pharmacokinetics  studies  on  tea  catechins  suggest  that  they  are  rapidly 
absorbed  with  the  bioavailability  of  EGCG  being  lower  than  that  of  EGC  and 
EC  (Hollman  et  aL,  1997). 
Absorption  of  tea  catcchins,  based  on  the  current  evidence  appears  to  be 
limited  and  inconclusive.  Catcchins  maybe  highly  absorbed  but  rapidly 
metabolised  to  other  forms  which  cannot  yet  been  detected  or  possibly 
sequestred  in  specific  organs  of  the  body  (He  &  Kies,  1994).  Absorbed 
catechins  have  been  shown  to  be  extensively  metabolised  and  converted  to 
glucuronides  and  sulphates  predominately  in  the  liver,  with  some  being 
methylated  by  catechol-0-methyl  transferase  (Hollman  et  aL,  1997). 
Unabsorbed  catechins  and  catechins  conjugates  are  secreted  with  bile  into  the 
small  intestine  and  are  degraded  by  bacteria  in  the  colon,  as  previously 
mentioned.  At  present  there  is  no  published  data  conceming  the  absorption  of 
theaflavins  and  thearubigens  from  black  tea. 
In  order  to  fully  understand  the  bioavailability  of  tea  catechins,  more 
human  studies  are  needed  that  focus  on  the  identification  and  quantification  of 
metabolites  in  body  fluids. Jennifer  McGinn,  2002  Chapter  2,93 
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Chapter  2  Materials  and  Methods 
To  investigate  the  activity  and  various  properties  of  polyphenolic 
compounds  in  vitro,  several  complementary  methods  were  employed  in  the 
course  of  this  study. 
2.1  Vasorelaxation  of  vascular  tissue  by 
polyphenolic  compounds 
Z  1.1  Rabbit  aortic  preparation 
Male  New  Zealand  rabbits  (3.5  Kg)  were  - 
anaesthetised  by  ix. 
administration  of  pentobarbitone  (100  mg  kg-1)  with  1000  IU  heparin  into  the 
marginal  ear  vein.  All  rabbits  used  in  the  course  of  this  study  were  obtained 
from  Harlan  UK,  Ltd,  a  credited  commercial  supplier  of  laboratory  animals. 
Once  the  animal  was  dead  the  descending  thoracic  aorta  was  then  carefully 
removed  and  cleaned  of  adhering  fat  and  connective  tissue  and  cut  into 
transverse  ring  segments  of  about  3-5  min  in  length.  The  rings  were  suspended 
from  force  displacement  transducers  in  10  mL  organ  baths  (Figure  11)  filled 
with  Kreb's  buffer  solution  (pH  7.4)  [composition  in  mmol:  NaCl  118.4; 
NaIIC03  25;  KCI  4.7;  KH2P04  1.2;  MgS04  1.2;  CaC12  2.5;  D-glucose  11], 
continuously  oxygenated  with  16%  02,5%  C02  and  79%  N2,  and  maintained 
at  37'C,  to  mimic  the  internal  environment  as  closely  as  possible.  Aortic  ring 
segments  were  set-up  in  the  organ  baths  within  20  mins  of  the  sacrifice  of  the 
animal.  Rings  were  placed  under  the  optimal  resting  tension  of  2g  (oxygen 
tension  of  120  mm  Hg).  This  tension  was  kept  constant  throughout  the  course 
of  all  experiments.  Vessel  contraction/relaxation  was  measured  via  an 
isometric  force  transducer,  linked  in  turn  to  a  data  handling  system  (Chart 
V3.5,  MacLab  Data  Acquisition  System,  Version  8E,  AD  Instruments  Pty  Ltd, 
Australia)  to  record  all  changes  in  vascular  tension. Jennifer  McGinn,  2002  Chapter  2,95 
Z  1.2  Experimental  Protocol 
After  an  equilibration  period  of  45  min,  vessels  were  maximally 
contracted  twice  with  KCI  (50  mM).  After  each  contraction,  vessels  were 
washed  out  with  Kreb's  solution.  In  some  experiments,  the  endothelium  was 
mechanically  removed  by  gently  rubbing  the  luminal  surface  with  ridged 
forceps.  The  presence  of  functional  endothelium  was  assessed  in  all 
preparations  by  determining  the  ability  of  acetylcholine  (I  PM)  to  induce  more 
than  50%  relaxation  in  rings  pre-contracted  with  phenylephrine  (I  [IM). 
Vessels  were  considered  to  be  denuded  of  functional  endothelium  when  there 
was  no  relaxation  response  to  acetylcholine. 
2.2  Determination  of  the  grape  and  tea  extract 
vasodilator  effects  in  vitro 
After  washing  and  returning  to  initial  baseline  tension,  aortic  rings  with 
and  without  functional  endothelium  were  precontracted.  submaximally  with 
phenylephrine  (PE,  10-7  M).  In  some  experiments  where  indicated,  the 
thromboxane-mimetic  U46619  (10-9  M)  [G,  11-dideoxy-IIA-GA-epoxy- 
methano-PGF2A]  was  used  to  elevate  vascular  tone.  After  precontraction  of  the 
aortic  rings  the  effect  of  the  grape  skin  and  tea  extracts  on  vascular  tone  were 
studied.  Once  a  stable  plateau  had  been  reached,  cumulative  concentration 
response  curves  (CCRC)  for  the  diluted  grape  skin,  powder  and  seed  extracts, 
green  and  black  tea  extracts  and  theaflavin  extract  (2  x  104  -  14  mg  mI:  1; 
0.0002  -  14  mg  mL")  were  obtained.  Dilutions  of  increasing  concentration 
were  added  directly  to  the  organ  bath  at  15  mins  intervals  for  each  individual 
extract.  Time  matched  controls  for  each  extract  were  run  to  demonstrate  the 
effect  of  each  extract  on  vascular  tension  as  opposed  to  the  natural  relaxation 
response  of  each  vessel  with  time. 
The  mechanisms  and  pathways  of  vasodilation  in  the  grape  and  tea 
based  extracts  in  vitro  was  also  investigated.  In  some  vessels,  the  NO  synthase Jennifer  McGinn,  2002  Chapter  2,96 
inhibitor,  L-NAME  (100  [M)  or  the  prostaglandin  cyclo-oxygenase  inhibitor, 
indomethacin  (1,100  pM)  was  added  40  min  prior  to  precontraction  with  PE 
and  the  addition  of  the  extracts.  In  some  experiments,  where  indicated,  the 
thromboxane  antagonists  ICI  192,605  (10  gM),  I  gM  GR  32191  or  the  soluble 
guanylate  cyclase  inhibitor  ODQ  (IH-[1,2,4]  Oxadiazolo  [4,3-a]quinoxalin-l- 
one,  10  gM)  were  added  15  mins  prior  to  precontraction  with  PE.  To  rule  out 
the  presence  of  prostanoid  receptors  in  the  rabbit  aortic  smooth  muscle, 
CCRC's  were  obtained  to  prostacyclin  (PG12,10-10  -  3xlO-7  M)  and  the 
selective  prostacyclin  receptor  agonist,  cicaprost  (10-12  -  R10-8  M).  The 
combined  effects  of  endotheliurn  removal,  and  incubation  with  L-NAME, 
indomethacin  and  ICI  192,605  were  also  investigated. 
Following  preconstriction  with  PE,  the  absolute  preconstriction  of  the 
vessel  was  measured.  With  each  addition/dose  of  each  individual  extract  to  the 
organ  bath  the  ensuing  vasorelaxation  was  measured  and  expressed  as  a%  of 
the  degree  of  preconstriction  with  PE.  This  was  repeated  in  at  least  6  vessels 
and  the  %  relaxation  for  each  dose  calculated  and  expressed  as  the  % 
vasorelaxation  induced  by  each  gape  and  tea  based  extract  following 
precontraction  with  PE.  Data  shown  as  mean  %  relaxation  ±  standard  error  of 
mean  (n  =  6-7)  for  the  grape  and  tea  based  extracts  and  as  mean  %  relaxation 
standard  error  of  mean  (n=3)  for  the  theaflavin  extract. 
2.3  Determination  of  green  tea  catechins  & 
epicatechins  vasodilator  effects  in  vitro 
After  washing  and  returning  to  starting  baseline  tension,  aortic  rings 
with  and  without  functional  endothelium  were  submaximally  precontracted 
with  PE  (10-7  M).  After  precontraction  of  the  aortic  rings  the  effects  of  the 
catechin  derivatives:  epicatechin  (EC),  epicatechin  gallate  (ECG), 
epigallocatechin  (EGC),  epigallocatechin  gallate  (EGCG),  catechin  and 
catechin  gallate  (CG)  on  vascular  tension  in  vitro  were  studied.  Once  a  stable 
plateau  had  been  reached  and  was  maintained,  CCRC  to  the  diluted  catechin Jennifer  McGinn,  2002  Chapter  2,97 
derivatives  (10-8  -  3xlO-4  M)  were  obtained.  Catechin  and  epicatechin 
dilutions  of  increasing  concentration  were  added  directly  to  the  organ  bath  at 
15  mins  intervals.  Time  matched  controls  for  each  derivative  were  also  run  to 
demonstrate  the  effect  of  each  derivative  on  vascular  tension  as  opposed  to  the 
natural  relaxation  response  of  each  vessel  with  time. 
To  investigate  the  role  of  nitric  oxide  in  the  vasodilator  effect  induced 
by  the  catechin  derivatives,  L-NAME  (100  [M),  was  added  to  selected 
vessels,  40  mins  prior  to  precontraction  with  PE  and  the  addition  of  the  diluted 
catechin  and  epicatechin  derivatives. 
Following  preconstriction  with  PE,  the  absolute  preconstriction  of  the 
vessel  was  measured.  With  each  addition/dose  of  each  catechin  and 
epicatechin  derivative  to  the  organ  bath  the  ensuing  vasorelaxation  was 
measured  and  expressed  as  a%  of  the  degree  of  preconstriction  with  PE.  This 
was  repeated  in  at  least  5  vessels  and  the  %  relaxation  for  each  dose  calculated 
and  expressed  as  the  %  vasorelaxation  induced  by  each  green  tea  catechin  and 
epicatechin  derivative  following  precontraction  with  PE.  Data  shown  as  mean 
%  relaxation  ±  standard  error  of  mean  (n  =  5-6). 
2.4  Determination  of  green  tea  fractions 
vasodilator  effects  in  vitro 
After  washing  and  returning  to  starting  baseline  tension,  aortic  rings 
with  functional  endothelium  were  submaximally-  precontracted  with  PE  (10-7 
M).  Following  precontraction  of  the  aortic  rings  the  effects  of  the  green  tea 
fractions  on  vascular  tension  in  vitro  were  studied.  Once  a  stable  plateau  had 
been  reached  and  was  maintained,  20  pg  mL"  (twice  10  pg  mL"  aliquots)  of 
each  green  tea  fraction  concentrate  was  added  to  the  organ  bath  at  15  minute 
intervals  to  induce  vasodilation  in  the  aortic  ring  segments.  Time  matched 
controls  for  each  fraction  were  also  run  to  demonstrate  the  effect  of  each Jennifer  McGinn,  2002  Chapter  2,98 
fraction  on  vascular  tension  as  opposed  to  the  natural  relaxation  response  of 
each  vessel  with  time 
Following  preconstriction  with  PE,  the  absolute  preconstriction  of  the 
vessel  was  measured.  With  each  addition/dose  of  each  green  tea  fraction  to  the 
organ  bath  the  ensuing  vasorelaxation  was  measured  and  expressed  as  a%  of 
the  degree  of  preconstriction  with  PE.  This  was  repeated  in  2  vessels  and  the 
%  relaxation  for  each  fraction  addition  calculated  and  expressed  as  the  % 
vasorelaxation  induced  by  each  green  tea  fraction  following  precontraction 
with  PE.  Data  shown  as  mean  %  relaxation  for  2  vessels  (n  =  2). 
2.5  Drugs  and  Solutions:  vasoclilation  method 
Acetylcholine  (ACh),  phenylephrine  (PE),  L-NAME,  indomethacin  and 
U46619  were  purchased  from  Sigma-Aldrich  Chemical  Co.  (Dorset,  England). 
ICI  192,605,  and  ODQ  was  purchased  from  Tocris  Cookson  Ltd  (Bristol, 
England).  All  drugs  were  dissolved  in  distilled  water,  with  the  exception  of 
indomethacin,  which  was  dissolved  in  0.5  M  NaHC031  U46619  which  was 
dissolved  in  absolute  ethanol  and  ICI  192,605  which  was  dissolved  in  DMSO 
(dimethyl  sulfoxide).  The  French  grape  skin  and  French  grape  seed  extracts 
were  obtained  from  Prof  P.  L.  Teissedre,  University  of  Montpellier,  France 
(acquired  from  E.  Fesquet  &  N.  Urban,  La  Gardonnenqye,  30  360  Cruviers- 
Lascours,  France),  and  the  grape  powder,  grape  skin,  green  tea  and  black  tea 
and  theaflavin  extracts  were  obtained  from  Dr  G.  G.  Duthie  and  Dr  P.  T. 
Gardner,  Rowett  Research  Institute,  Aberdeen,  Scotland  (acquired  from 
Unilever,  Wageningen,  Netherlands).  All  grape  and  tea  based  and  theaflavin 
extract  used  in  this  study  were  received  in  the  dry  powdered  form.  1:  10 
dilutions  of  an  initial  30  mg  of  extract  was  fully  dissolved  in  Kreb's  solution 
and  dilutions  freshly  prepared  for  each  experiment.  All  catechins  and 
epicatechin  compounds  used  in  this  study  (EC,  ECG,  EGC,  EGCG,  Catechin 
and  CG)  were  obtained  from  Sigma-Aldrich  Chemical  Co.  (Dorset,  England), 
and  were  prepared  in  distilled  water. Jennifer  McGinn,  2002  Chapter  2,99 
The  chemical  composition  of  selected  grape  and  tea  based  extracts  (g 
100  gý)  received  from  Dr  G.  G.  Duthie  and  Dr  P.  T.  Gardner,  Rowett  Research 
Institute,  Aberdeen,  Scotland  (acquired  from  Unilever,  Wageningen, 
Netherlands)  was  determined  by  HPLC  and  is  shown  in  Tables  12  to  14. 
Chemical  composition  analysis  of  the  extracts  by  HPLC  was  carried  out  by 
Thomas  J  Lipton  Inc.  (London,  UK). 
2.6  Fractionation  of  green  tea  &  black  tea 
Samples  of  green  and  black  tea  were  fractionated  with  the  aim  of 
isolating  and  identifying  the  zone  of  antioxidant  and  vasodilatory  activity  and 
to  determine  the  phenolics,  specifically  catechins,  present. 
2.6.1  Pre-fractionation  tea  preparation 
An  initial  amount  of  Ig  of  Tetlcy's  (Dr.  J.  Leah,  The  Tetley  Group, 
325/347,  Oldfield  Lane  North,  Greenford,  Middesex,  UB6  OAZ)  coarse  grain 
green  tea  (code  B-50048)  and  dry  medium  ground  black  tea  (code  U-1704) 
was  brewed  in  100  mL  of  boiling  water  for  10  mins  to  allow  the  full  infusion 
of  the  tea  leaves  into  solution.  The  brewed  tea  was  then  allowed  to  cool  at 
room  temperature  for  30  mins  before  being  filtered  and  centrifuged  to  separate 
any  particles  from  the  tea  solution  and  stored  at  -80"C  for  further  analysis. 
Z6.2  Fractionation  of  green  tea 
A  preparative  HPLC  system  was  used  for  a  large-scale  fractionation 
based  on  differences  in  polarity  of  the  various  green  tea  catcchins.  The  system 
comprised  of  a  Rhcodyne  injector  model  3725  with  a  10  mL  injector  loop 
(HPLC  technology,  Herts,  UK),  Capital  25  cm  x  30  nim  i.  d.  10  [Im  ODS-H- 
optimal  HPLC  column  (Capital  HPLC,  Broxbum,  UK),  two  LC-  I  OA  pumps,  a 
CTO-6A  column  oven  set  at  40"C,  a  Shimadzu.  SPD  I  OAvp  absorbancc Jennifer  McGinn,  2002  Chapter  2,100 
Component  Grape  skin  extract 
(g/  I  00g- 
Grape  powder  extract 
(g/loog-1) 
Gallic  acid  1.540  1.929 
Caffeic  acid  1.842  2.727 
Ferulic  acid  0.192  1.428 
Catechin  6.701  15.080 
Epicatechin  4.089  2.583 
Quercetin  1.421  1.939 
Rutin  0.179  2.546 
Myricetin  0.779  2.991 
Cyanidin  chloride  0.765  1.048 
Malvidin  chloride  0.128  1.504 
Resveratrol  0.232  18.450 
TOTAL  17.868  52.125 
Table  12  Chemical  composition  of  grape  skin  and  grape  powder  extracts  as 
deten-nined  by  HPLC. 
Data  from  Thomas  J  Lipton  Ltd  (London,  UK) Jennifer  McGinn.  2002  Chapter  2,101 
Component  Green  tea 
extract  (g/100t 
(+)-Catechin  1.85 
Black  tea 
extract  (g/100g-1) 
1.7u 
(+)-Gallocatechin  0.80  2.40 
(+)-Gallocatechin  gallate  1.09  - 
(-)-Epicatechin  5.57  9.80 
(-)-Epigallocatechin  1.58  8.60 
(-)-Epicatechin  gallate  10.61  13.20 
(-)-Epigallocatechin  gallate  17.52  43.70 
Theaflavins  12.93  See  Table  14  below 
Flavonols  1.64  n.  s. 
Gallic  acid  4.53  n.  s. 
N-containing  compounds  0.90  0.80 
TOTAL  59.02  80.20 
Table  13  Chemical  composition  of  green  and  black  tea  extracts  as  determined 
by  HPLC. 
n.  s  =  not  specified.  Data  from  Thomas  J  Lipton  Ltd  (London,  UK) 
Theaflavin  21.4 
Theaflavin  3-gallate  -  29.9 
Theaflavin  Y-gallate  -  15.2 
Theaflavin  3,3'-digallate  -  27.5 
Unknown  -  5.9 
Table  14  Chemical  composition  of  black  tea  theaflavin  extract  as  determined 
by  HPLC  (g/100-1g). 
Data  from  Thomas  J  Lipton  Ltd  (London,  UK) Jennifer  McGinn,  2002  Chapter  2,102 
(Glasgow,  UK)  2700  data  handling  system  and  a  Gilson  FC  203  fraction 
collector  (Gilson  Medical  Electronics  Inc.,  USA)  (Figure  12).  Samples  were 
eluted  by  a7-  30%  gradient  of  acetonitrile  in  2%  formic  acid  and  held  at  30% 
for  5  mins.  Operating  at  20  mL  min",  fifty  successive  fractions  were  collected 
every  30  seconds  from  an  injection  of  10  mL  of  green  tea,  with  each  fraction 
containing  10  mL  of  cluent.  The  first  6  mins  of  eluent  was  discarded 
accounting  for  the  dead  volume  of  the  column.  Four  identical  10  mL  injection 
system  runs  were  carried  out,  with  a  total  pool  of  40  mL of  each  fraction  being 
collected  overall.  All  fractions  were  stored  at  -80*C. 
Z6.3  Fractionation  of  black  tea 
A  preparative  HPLC  system  was  used  for  a  large-scale  fractionation 
based  on  differences  in  polarity  of  the  various  tea  catechins  present  in  black 
tea  (Figure  12).  The  system  comprised  of  a  Rheodyne  injector  model  3725 
with  a  10  mL  in  ector  loop  (HPLC  technology,  Herts,  UK),  two  LC-10A 
pumps,  a  CTO-6A  column  oven  set  at  40'C,  a  Shimadzu  SPD  10Avp 
absorbance  detector  set  at  280  -  365  mn  (Shimadzu,  Kyoto,  Japan),  linked  to  a 
Reeve  analytical  (Glasgow,  UK)  2700  data  handling  system  and  a  Gilson  FC 
203  fraction  collector  (Gilson  Medical  Electronics  Inc.,  USA).  Samples  were 
run  using  a  Capital  15  cm  x  20  mm  i.  d.  ODS-H  optimal  column  (Capital 
HPLC,  Broxbum,  UK),  over  a5-  15  %  gradient  of  acetonitrile  in  2%  formic 
acid  over  the  initial  20  minutes,  then  15  -  35  %  over  the  remaining  20  -  30 
minutes.  The  first  6  min  of  eluent  was  discarded  accounting  for  the  dead 
volume  of  the  column.  Operating  at  10  mL/min,  sixty  successive  fractions 
were  collected  every  30  seconds  from  an  injection  of  10  mL  of  black  tea,  with 
each  fraction  containing  5  mL  of  eluent.  All  fractions  were  stored  at  -80"C. Jennifer  McGinn,  2002  Chapter  2,103 
2.6.4  Mass  Spectroscopy  analysis  of  green  &  black  tea 
fractions 
The  phenolic  profile  of  selected  green  and  black  tea  fractions 
exhibiting  high  antioxidant  activity  was  analysed  by  high  performance  liquid 
chromatography  -  mass  spectroscopy  -  mass  spectroscopy  (HPLC-MS-MS., 
Thermoquest,  San  Jose,  California).  A  LCQ  Duo  Instrument  MS 
(Thermoquest,  LTK)  comprising  a  TSP  AS  3000  series  auto-sampler  and  a  TSP 
P4000  quaternary  pump.  Reversed  phase  separations  were  carried  out  at  401C 
using  a  250  x  4.6  mm.  i.  d.  MAX-RP  80A  HPLC-  column  (Phenomemex, 
Macclesfield,  UK).  The  mobile  phase  was  a5-  30%  linear  gradient  over  60 
mins  of  acetonitrile  in  1%  formic  acid  eluted  at  a  flow  rate  of  I  mL  min-1. 
Short  isocratic  runs  (75%  B)  were  used  to  analyse  the  preparative  HPLC  tea 
fractions.  In  all  cases,  100  pL  of  each  selected  fraction  was  analysed  in  both 
positive  and  negative  ion  mode  (scanning  from  100.0  -  2000.0  amu),  using 
data  dependent  MS/MS.  Column  eluent  was  directed  to  a  UV-vis  6000 
photodiode  array  detector  operating  at  wavelengths  250  -  700  nrn. 
Spectral  and  colorimetric  methods 
Throughout  the  course  of  this  study,  the  use  of  colorimetric  and  spectral 
assays  have  played  an  important  role  in  determining  the  antioxidant  capacity 
and  presence  of  total  phenolics  and  catechins  in  various  samples.  These  assays 
have  been  used  in  several  different  sections  throughout  the  course  of  this 
study,  enabling  us  to  highlight  individual  features  of  individual  samples,  or 
allow  comparison  between  samples  in  each  study,  in  relation  to  their  activity, 
chemical  composition  and  content. Jennifer  McGinn,  2002 
2.7  Spectral  Assays 
Chapter  2,104 
2.7.1  Electron  Spin  Resonance:  a  measurement  of 
antioxidant  capacity 
The  ability  of  phenolic  compounds  to  reduce  radicals  in  the  aqueous 
phase  was  estimated  by  their  ability  to  reduce  the  Fremy's  salt  (potassium 
nitrosodisulphonate)  radical,  determined  by  adding  equal  volumes  of  the 
Fremy's  free  radical  and  the  compound  of  interest.  The  ESR  spectra  of  the 
low-field  resonance  of  the  Fremy's  radical  was  obtained  6  mins  after  the 
addition  of  the  mixture  by  which  time  the  reaction  was  complete.  Signal 
intensity  was  obtained  by  double  integration  and  the  concentration  calculated 
by  comparison  with  a  control  reaction  with  distilled  water  (Gardner  et  aL, 
1998). 
Spectra  were  obtained  at  21*C  on  a  Bruker  ECS  106  spectrometer 
operating  at  ca  9.5  GHz  (X-band  frequency)  and  equipped  with  a  cylindrical 
(TMIIO  mode)  cavity.  A  microwave  power  of  2  mW  and  a  modulation 
amplitude  of  0.01  mT  were  used. 
2.7.1.1  ESR  Analysis:  grape  and  tea  extracts 
The  ability  of  the  grape  and  tea  extracts  and  to  reduce  radicals  in  the 
aqueous  phase  were  estimated  by-  adding  3  mL  (0.0025%  solution)  of  the 
extract  to  an  equal  volume  of  a1  mM  solution  of  Fremy's  free  radical  salt 
(potassium  nitrosodisulphonate)  in  an  ethanol/water  mix  (12:  88  v/v),  operating 
on  the  system  described  above  (Section  2.7.1).  All  samples  were  run  in 
duplicate,  standardised  using  Trolox.  Results  expressed  as  the  mean  number  of 
radicals  reduced/L. Jennifer  McGinn,  2002  Chapter  2,105 
2.7.1.2  ESR  Analysis:  green  tea  fractions 
The  ability  of  the  green  tea  fractions  to  reduce  radicals  in  the  aqueous 
phase  was  estimated  by  adding  3mL  (0.0025%  solution)  of  a  fraction  to  an 
equal  volume  of  a  50  ýLM  solution  of  Fremy's  free  radical  salt  (potassium 
nitrosodisulphonate)  in  an  ethanol/water  mix  (12:  88  v/v),  operating  on  the 
system  described  above  (Section  2.7.1).  All  samples  were  ran  in  duplicate, 
standardised  using  Trolox,  and  are  expressed  as  the  mean  number  of  radicals 
reduced/L. 
Z7.2  Ferric  Reducing  Ability  of  Plasma:  an  index  of 
antioxidant  activity 
Plasma  antioxidant  capacity  was  estimated  from  its  ferric  reducing 
ability  (FRAP)  where  development  of  an  intense  blue  colour  resulting  from 
the  conversion  of  a  Fe  (III)-2,4,6-Tri  (2-pyr-idyl)-s-triazine  (iron  chloride- 
TPTZ)  complex  to  Fe  QI)-TPTZ  (iron  sulphate-TPTZ),  with  an  concomitant 
increase  in  absorbance  at  593  mn,  being  directly  related  to  the  amount  of  the 
reductant  present  in  each  sample.  Grape  and  tea  extracts,  epicatechin  and 
catechin  derivatives  (I  mM)  and  green  and  black  tea  fractions  were  run  on  the 
spectrometer  (Cecil  3000  series  UV/visible  spectrophotometer,  Cecil 
Instruments  Ltd,  Cambridge,  UK)  4  mins  after  the  addition  of  the  FRAP 
reagent  (acetate  buffer,  pH  3.6;  FeC13,  TPTZ  in  40  mM  HCI)  to  the  reaction 
mixture  (0.025%  solution).  The  absorbance  change  of  the  aliquot  diluted  in 
distilled  water  is  due  to  the  combined  reductive  activity  of  all  the  reacting 
antioxidants  present  in  the  sample.  Optical  density  was  compared  to  a  standard 
curve  prepared  with  0-1.0  mM  ferrous  sulphate  (FeSOA  Grape  and  tea 
extract,  epicatechin  derivates  and  green  and  black  tea  fractions  were  all  run  in 
duplicate.  Results  are  expressed  as  the  mean  concentration  of  Fe  (II) 
produced/mM  of  2  samples  (Benzie  &  Strain,  1996). Jennifer  McGinn,  2002  Chapter  2,106 
2.8  Colorimetric  Assays 
2.8.1  Determination  of  Total  Phenol  Content 
The  total  phenol  content  is  determined  using  the  Folin-Ciocalteu 
method  of  Singleton  and  Rossi  (1965)  In  brief,  0.1  mL  of  grape  or  tea  based 
extracts,  green  tea  epicatechin  and  catechin  derivatives  and  green  and  black 
tea  fractions  were  added  to  5  mL  of  a  1:  10  dilution  of  Folin-Ciocalteu  reagent 
and  0.9  mL  of  distilled  water.  After  five  minutes,  3.5  mL  of  115g  Na2C03/L 
was  added  and  left  at  room  temperature  for  2  hours.  Absorbance  was  read  at 
765  nm  against  a  water  blank  using  a  Cecil  3000  series  UV/visible 
spectrophotometer  (Cecil  Instruments  Ltd.,  Cambridge,  UK).  Optical  density 
was  compared  to  a  standard  curve  prepared  with  0  to  500  pL  gallic  acid  mL", 
with  results  being  expressed  as  mean  pg/mL  gallic  acid  equivalents  (GAE). 
Grape  and  tea  extracts,  epicatechin  derivates  and  green  and  black  tea  fractions 
were  all  run  in  duplicate. 
Z8.2  Spectral  Assay  for  Determination  of  Total 
Catechins 
The  total  catechin  content  of  the  epicatechin  and  catechin  derivatives 
and  the  green  and  black  tea  fractions  was  determined  using  a  method  adapted 
by  Kivitis  et  aL,  (1997).  Total  catechin  content  of  the  green  tea  derivatives  and 
tea  fractions  was  determined  by  adding  3  mL  of  6  mM  DMACA 
(dimethylaminocinnamaldehyde)  in  a  methanol/percholoric  acid  /water  mix 
(v/v  8:  1:  1)  to  I  mL  of  the  tea  fractions  or  epicatechin  derivative.  The 
absorption  spectrum  of  the  DMACA/fraction  mix  was  measured  from  500  - 
750  mn,  4  min  after  the  addition  of  the  DMACA  reagent.  All  samples  were 
run  in  duplicate.  The  concentration  of  catechin  present  was  calibrated,  from  0 
to  100  ýig  mL-1,  and  related  to  the  peak  area  of  absorption.  Sample  blanks 
were  also  measured.  To  quantify  the  total  amount  of  catechin  present  in  a 
given  fraction,  the  absorbance  was  measured  between  2  wavelengths  specific Jennifer  McGinn,  2002  Chapter  2,107 
for  catechins,  604  mn  and  684  run.  With  the  addition  of  the  DMACA, 
solutions  are  seen  to  develop  a  highly  specific  colour  complex,  turning  from 
pale  yellow  to  a  dark  blue  with  increasing  catechin  content.  Results  are 
expressed  as  mean  total  catechins  (mg/L). 
2.9  Chemicals:  HPLC,  spectral  &  colorimetric 
analysis 
Methanol  (HPLC  grade),  ethanol  and  acetonitrile  (HPLC  Grade)  were 
obtained  from  Rathbum  Chemicals  (Walkerburn,  UK).  Formic  acid, 
percholoric  acid,  hydrochloric  acid,  acetic  acid,  Folin  and  Ciocalteu  Reagent 
(2.0  normal),  DMACA,  TPTZ,  potassium  nitrodisulphonate,  sodium  acetate, 
Trolox  (a  tocopherol  analogue),  gallic  acid,  catechin,  iron  sulphate  (FeS04) 
and  iron  chloride  (FeC13)  were  supplied  by  Sigma-Aldrich  Chemical  Co. 
(Poole,  Dorset,  UK).  Disodiurn  carbonate  (Na2C03)  were  obtained  from  BDH 
Laboratory  Supplies  (Poole,  UK). 
2.10  Statistical  analysis  of  vasodilatory,  spectral 
colorimetric  assays 
All  vasodilatory  experimental  results  are  expressed  as  mean  values  ± 
standard  error  of  mean  of  n  experiments,  where  n=  the  number  of  animals  for 
each  set  of  experiments.  Analysis  was  carried  out  using  a  one-way  analysis  of 
variance  (ANOVA),  followed  by  a  Dunnet's  Multiple  comparisons  test,  where 
ns  =  not  significant,  *P<0.05,  **P<0.01,  ***P<0.001  as  compared  to 
experimental  control. 
Multivariate  correlation  analysis  of  experimental  data  was  performed 
according  to  Pearson.  Correlation  calculations  quantified  the  relationship 
between  two  sets  of  experimental  variables.  The  correlation  coefficient  r, 
quantified  the  direction  and  magnitude  of  the  correlation  and  ranged  from  -1 
to  +1.  Values  where  P<0.05  were  considered  statistically  significant. Jennifer  McGinn,  2002  Chapter  2,108 
Due  to  the  complex  nature  of  the  biphasic  extract  response  curves, 
pIC50  (inhibitory  concentration  which  induces  50%  of  maximum 
vasorelaxation)  values  were  not  calculated.  pIC50  values  have  been  calculated 
for  ACh  CCRC.  Threshold  concentrations  for  the  induction  of  the  second 
phase  vasodilator  response,  were  calculated  from  each  individual  experimental 
trace  to  reflect  differences  in  potency  for  each  individual  grape  and  tea  based 
extract  and  green  tea  catechin  and  epicatechin  derivates  used  in  the  course  of 
this  study.  The  threshold  concentration  is  defined  as  the  lowest  concentration 
of  extract  that  caused  a  significant  vessel  relaxation. 
All  spectral  and  colorimetric  assay  results  with  rape  and  tea  extracts  and 
epicatechin  derivatives  are  expressed  as  mean  values,  where  all  samples  have 
been  run  in  duplicate  and  calibrated  against  relevant  standards.  Analysis  was 
carried  out  using  a  one-way  analysis  of  variance  (ANOVA),  followed  by  a 
Dunnet's  Multiple  comparisons  test,  where  ns  =  not  significant,  *P<0.05, 
**P<0.01,  ***P<0.001,  as  compared  to  relevant  control  for  each  individual 
assay. 
The  Dunnet's  Multiple  comparisons  test,  like  that  of  the  Bonferroni, 
Tukey  and  Newman-Kuels,  are  post  test  which  are  modifications  of  standard  t- 
tests.  They  account  for  multiple  comparisons  as  well  as  the  fact  that  the 
comparisons  maybe  interrelated.  Dunnet's  Multiple  comparisons  test  allows 
the  control  data  to  be  compared  to  all  other  variables  but  not  to  one  another. Jennifer  McGinn,  2002 
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Chapter  3  Vasodilation  and  antioxidant 
activities  of  grape  and  tea  based  extracts 
3.1  Introduction 
The  incidence  of  CHD  mortality  in  France  has  been  shown  to  be 
significantly  lower  than  that  of  other  western  industrialised  countries  with 
similar  high  dietary  fat  intakes  and  smoking  tendencies.  This  phenomenon 
discussed  in  more  detail  in  Chapter  1,  has  been  referred  to  as  the  'Trench 
Paradox"  and  has  been  attributed  to  the  high  consumption  of  red  wine  by  the 
French  (Renaud  &  de  Logeril,  1992). 
There  is  evidence  that  the  phenolic  components  of  red  wine  may  be 
cardio-protective  and  decrease  the  risk  of  CHD  mortality.  Ingestion  of  red 
wine  significantly  increases  plasma  phenolic  acid  concentration  (Duthie  et  aL, 
1998;  Cacetta  et  aL,  2000).  Polyphenols  inhibit  human  platelet  aggregation 
and  eicosanoid  synthesis  (Demrow  et  aL,  1995;  Pace-Asiak  et  aL,  1996)  and 
reduce  the  susceptibility  of  human  plasma  low-density  lipoprotein  to  lipid 
peroxidation  (Frankel  et  aL,  1993;  Furhman  et  aL,  1995).  Their  alleged 
beneficial  effects  have  been  attributed  to  their  antioxidant  activity. 
Natural  dietary  phenolics  have  been  shown  to  induce  endothelium- 
dependent  vasodilation  in  both  human  and  rodent  arteries  (Andriambeloson  et 
aL,  1998;  Flesch  et  aL,  1998).  The  mechanism  of  this  endothelium-dependent 
vasodilation  is  considered  to  be  via  nitric  oxide  (NO)  and  subsequent  increases 
in  cGMP  (Fitzpatrick  et  aL,  1993;  Andriambeloson  et  aL,  1997;  Flesch  et  aL, 
1998).  However,  the  phenolic  component(s)  within  the  grape  which  are 
responsible  for  inducing  this  event  and  the  exact  mechanisms  by  which  these 
compounds  produce  this  effect  remain  unknown. 
Tea,  like  red  wine,  is  a  rich  source  of  polyphenols.  Tea  leaves  have  been 
found  to  contain  more  than  35%  of  their  dry  leaf  weight  as  polyphenols Jennifer  McGinn,  2001  Chapter  3,113 
(Scrafini  et  aL,  1996).  Both  green  and  black  tea  posses  strong  antioxidant 
activity  and  can  enhance  plasma  antioxidant  capacity  (Xic  et  aL,  1993; 
Serafini  et  aL,  1996;  Yokozawa  &  Dong,  1997).  Black  tea  has  also  been 
shown  to  have  anti-atherosclcrotic  activity  (Yokozawa.  et  A,  1998).  The 
vasodilator  activity  of  green  tea  has  been  attributed  to  its  (-)-epicatechin 
content,  to  the  release  of  NO  from  vascular  cndothelial  cells,  and  to  the 
inhibition  of  calcium  influx  (Huang  et  aL,  1998;  1999).  The  vasodilator  effect 
of  black  tea  has  not  been  investigated  to  date. 
Recently  a  striking  correlation  has  been  identified  between  the  ability  of 
red  wines  to  induce  vasodilation  in  the  isolated  rabbit  aorta  and  the  antioxidant 
activity  of  the  same  wines  (Bums  et  aL,  2000).  This  study  will  determine  the 
vasodilator  effects  of  grape  and  tea  based  extracts  in  vitro,  investigate  their 
mechanisms  of  vasodilation  and  to  relate  this  to  the  antioxidant  activity  and 
phenolic  content  of  each  extract. 
3.2  Materials  &  Methods 
3.2.1  Vasodilation  activity 
In  brief,  isolated  rabbit  aortic  vessels  were  suspended  in  standard  10 
mL  organ  baths  (Figure  11)  filled  with  Krebs  buffer  solution,  continuously 
oxygenated  with  16%  02,5%  C02  and  79%  N2  and  maintained  at  37'C,  to 
mimic  the  internal  environment.  Vessels  were  placed  under  an  optimal  resting 
tension  of  2  g.  Vessel  contraction/relaxation  was  measured  via  an  isometric 
force  transducer. 
After  an  equilibration  period,  vessels  were  twice  maximally  contracted 
with  50  mM  KCI  and  washed  out  thoroughly  with  Krebs  solution.  In  some 
experiments  the  luminal  endothelium  was  removed  prior  to  the  start  of  the 
experiment.  After  washing  and  returning  to  initial  baseline  tension,  vessels 
with  and  without  functional  endothelium  were  precontracted  with Jennifer  McGinn,  2001  Chapter  3,114 
submaximally  PE  (10-7  M).  In  some  experiments  where  indicated,  the 
thromboxane-mimetic  U44619  (10-9  M)  was  used  to  elevate  vascular  tone. 
Once  a  stable  plateau  had  been  reached,  CCRC  for  the  diluted  grape 
and  tea  based  extracts  (0.0002  -  14  mg  ml;  ')  were  obtained.  The  mechanisms 
of  vasodilation  were  investigated  in  the  presence  of  several  pharmacological 
inhibitors,  namely,  the  NO  synthase  inhibitor,  L-NAME  (100  PM),  the 
prostaglandin  cyclo-oxygenase  inhibitor,  indomethacin  (1,100  gM),  the 
thromboxane  antagonists,  ICI  192,605  (10  gM)  and  GR  32191  (1  [M)  and 
ODQ  (10  gM),  the  soluble  guanylate  cyclase  inhibitor,  individually  and  in 
combination. 
3.  Z2  Antioxidant  activity 
Antioxidant  activity  of  the  grape  and  tea  based  extracts  in  this  study, 
wcre  determined  using  spccific  spcctral  and  colorimetric  assays  discusscd  in 
detail  in  Chapter  2. 
Total  antioxidant  activity  of  each  extract  was  detennined  using  ESR 
spectroscopy,  where  the  ability  of  the  extracts  to  reduce  radicals  in  the 
aqueous  phase  was  estimated  by  adding  the  extract  to  an  equal  volume  of  a1 
mM  Fremy's  salt  free  radical.  Results  were  standardised,  using  Trolox. 
Plasma  antioxidant  capacity  was  also  estimated  from  the  extracts  ferric 
reducing  ability  (FRAP)  at  593  run.  The  development  of  an  intense  blue  colour 
resulting  from  the  conversion  of  a  Fe(III)-2,4,6-Tri-2-pyr-idyl)-s-triazine 
(TPTZ)  complex  to  Fe(II)-TPTZ  being  directly  related  to  the  amount  of 
reductant  present  in  the  sample.  Results  are  expressed  as  the  concentration  of 
Fe(H)  produced/mM  (Benzie  &  Strain,  1996). 
Total  phenol  content  of  the  grape  and  tea  based  extracts  was 
determined  and  expressed  as  gallic  acid  equivalents  (GAE)  using  the  Folin- 
Ciocalteu  method  at  765  run  (Singleton  &  Rossi,  1965). Jennifer  McGinn,  2001 
3.3  Results 
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3.3.1  Vasodilator  effect  of  grape  &  tea  based  extracts 
Vasorelaxation  was  induced,  to  varying  degrees,  by  all  grape  and  tea 
based  extracts  investigated  in  this  study.  The  CCRCs  to  each  extract,  from 
0.0002  to  14  mg  mL",  in  isolated  rabbit  aortic  vessels  precontracted  with  PE 
is  shown  in  Graph  2.  Time  matched  controls  for  each  extract  were  also  run  to 
demonstrate  the  effect  of  each  extract  on  vascular  tension  as  opposed  to  the 
natural  relaxation  response  of  each  vessel  with  time  (Graph  3).  Relaxation 
induced  by  acetylcholine  (ACh)  in  vessels  with  functional  endothelium, 
induced  a  maximum  relaxation  of  97%  with  a  pIC50  of  7.5  ±  0.1,  and  23%  in 
vessels  without  intact  functional  endothelium  with  a  pIC50  of  1.2  :h0.2  of  PE- 
induced  tone,  as  compared  to  vasorelaxation  induced  by  each  extract  shown  in 
Graph  4. 
Figure  13  displays  a  sample  vasorelaxation  trace  of  vasodilation 
induced  by  ACh  with  and  without  functional  endothelium.  following 
preconstriction  with  PE.  Similarly,  Figure  14  displays  a  sample  trace  of  vessel 
maximal  contractile  responses  to  50  mM  KCL  Table  15  displays  the  threshold 
concentrations,  that  is  the  lowest  concentration  that  caused  a  significant 
relaxation,  for  the  second  phase  and  maximum  relaxation  values  for  all 
extracts  tested  in  this  study.  Hence,  the  extracts  were  less  potent  than  ACh, 
inducing  a  maximum  vasodilation  of  only  68%.  Figure  15  show  a  sample  trace 
of  the  vasorelaxation  induced  by  green  tea,  grape  powder  and  grape  skin 
extracts. (D 
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3.3.2  Vasodilation  induced  by  grape  based  extracts 
The  CCRCs  for  grape  skin,  grape  powder,  French  grape  seed  and  French 
grape  skin  extracts  were  all  biphasic.  There  is  a  small  vasodilation  (8  -  25%  of 
maximum  vasodilation)  at  low  concentrations,  which  has  been  termed  the  first 
phase,  and  a  more  profound  relaxation  at  higher  increasing  extract 
concentrations  (-60%  relaxation  of  PE-induced  preconstriction),  subsequently 
termed  the  second  phase.  In  the  case  of  all  grape  based  extracts,  this  second 
phase  was  not  maintained  at  higher  extract  concentrations,  with  vasodilation 
reversing  in  a  concentration  dependent  manner  (Graph  2).  Graph  2  also 
demonstrates  that  the  French  grape  seed  extract,  which  although  did  not 
induced  the  highest  maximum  vasorelaxation  value,  was  the  most  potent  with 
a  maximum  relaxation  being  achieved  by  0.04  mg  mL-1  compared  to  other 
extracts  which  did  not  achieved  vasodilation  until  concentrations  greater  than 
0.14  mg  m1:  1. 
3.3.2.1  Grape  skin  extract 
Grape  skin  extract  induced  the  greatest  degree  of  vasorelaxation 
(63.8%  PE-induced  preconstriction)  of  all  extracts  investigated  in  this  study. 
The  first  phase  of  the  vasodilator  response  was  not  abolished  by  the  presence 
the  of  the  nitric  oxide  synthase  inhibitor  L-NAME  (100  [M)  or  removal  of  the 
endotheliurn  (Graph  5)  but  was  inhibited  by  the  prostaglandin  cyclo- 
oxygenase  inhibitor  indomethacin  (100  [tM,  but  not  1  ýM)  (P<0.001  at  0.014 
mg  ml;  ')  and  by  10  pM  ICI  192,605  (P<0.05  at  0.014  mg  ml;  ')  (Graph  6). 
Neither  indomethacin  or  ICI  192,605  inhibited  the  second  phase,  which  was 
however,  abolished  by  L-NAME  and  removal  of  the  endothelium  (Graph  5). 
This  indicates  that  the  grape  skin  extract  induced  endothelium-NO- 
independent  prostaglandin  related  vasodilation  in  the  first  phase  response  and 
endothelium-NO-dependent  vasorelaxation  in  the  second  phase. 
The  thromboxane  A2  (TXA2)  antagonist  devoid  of  partial  agonist 
activity,  GR  32191  did  not  inhibit  the  first  phase,  but  this  was  subsequently 
inhibited  by  10  pM  ODQ  (P<0.05  for  concentrations  >0.1  mg  ml;  ')  (Graph Jennifer  McGinn,  2002  Chapter  3,121 
7).  A  combination  of  removal  of  the  endothelium,  presence  of  L-NAME  and 
indomethacin  (100  pM)  were  required  to  totally  abolished  the  grape  skin 
extract  vasorelaxation  at  all  concentrations  of  the  extract  (Graph  8). 
The  vasodilator  response  to  the  grape  skin  extract  when  the 
thromboxane  mimetic  U44619  (Table  16)  was  used  to  elevate  vascular  tone  as 
compared  to  PE  (10"9  M)  demonstrated  a  concentration-dependent  response. 
The  biphasic  nature  of  the  response  curve  was  retained,  but  the  second  phase 
was  maintained  at  higher  extract  concentrations  in  U46619-precontracted 
vessels  (Graph  9)  as  compared  to  PE-precontracted  vessels  where  there  was 
reversal  of  the  relaxation  response. 
Table  16  Preconstriction  to  PE  and  U44619. 
Degree  of  preconstriction  to  PE  (10-7  M)  and  U46619  (10-9  M)  in  all 
experimental  groups,  in  the  presence  of  L-NAME  (100  pM)  and  L-NAME  and 
indomethacin  (I  pM)  as  a%  KCI  contraction  (50  mM)  in  intact  aortic  vessels. 
Exp.  Group  PE  n  U46619  n 
Extract  67%  ±2  6  71%  ±1  6 
Extract  &  L-NAME  68%±  6  6  75%±4  4 
Extract  &  L-NAME  79%  ±3  6  76%±2  4 
&  indomethacin 
All  data  expressed  as  mean  %  relaxation  values  ±  standard  error  of  mean.  n 
number  of  animals. 
3.3.2.2  Grape  powder  extract 
A  grape  powder  extract  was  also  able  to  induce  vasorelaxation  in 
preconstricted  vessels.  This  extract  constituted  a  powder  extract  of  the  whole 
grape,  both  skin,  seeds  and  pulp.  The  grape  powder  extract  induced  biphasic 
vasorelaxation,  with  maximum  relaxation  value  of  up  to  59%  of  PE-induced 
preconstriction  (Table  15),  then  reversal  of  the  vasodilator  response  with 
increasing  extract  concentrations.  As  with  the  grape  skin  extract,  the  presence Jennifer  McGinn,  2002  Chapter  3,122 
of  L-NAME  was  not  able  to  abolish  the  first  phase  response,  but  did  abolish 
the  second  phase  (Graph  10),  indicating  the  grape  powder  extracts  induces 
vasodilation  via  endothelium-dependent  and  independent  mechanisms.  Due  to 
the  limited  supply  of  the  grape  powder  extract,  no  further  studies  were  carried 
out  using  this  extract.  Graph  II  shows  a  comparison  of  the  vasodilator 
responses  of  the  grape  powder  and  skin  extracts  in  vitro. 
3.3.2.3  French  grape  seed  &  skin  extracts 
The  vasodilation  induced  in  vitro  by  a  French  grape  seed  extract  and  a 
French  grape  skin  extract  were  also  investigated.  Both  extracts  induced 
significant  vasorelaxation  in  vessels  preconstricted  with  PE.  As  before,  both 
extracts  induced  biphasic  vasodilation,  with  an  initial  first  phase  of  dilation  at 
low  extract  concentrations  (-  10  %  PE  precontraction),  then  a  further  second 
phase  with  increasing  concentrations  that  was  not  maintained  with  the  highest 
extract  concentrations  inducing  reversal  of  the  relaxation  response  (Graph  12). 
French  grape  seed  extract  was  found  to  be  the  most  potent  all  extracts 
investigated  in  this  study  inducing  vasorelaxation  at  a  lower  concentration 
than  all  other  extracts. 
In  the  case  of  both  extracts,  the  concentration  dependent  response 
curve  induced  by  both  extracts  was  abolished,  in  the  first  and  second  phases, 
by  the  presence  of  L-NAME  and  removal  of  the  endothelium  (Graphs  13  & 
14),  indicating  vasorelaxation  by  the  2  extracts  to  be  via  endothelium-NO- 
dependent  mechanisms. 
3.3.3  Vasodilation  induced  by  tea  based  extracts 
The  CCRCs  for  green  and  black  tea  and  black  tea  theaflavin 
derivatives,  were  also  all  biphasic  (Graph  15)  and  remarkably  similar  to  one 
another,  with  a  first  phase  equivalent  to  that  observed  with  the  grape  based 
extracts  and  slight  reversal  of  the  vasodilation  response.  The  second  phase  of 
relaxation,  of  25  -  40%  PE-induced  preconstriction,  occurred  at  higher Jennifer  McGinn,  2002  Chapter  3,123 
threshold  concentrations  than  those  required  to  initiate  the  second  phase 
contractions  by  the  grape  extracts  (Graph  2). 
Table  15  shows  the  threshold  concentrations  for  the  second  phase  and 
maximum  vasorelaxation  values  induced  in  the  isolated  aortic  vessels  for  the 
green  and  black  tea  extracts. 
3.3.3.1  Green  tea  extract 
The  first  phase  of  the  response  was  not  observed  in  the  presence  of  100 
pM  L-NAME,  100  gM  indomethacin,  10  ptM  ICI  192,605  or  after  the 
removal  of  the  endothelium.  (Graphs  16  &  17).  The  presence  of  indomethacin 
(100  pM)  and  ICI  (10  M)  both  induced  vasoconstriction  in  the  aorta  (Graph 
17).  10  IiM  ICI  192,605,100  ptM  L-NAME,  100  gM  indomethacin  and 
endothelial.  removal  on  their  own  did  not  inhibit  the  second  phase  vasodilation 
to  higher  concentrations  of  the  extract  (Graph  17).  Only  the  combination  of 
endothelial  removal  and  indomethacin  significantly  reduced  the  second  phase 
response  (P<0.01  at  1.4  ing  mL";  P<0.001  at  14  mg  m1:  1). 
3.3.3.2  Black  tea  extract 
The  first  phase  response  was  abolished  in  the  presence  of  100pt  M  L- 
NAME  (Graph  18)  and  after  removal  of  the  endothelium,  100  gM 
indomethacin  and  10  [tM  ICI  192,605  (Graph  19).  As  with  the  green  tea 
extract,  the  black  tea  extract  also  induced  a  vasoconstriction  in  the  presence  of 
indomethacin  and  ICI  (Graph  19).  100  gM  L-NAME  and  removal  of  the 
endotheliurn  reduced  the  second  phase  vasodilator  response  to  high  extract 
concentrations  (P<0.05  at  1.4  and  4  mg  mL").  Combinations  of  L-NAME, 
indomethacin  and  endothelial  removal  were  not  able  to  abolish  this  second 
phase  (Graph  19),  although  this  combination  did  abolish  these  responses  to  the 
grape  skin  extract.  Only  a  combination  of  endothelial  removal  and 
indomethacin  appear  to  be  able  to  abolish  this  response. Jennifer  McGinn,  2002  Chapter  3,124 
3.3.3.3  Black  tea  theaflavin  extract 
Theaflavins  are  formed  by  the  enzymatic  oxidation  of  catechins  in 
green  tea  during  fermentation  in  the  manufacture  of  black  tea.  They  are  high 
molecular  weight  compounds  which  give  black  tea  its  characteristic  astringent 
taste  and  black  colour  (Balentine  et  aL,  1997). 
The  vasodilation  induced  by  the  black  tea  theaflavin  derivative  was 
also  investigated.  This  extract  produce  a  similar  biphasic  response  curve  to 
that  of  the  green  and  black  tea  extracts,  with  an  initial  first  phase  response  at 
low  extract  concentrations  (-12%  of  PE-induced  preconstriction)  and 
subsequent  reversal  of  the  response  then  a  second  profound  phase  of 
relaxation,  to  the  extracts  maximum  vasodilatory  response  (28.3  %  PE- 
induced  preconstriction)  at  the  highest  extract  concentrations  (Graph  20). 
3.3.4  Antioxidant  activities  of  grape  &  tea  based  extracts 
To  investigate  the  antioxidant  abilities  of  the  grape  and  tea  extracts,  3 
specific  spectral  and  colorimetric  antioxidant  assays  were  carried  out.  ESR, 
determines  the  radical  quenching  ability  of  the  extracts,  FRAP  analysis, 
estimates  their  ferric  reducing  ability  and  the  total  phenol  content.  Table  17, 
displays  the  values  obtained  by  each  individual  extract  in  each  of  the  3  assays. 
3.3.4.1  Electron  Spin  Resonance  (ESR)' 
The  antioxidant  activity  by  ESR  for  each  of  the  grape  and  tea  extracts,  with 
the  exception  of  the  Theaflavin  extract,  is  shown  in  Graph  21.  All  results  are 
expressed  as  the  number  of  radicals  reduced  by  each  individual  extract/mg  x 
1018  .  The  green  tea  extract  is  found  to  have  the  highest  antioxidant  capacity 
followed  closely  by  the  black  tea  extract.  All  the  grape  based  extracts  have 
dramatically  lower  antioxidant  capacity  as  compared  to  the  tea  extracts  (Graph 
21). (4-4 
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3.3.4.2  Ferric  reducing  ability  (FRAP) 
Antioxidant  ability  has  also  been  determined  by  the  ferric  reducing 
ability  of  each  extract,  analysed  by  the  FRAP  assay.  All  results  are  expressed 
as  the  concentration  of  Fe(II)  produced  by  each  extract  during  its  reduction 
from  Fe(III).  As  with  the  previous  spectral  assay  a  similar  pattern  emerges, 
with  the  tea  extracts  being  higher  in  activity  than  the  grape  based  extracts 
(Graph  22).  In  addition,  the  French  grape  seed  extract  is  also  significantly 
higher  in  activity  than  the  other  related  grape  based  extracts. 
3.3.4.  .3  Total  phenolic  content 
The  total  phenol  colorimetric  assay,  is  a  non-specific  assay  which 
identifies  the  presence  of  gallic  acid  groups,  with  all  results  being  expressed  as 
gallic  acid  equivalents  (GAE).  As  with  the  previous  2  spectral  assays,  the  tea 
extracts  and  the  French  grape  seed  extract  are  higher  in  total  phenols  than  the 
remaining  grape  extracts  (Graph  23). 
The  statistical  significance  of  the  relationships  between  the  antioxidant 
activity,  total  phenolic  content  and  the  maximum  %  vasodilation  induced  by 
each  extract  was  analysed  using  Pearsons  correlation  (Graph  23).  Using 
correlation  analysis,  maximum  vasodilation  was  inversely  correlated  to 
antioxidant  activity  as  determined  by  ESR  (r  =  -0.87,  P>0.05,  P=0.02)  but 
not  significantly  correlated  to  antioxidant  activity  by  FRAP  analysis  (r  =- 
0.74,  p=0.09).  The  small  P  value  indicates  that  this  is  a  true  relationship 
between  the  vasodilation  and  ESR  and  is  not  coincidental.  Total  phenol 
content  was  also  determined  to  be  significantly  correlated  with  the  maximum 
vasodilation  induced  by  each  extract  (r  =  -0.95,  P<0.01,  P=0.01).  The 
negative  r  values  indicate  that  as  one  variable  increases  the  other  decreases.  It 
is  therefore  evident  that  higher  the  antioxidant  activity  of  the  extracts,  the  less 
active  they  are  as  vasodilators  of  isolated  aortic  vessels  in  vitro. Jennifer  McGinn,  2002 
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These  results  demonstrate  that  all  the  extracts'  tested  in  this  study, 
induced  vasodilation  in  isolated  aortic  vessels,  to  varying  degrees.  The  grape 
and  tea  extracts  all  produced  easily  distinguishable  concentration  response 
curves.  All  extracts  induced  a  biphasic  concentration-dependent 
vasorelaxation  in  aortic  rings.  The  antioxidant  capacity  of  the  extracts 
consistently  showed  the  tea  extracts  to  be  more  effective  antioxidants  than  the 
grape  based  extracts,  with  the  exception  of  the  French  grape  seed  extract,  the 
opposite  pattern  as  highlighted  by  the  vasodilation  studies. 
3.4.1  Grape  skin  extract 
Vasorelaxation  with  the  grape  skin  extract,  in  the  first  phase  response, 
was  unaffected  by  the  removal  of  the  endothelium,  by  the  presence  of  the  NO 
synthase  inhibitor  L-NAME  or  by  indomethacin  (100  [iM),  indicating  that 
endothelium-derived  NO  is  not  responsible  for  this  vasodilator  effect.  ODQ 
suppressed  the  first  phase  response  of  the  grape  skin  extract  induced 
suggesting  that  soluble  guanylate  cyclase  activation  may  be  involved  in  this 
response.  ICI  192,605,  the  TXA2  inhibitor,  also  inhibited  this  first  phase 
response,  but  this  inhibitor  only  has  partial  agonist  activity,  so  the  effects  of 
GR  32191,  the  TXA2  antagonist  devoid  of  partial  activity  was  also 
investigated.  GR  32192  did  not  affect  the  first  phase  vasodilator  response 
indicating  that  the  activation  of  TXA2  receptors  do  not  play  a  role  in  this 
response.  Therefore,  while  the  mechanism  involved  in  this  first  phase 
vasodilator  response  induced  by  the  grape  skin  extract  is  obviously  multi- 
factorial,  it  occurs  independent  of  the  vascular  endothelium  and  the  release  of 
NO. 
The  second  phase  of  the  grape  skin  extract  vasorelaxation  was  inhibited 
by  removal  of  the  endothelium,  L-NAME  and  ODQ  indicating  clearly  that 
endothelium-derived  NO  is  responsible  for  this  vasodilation.  This  phase  was 
resistant  to  indomethacin,  ICI  192,605  and  GR  32191,  ruling  out  a  role  for Jennifer  McGinn,  2002  Chapter  3,128 
prostaglandins  and  thromboxanes  in  this  effect.  The  second  phase  results  are 
consistent  with  previous  studies  that  red  wine  and  grape-derived  products 
induce  endothelium-NO-dependent  vasorelaxation  in  isolated  rat  aortic  vessels 
(Fitzpatrick  et  aL,  1993;  Andriambeloson  et  aL,  1997;  Flesch  et  A,  1998). 
Work  by  these  authors  did  not  highlight  a2  phase  response  by  red  wine  and 
grape  products  as  shown  in  this  study.  Anthocyanins  and  oligomeric 
condensed  tannins  isolated  from  grape  skin  extracts  have  been  previously 
shown  to  exhibit  vasorelaxation  to  the  same  extent  as  the  original  red  wine 
polyphenolic  fraction  (Andriambeloson  et  aL,  1997b). 
As  a  combination  of  endothelium  removal,  L-NAME  and  indomethacin 
totally  abolished  the  vasodilator  responses,  this  supports  the  assumption  that 
this  extract  induces  vasodilation  by  complex  mechanisms  including 
endothelium-independent  mechanisms,  possibly  via  vasodilating 
prostaglandins,  via  prostacyclin  and  endothelial  NO  production. 
3.4.2  Grape  powder  extract 
The  grape  powder  extract  first  phase  vasodilator  response  was  not 
inhibited  by  the  presence  of  L-NAME,  but  abolished  the'second  phase 
response,  indicating  that  as  with  the  grape  skin  extract  vasodilation  is 
occurring  via  endothelium-NO-independent  and  dependent  mechanisms  in  the 
rabbit  aortic  vessels.  On  comparison  of  the  grape  skin  and  powder  extracts,  the 
grape  powder  extract  is  found  to  be  more  potent  at  the  first  phase  vasodilator 
response  than  the  grape  skin  extract.  Indicating  that  the  both  the  flesh  and  the 
seeds  of  the  grape  also  have  a  potential  for  relaxation  and  not  all  vaso-active 
components  are  derived  from  primarily  the  grape  skin. 
3.4.3  French  grape  skin  &  seed  extracts 
Vasorelaxation  with  the  French  grape  seed  and  skin  extracts  in  the  first 
phase  vasodilator  response  was  abolished  by  the  presence  of  L-NAME  and 
removal  of  the  endothelium.  The  second  phase  response  was  also  abolished  by Jennifer  McGinn,  2002  Chapter  3,129 
the  French  grape  seed  and  skin  extracts  indicating  that  vasorelaxation  in  the 
isolated  rabbit  aortic  vessels  was  via  NO  derived  endothelial-dependent 
mechanisms.  The  French  grape  skin  extract  produced  a  comparable  CCRC  to 
the  original  gape  skin  extract  investigated  but  induced  a  lower  maximum 
relaxation  value. 
The  French  grape  seed  extract  was  found  to  be  the  most  potent  of  all 
tested  in  this  study.  Grape  seeds  contain  flavan-3-ols  or  catechins  as  compared 
to  the  anthocyanins  found  in  grape  skin  extracts  accounting  for  their  deep  red 
colour  (Fitzpatrick  et  aL,  1997).  Previous  studies  have  shown  epicatchin-3-0- 
gallate  isolated  from  grape  seed  extracts  have  potent  vasodilatory  activity  in 
vitro.  As  shown  with  the  antioxidant  work  in  this  chapter,  the  French  grape 
seed  extract  had  comparable  antioxidant  activity  to  the  green  and  black  tea  and 
was  consistently  higher  in  all  assays  than  other  grape  based  extracts,  which 
maybe  due  to  differences  in  its  chemical  composition. 
3.4.4  Green  tea  extract 
Indomethacin,  L-NAME,  endothelial  removal  and  ICI  192,605  all 
inhibited  the  first  phase  vasodilator  response.  The  presence  of  both  ICI  192, 
605  and  indomethacin  with  increasing  extract  concentrations  induced  a 
vasoconstriction  in  the  vessels,  suggesting  that  a  certain  concentrations,  green 
tea  extracts  may  exert  contractile  effects  which  are  normally  masked  by 
simultaneous  increased  activity  of  vasodilating  prostaglandins.  Caffeine, 
which  is  present  in  considerable  amounts  in  green  and  black  tea  (Worth  et  aL, 
2000),  up  to  40  mg  per  cup,  may  be  involved  in  this  vasoconstriction,  as  many 
of  the  flavonols  present  in  green  tea,  quercetin,  kaempferol,  myricetin, 
apigigin  and  luteolin,  with  the  exception  of  rutin,  have  all  previously  been 
shown  to  be  potent  vasodilators  in  isolated  pulmonary  arteries  (MacLean  et 
aL,  1997).  Caffeine  has  recently  been  shown  to  induce  vasoconstriction  in 
many  arteries  including  the  rabbit  aorta  (Luo  et  al.,  2000)  and  has  recently 
been  identified  during  the  large-scale  preparatory  fractionation  of  a  sample  of 
green  tea  (to  be  discussed  in  detail  in  Chapter  5).  Therefore,  the  mechanisms Jennifer  McGinn,  2002  Chapter  3,130 
behind  the  fast  phase  are  more  complex  than  those  mediating  the  first  phase 
vasodilator  response  of  the  grape  skin  extract.  They  may  include  endothelial 
prostacyclin  and  NO  release. 
The  second  phase  vasodilator  response  induced  by  the  green  tea  extract 
was  reduced  but  not  abolished  by  L-NAME  and  removal  of  the  endothelium. 
The  dilator  response  was  also  partially  resistant  to  the  effects  of  L-NAME, 
indomethacin  and  endothelial  removal  in  combination,  indicating  that  while 
endothelium-dependent  NO/prostacyclin  activity  may  be  involved,  other  as  of 
yet  undetermined  mechanisms  play  also  play  a  role. 
3.4.5  Black  tea  extract 
As  observed  with  the  green  tea  extract,  L-NAME,  removal  of  the 
endothelium,  indomethacin  and  ICI  192,605  all  inhibited  the  first  phase 
response,  with  the  black  tea  extract  inducing  a  vasoconstriction  in  the  aortic 
vessels  in  the  presence  of  indomethacin. 
The  second  phase  of  the  vasodilator  response  to  black  tea  extract  was 
resistant  to  L-NAME,  removal  of  the  endothelium,  indomethacin,  ICI  192,605 
and  all  combinations  of  these.  The  second  phase  was  only  abolished  in  the 
presence  of  indomethacin  and  after  removal  of  the  endothelium.  Therefore,  the 
mechanism  of  vasodilation  for  the  black  tea  extract  is  very  different  from  that 
observed  with  the  grape  skin  extract,  in  the  both  first  and  second  phase 
responses,  initiating  vasodilation  via  similar  mechanisms  to  the  green  tea 
extract.  These  results  suggest  that  the  vasorelaxation  induced  by  this  extract 
are  due  to  the  combined  interactions  between  vasodilating,  endothelium- 
dependent  prostaglandins.  No  literature  is  available  at  present  of  the 
mechanisms  and  vasorelaxation  induced  by  black  tea. Jennifer  McGinn,  2002 
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As  observed  with  the  green  and  black  tea  extracts,  the  thcaflavin 
extract,  a  product  formed  from  the  oxidation  of  green  tea  catechins  during 
fermentation,  also  induced  a  biphasic  CCRC  in  the  isolated  rabbit  aortic 
vessels.  Due  to  the  limited  amount  of  extract  available,  only  the  basic 
cumulative  concentration  response  curve  for  the  extract  was  determined.  The 
theaflavin  extract  induced  a  comparable  CCRC  to  that  induced  by  the  black 
tea  extract  as  shown.  However,  the  theaflavin  extract  induced  lower  relaxation 
values  at  all  concentrations,  indicating  that  the  black  tea  extract  has  other 
vaso-active  components  present.  Catechins  and  other  flavonoids  which  are 
present  in  black  tea  and  have  not  yet  been  identified,  may  account  for  this  role. 
3.4.7  Antioxidant  activity 
It  has  previously  been  demonstrated  that  red  wine  extracts  induce 
vasorelaxation  in  rabbit  aortic  vessels  and  that  the  potency  is  directly 
correlated  with  their  antioxidant  activity  and  total  phenolic  content  (Bums  et 
aL,  2000).  However,  the  results  of  this  study  demonstrate  that  the  grape  and 
tea  extracts  examined  induce  vasorelaxation  that  is  inversely  and  significantly 
correlated  to  their  antioxidant  activity  by  ESR  and  their  total  phenolic  content. 
The  higher  the  antioxidant  activity  of  the  extracts,  the  less  active  they  are  as 
vasodilators  and  vice  versa,  as  determined  by  multivariate  correlation  analysis. 
Study.  This  also  indicates  that  the  compounds  responsible  for  their  antioxidant 
activity  are  distinct  from  those  responsible  for  inducing  their  vasodilator 
activity  in  vitro.  The  opposite  nature  of  the  results  published  by  Bums  et  aL, 
(2000)  as  compared  to  the  present  study  may  be  due  to  genuine  differences  in 
the  initial  starting  products  rather  than  differences  in  methodology.  Alcohol 
free  full  red  wine  extracts  were  investigated  for  their  antioxidant  and 
vasodilatory  activity  as  compared  to  various  dried  grape  based  extracts  in  this 
study.  The  red  wine  extracts  may  have  contained  a  wider  range  of  active 
compounds  than  the  grape  based  extracts  which  may  have  enhanced  their 
vasodilatory  and  antioxidant  capabilities.  Red  wine  will  also  have  a  different Jennifer  McGinn,  2002  Chapter  3,132 
composition  to  that  of  grape  extracts  because  of  the  chemical  changes  that 
occur  during  extraction,  vinification  and  maturation  of  the  finished  wine. 
3.4.8  Conclusion 
In  conclusion,  this  study  has  demonstrated  that  a  variety  of  grape  and  tea 
based  extract  induce  vasorelaxation  in  isolated  rabbit  aortic  vessels  and  has 
determined  that  they  are  also  effective  antioxidants  in  vitro,  within  a 
concentration  range  that  may  be  reached  by  moderate  wine  and  tea 
consumption.  This  study  also  indicates  that  consumption  of  green  tea  may 
have  greater  possible  cardiovascular  benefits  compared  to  black  tea  in  terms  of 
their  vasodilatory  activity  and  antioxidant  capacity.  The  data  presented  here 
however  do  not  however  take  in  account  absorption  and  metabolism  of  grape 
and  tea  phenolics  in  vivo.  The  grape  and  tea  extracts  both  produced  easily 
distinguishable  concentration  response  curves.  The  isolation  and  identification 
of  the  vaso-active  substances  present  in  these  extracts  and  their  possible 
effects  in  vivo  continues  to  be  fully  determined.  It  seems  likely  that  the  alleged 
beneficial  effects  of  red  wine  and  tea  are  due  to  the  cumulative  effects  of 
several  polyphenols  working  in  synergy  rather  than  one  individual  compound 
present. Jennifer  McGinn,  2002 
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Graph  2  Vasorelaxation  induced  by  grape  extracts  and  tea  extracts  in  aortic 
vessels 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean.  For 
individual  maximum  relaxation  values  see  Table  15. 
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Graph  3  Vessel  matched  time  controls  for  all  experimental  groups 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  4  CCRC  to  ACh  in  vessels  with  and  without  functional  endothelium 
following  preconstriction  with  PE 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  5  Grape  skin  extract  induced  vasorelaxation  in  the  presence  of  L- 
NAME  and  after  removal  of  the  endothelium 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
V  Grape  skirV-endothelium  (n=6) Jennifer  McGinn,  2002  Chapter  3,137 
-§F-  Grape  skin  (n=6) 
&  Grape  skin  &  ICI  192,605  (n=6) 
V  Grape  skin  &  Indomethacin  (1  pm)  (n=6) 
Grape  skin  &  Indomethacin  (100  pm)  (n=6) 
70 
0 
0 
LU 
a. 
45 
0 
20 
x 
-5  111111  ------  1 
10-5  10-4  10-1  10-1  10-1  100  101 
[Extra  ct)  m  gim  L 
Graph  6  Grape  skin  extract  induced  vasorelaxation  in  the  presence  of 
indomethacin  &  ICI  192,605 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  7  Grape  skin  induced  vasorclaxation  in  the  presence  of  ODQ  and 
GR32191 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  8  Grape  skin  extract  induced  vasorelaxation  in  the  presence  of  L- 
NAME,  indomethacin,  ICI  192,605  and  endothelial  removal 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  9  Grape  skin  extract  induced  vasorelaxation  following  preconstriction 
with  PE  &  U46619 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  10  Grape  powder  extract  induced  vasorelaxation,  and  in  the  presence 
of  L-NAME 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  II  Comparison  of  the  vasorelaxation  induced  by  grape  skin  and  grape 
powder  extracts 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
For  individual  maximum  relaxation  values  see  Table  15. 
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Graph  12  Comparison  of  the  vasorelaxation  induced  by  French  grape  seed 
and  skin  extracts 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
For  individual  maximum  relaxation  values  see  Table  15. 
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Graph  13  French  grape  seed  (FGSeed)  extract  induced  vasorelaxation  in  the 
presence  of  L-NAME  and  after  removal  of  the  endothelium 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  14  Vasorelaxation  induced  by  French  grape  skin  (FGSkin)  extract  in 
the  presence  of  L-NAME  and  after  removal  of  the  endothelium 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  15  Comparison  of  the  vasorelaxation  induced  by  green,  black  and 
theaflavin  extracts 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
For  individual  maximum  relaxation  values  see  Table  15. 
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Graph  16  Green  tea  extract  induced  vasorelaxation  in  the  presence  of  L- 
NAME  and  following  the  removal  of  the  endothelium 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. Jennifer  McGinn,  2002 
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Graph  17  Green  tea  extract  induced  vasorelaxation,  in  the  presence  of  L- 
NAME,  indomethacin,  ICI  192,605,  &  endothelial  removal  in  combination 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. Jennifer  McGinn,  2002 
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Graph  18  Black  tea  extract  induced  vasorelaxation,  in  the  presence  of  L- 
NAME  and  following  removal  of  the  endothelium 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  19  Black  tea  extract  induced  vasorelaxation,  the  presence  L-NAME, 
indomethacin,  ICI  192,605  &  endothelial  removal  in  combination 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. Jennifer  McGinn,  2002 
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Graph  20  Vasorelaxation  induced  by  theaflavin  extract  in  preconstricted 
aortic  vessels 
Values  expressed  as  mean  %  relaxation  ±  standard  error  of  mean. 
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Graph  21  Antioxidant  activity  of  grape  and  tea  fractions  by  ESR 
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Graph  22  Antioxidant  activity  by  FRAP  analysis  of  grape  and  tea  extracts 
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Graph  23  Total  phenolic  content  of  grape  and  tea  extracts 
All  samples  run  in  duplicate  (n=2)  and  expressed  as  mean  values.  For 
individual  assay  values  for  each  extract  see  Table  17. 
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Graph  23  Relationship  between  vasodilatory,  antioxidant  activity  and  total  phenol  content 
of  grape  and  tea  extracts. 
All  antioxidant  assay  values  expressed  as  mean  of  n  =2.  See  Table  17  for  individual  assay  values. 
Vasodilatory  maximum  relaxation  values  expressed  as  mean  %  relaxation  +/-  standard  error  of  mean. 
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Chapter  4  Vasodilation  and  antioxidant 
activities  of  green  tea  epicatechins 
4.1  Introduction 
Tea,  especially  that  of  green  tea,  has  received  attention  as  an  alleged 
protective  agent  against  cardiovascular  disease,  stroke  and  several  types  of 
cancer.  Tea,  like  red  wine,  is  recognised  for  its  high  content  of  polyphenols, 
which  account  for  more  than  35%  of  its  dry  weight  (Serafini  et  A,  1996),  and 
are  believed  to  be  responsible  for  its  alleged  cardio-protective  effect  in  vivo, 
functioning  principally  as  potent  antioxidants  and  effective  free  radical 
scavengers,  as  discussed  previously  in  Chapter  1. 
Catechins  are  a  group  of  natural  polyphenols  found  in  green  teas  usually 
accounting  for  30  -  42%  of  the  dry  weight  of  the  solids  in  brewed  tea  (Yang, 
1999).  Green  tea  is  manufactured  by  drying  fresh  tea  leaves,  therefore  its 
composition  resembles  that  of  the  fresh  tea  leaf,  containing  the  characteristic 
polyphenolic  compound,  (+)-catechin  and  its  isomer  (-)-epicatechin  (EQ,  (+ 
epicatechin  gallate  (ECG),  (-)-epigallocatechin  (EGC),  (-)-catechin  gallate 
(CG)  and  (-)-epigallocatechin  gallate  (EGCG)  (Balentine  et  aL,  1997).  EGCG 
is  the  most  abundant  constituent  of  green  tea  and  has  to  date  received  the  most 
attention  (Balentine  et  aL,  1997).  In  vitro  and  in  vivo  experiments  have  shown 
that  catechins  maybe  potentially  beneficial  to  human  health.  Green  tea 
epicatechins  have  been  previously  shown  to  be  effective  antioxidants  (Vinson 
et  aL,  1995,2000;  Wiseman  et  aL,  1997;  Gardner  et  aL,  1998),  scavengers  of 
free  radicals  (Salah  et  aL,  1995),  possess  anti-carcinogenic  properties 
(Mukhtar  et  aL,  1992),  be  vasodilators  in  vitro  (Huang  et  aL,  1998,1999)  and 
prevent  platelet  adhesion  and  aggregation  (Vinson  &  Dabbagh,  1998; 
Mizugaki  et  aL,  2000)  all  mechanisms  which  may  work  in  synergy  to  prevent 
or  retard  the  development  of  CHD  and  several  types  of  cancers. Jennifer  McGinn  2001  Chapter  4,154 
To  date,  literature  investigating  the  effect  of  green  tea  epicatechins  on 
vascular  function  in  vitro  is  scarce.  Present  evidence  suggests  that  the 
vasodilator  activity  of  green  tea  epicatechins  occurs  via  endothelium- 
dependent  and  -independent  mechanisms  (Huang  et  A,  1998).  This  has  been 
attributed  to  the  release  of  NO  from  vascular  endothelium,  the  inhibition  of 
calcium  influx  and  the  NO  activation  of  Ca2+  sensitive  K+  channels  (Huang  et 
aL,  1999). 
This  study  will  determine  the  vasodilator  effects  of  range  green  tea 
catechin  and  epicatechin  derivatives  in  vitro,  investigate  their  mechanisms  and 
pathway  of  vasodilation  in  the  cardiovascular  system  and  relate  their 
vasodilatory  to  their  antioxidant  activity  and  total  phenolic  content. 
4.2  Materials  &  Methods 
To  investigate  the  vasodilatory  and  antioxidant  activities  of  green  tea 
epicatechins,  several  complementary  methods  were  employed  in  the  course  of 
this  study.  These  are  explained  in  detail  in  Chapter  2. 
4.2.1  Vasodilation  activity 
In  brief,  isolated  rabbit  aortic  vessels  were  suspended  in  standard  10  ml 
organ  baths  (Figure  11),  filled  with  Krebs  buffer  solution,  continuously 
oxygenated  with  16%  02,5%  C02  and  79%  N2  and  maintained  at  37T,  to 
mimic  the  internal  environment.  Vessels  were  placed  under  an  optimal  resting 
tension  of  2  g.  Vessel  contraction/relaxation  was  measured  via  an  isometric 
force  transducer. 
After  an  equilibration  period,  vessels  were  twice  maximally  contracted 
with  50  mM  KCI  and  washed  out  thoroughly  with  Krebs  solution.  To 
investigate  the  role  of  the  endotheliurn  in  the  vasodilation  response,  in  some 
experiments  the  luminal  endotheliurn  was  removed  prior  to  the  start  of  the 
experiment  by  the  gentle  mechanical  rubbing  of  the  vessels  with  ridged Jennifer  McGinn  2001  Chapter  4,155 
forceps.  After  washing  and  returning  to  initial  baseline  tension,  vessels  with 
and  without  fimctional  endothelium  were  precontracted  submaximally  with  PE 
(10-7  M)  and  relaxed  with  ACh.  Vessels  were  considered  to  be  denuded  of 
functional  endothelium  when  there  was  no  relaxation  response  to  1ýtM  ACh 
(see  Figure  13). 
Once  a  stable  plateau  had  been  reached,  CCRC's  for  the  green  tea 
epicatechin  derivatives  (10-8  -  3xI04'M)  were  obtained.  The  mechanisms  of 
vasodilation  were  investigated  in  the  presence  of  the  NO  synthase  inhibitor,  L- 
NAME  (100  ýM),  added  to  selected  vessels  40  min  prior  to  PE-induced  tone. 
4.  Z2  Antioxidant  activity 
Antioxidant  activity  and  phenolic  and  catechin  content  of  the  green  tea 
epicatechins  tested  in  this  study,  were  determined  using  specific  spectral  and 
colorimetric  assays  discussed  in  detail  in  Chapter  2.  In  brief- 
The  plasma  antioxidant  capacity  of  the  green  tea  epicatechins  was 
estimated  from  its  ferric  reducing  ability  (FRAP)  analysed  at  593  nm.  The 
development  of  an  intense  blue  colour  resulting  from  the  conversion  of  a 
Fe(III)-2,4,6-Tri-2-pyr-idyl)-s-triazine  (TPTZ)  complex  to  Fe(II)-TPTZ  being 
directly  related  to  the  amount  of  reductant  present  in  each  epicatechin  sample. 
Results  are  expressed  as  the  concentration  of  Fe(Il)  produced/mM  (Benzie  & 
Strain,  1996). 
The  total  phenolic  content  of  the  green  tea  epicatechin  derivatives  was 
determined  and  expressed  as  gallic  acid  equivalents/mL  (GAE)  using  the 
Folin-Ciocalteu.  method  (Singleton  &  Rossi,  1965).  Sample  absorbance  read  at 
765  mn. 
The  total  catechin  content  of  each  green  tea  epicatechin  derivative  was 
determined  using  the  method  of  Kivitis  et  al  (1997).  Total  content  is 
determined  by  the  addition  of  a  DMACA  in  a  methanol/perchloric  acid/water Jennifer  McGinn  2001  Chapter  4,156 
mix  to  the  epicatechin  derivative.  With  the  addition  of  the  DMACA  solution, 
samples  are  seen  to  develop  highly  specific  colour  complexes  dependent  on 
total  catechin  content.  Absorbance  was  measured  between  604  and  684  nm. 
Results  are  expressed  as  total  catechins  (g/L). 
4.3  Results 
4.3.1  Vasodilator  effects  of  green  tea  epicatechins 
The  cumulative  concentration-response  curves  (CCRC's)  to  each 
epicatechin  derivative,  from  10-8  to  RIO-4  M,  in  isolated  rabbit  aortic  vessels 
preconstricted  with  PE,  is  shown  in  Graph  24.  Time  matched  controls  of  each 
epicatechin  derivative  were  also  run  to  demonstrate  the  effect  of  each 
epicatechin  on  vascular  tension  as  opposed  to  the  natural  relaxation  response 
of  each  vessel  with  time  (see  Graph  3).  Figure  16  displays  a  sample 
vasorelaxation  trace  of  CCRC's  to  EGCG  and  CG  in  vitro.  The  effect  of  L- 
NAME  and  removal  of  the  endothelium  on  the  CG  concentration-dependent 
vasorelaxation  response  curve  is  also  shown  in  Figure  16.  EGCG,  ECG,  EGC 
and  CG  all  induced  significant  vasodilation  in  the  aortic  vessels.  EC  and 
catechin  did  not  have  a  significant  effect  on  vascular  tension  in  vitro.  EGCG 
induced  the  greatest  maximum  relaxation  (40%  of  PE-induced  tone,  P<0.01), 
but  CG  was  the  most  potent  epicatechin  derivative,  inducing  maximum 
vasodilation  at  3xlO-6  M  (P<0.01),  as  compared  to  3xI  0-5  to  104  M  for  all 
other  epicatechins  investigated.  The  maximum  vasorelaxation  values  (as  a% 
PE-induced  tone)  and  the  relaxation  threshold  values,  the  lowest  concentration 
that  induced  a  significant  relaxation,  reflecting  differences  in  potency  for  each 
epicatechin  and  catechin  derivative  is  shown  in  Table  18. r- 
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4.3.1.1  Epicatechin  (EC) 
Chapter  4,159 
The  CCRC  to  epicatechin  (EC)  is  shown  in  Graph  25.  EC  at 
concentrations  ranging  from  10-8  to  RIO-4  M  had  very  little  effect  on  vascular 
tension  in  vitro,  inducing  a  maximum  vasodilation  at  the  highest  concentration 
of  EC  added  to  the  organ  bath.  L-NAME  and  removal  of  the  endothelium  had 
no  further  influence  on  the  vasodilator  effect  of  EC  (Graph  25). 
4.3.1.2  Epicatechin  gallate  (ECG) 
Vasorelaxation  with  epicatechin.  gallate  (ECG)  in  isolated  rabbit  aortic 
vessels  is  shown  in  Graph  26.  The  addition  of  ECG  induced  a  minor  vessel 
vasorelaxation  and  reversal  back  to  baseline  with  increasing  ECG 
concentrations.  Maximum  vasorelaxation  was  induced  at  10  -4  M  producing  a 
biphasic  response  curve.  ECG  induced  a  maximum  relaxation  value  of  16% 
(Table  18).  The  presence  of  L-NAME  and  removal  of  the  endothelium  prior  to 
ECG  addition  completely  abolished  the  vasorelaxation  response,  indicating 
that  vasorelaxation  is  occurring  via  NO  mediated  endothelium-dependent 
mechanisms. 
4.3.1.3  Epigallocatechin  (EGC) 
The  CCRC  to  epigallocatechin  (EGC)  induced  vasorelaxation  is  shown 
in  Graph  27.  EGC  induced  slight  vessel  contraction  with  increasing 
concentration  up  to  3xI  0-5  M,  as  compared  to  the  time  control.  Rapid 
maximum  vasorelaxation  was  induced  only  at  high  vessel  concentrations  (10-4 
M).  EGC  induced  a  maximum  relaxation  value  of  17.5%  of  PE-induccd  tonc 
(Table  18).  The  removal  of  the  cndothelium  and  the  addition  of  L-NAME  also 
abolished  the  vasorelaxation  response  induced  by  EGC,  indicating  NO  and 
endothelium-dependent  vasorelaxation. Jennifer  McGinn  2001  Chapter  4,160 
4.3.1.4  Epigallocatechin  gallate  (EGCG) 
Epigallocatechin  gallate  (EGCG)  was  identified  to  be  the  most 
effective  derivative  vasodilator  (P<0.01)  but  not  the  most  potent,  that  is 
inducing  the  highest  maximum  vasodilation  value  but  not  at  the  lowest 
concentration  of  all  derivatives  investigated.  The  CCRC  to  EGCG  is  shown  in 
Graph  28.  EGCG  induced  vessel  contraction  at  10-8  to  R10-6,  inducing 
maximum  vessel  vasodilation  at  10-5  M.  EGCG  induced  a  maximum 
vasorelaxation  value  of  40%  of  PE-induced  tone  (Table  18).  As  with  previous 
epicatechins,  the  presence  of  L-NAME  and  removal  of  the  endothelium 
abolished  the  concentration  dependent  vasorelaxation  response  (Graph  28), 
indicating  NO  and  endothelium-dependent  vasorelaxation. 
4.3.1.5  Catechin 
Catechin  induced  vasorelaxation  in  isolated  rabbit  aortic  vessels,  like 
that  of  EC,  had  very  little  effect  on  overall  vascular  tone  in  vitro  (Graph  29). 
Catechin  induced  a  maximum  vessel  non-significant  vasorelaxation  value  of 
8.5%  of  PE-induced  tone  (Table  18).  This  minor  degree  of  vasodilation  was 
mediated  via  the  release  of  NO  and  was  dependent  upon  the  presence  of  intact 
functional  endothelium  as  the  vasorelaxation  response  was  abolished  by  the 
presence  of  L-NAME  and  removal  of  the  endothelium  prior  the  addition  of 
catechin  (Graph  29). 
4.3.1.6  Catechin  gallate  (CG) 
Finally,  catechin  gallate  (CG)  was  identified  to  be  the  most  potent  of 
all  the  green  tea  epicatechin  derivatives  investigated  in  this  study  inducing 
vasorelaxation  at  a  lower  derivative  concentration  than  all  other  catechin  and 
epicatechins.  CG  induced  maximum  vessel  vasorelaxation  at  3xI  0-6  M  (Graph 
30)  as  compared  to  relaxation  induced  at  3x1  0,5  to  10-4  M  by  the  other 
epicatechins  examined.  Lower  concentrations  of  CG  (10-8  -  10-6  M)  had  no 
effect  on  vascular  tension  in  vitro.  CG  induced  vasorelaxation  up  to  21%  of Jennifer  McGinn  2001  Chapter  4,161 
PE-induced  tone  (Table  18).  As  with  all  other  epicatechin  derivatives 
investigated  in  this  study,  the  presence  of  L-NAME  and  the  removal  of 
functional  intact  endothelium  abolished  the  vasorelaxation  response  (Graph 
30),  indicating  NO  and  endothelium-dependent  vasorelaxation. 
4.3.2  Antioxidant  activities  of  green  tea  epicatechins 
To  investigate  the  antioxidant  ability  and  the  total  phenolic  and 
catechin  content  of  the  green  tea  epicatechin  derivatives,  specific  colorimetric 
and  spectral  assays  were  carried  out.  Antioxidant  capacity  was  determined  by 
FRAP  analysis.  Table  19  displays  the  values  obtained  by  each  individual 
epicatechin  in  each  of  the  3  assays  and  Graph  34  demonstrates  their 
correlation  to  one  another. 
4.3.2.1  Total  phenolic  content 
The  total  phenolic  colorimetric  assay  is  a  non-specific  test  which 
identifies  the  presence  of  gallic  acid  groups,  with  all  results  being  expressed  as 
gallic  acid  equivalents  (GAE)  mgfL  (Singleton  &  Rossi,  1965).  EGCG  is 
identified  to  have  the  highest  total  phenol  content  (Graph  3  1)  with  a  content  of 
238  mg/L  of  total  phenols  (Table  19),  followed  closely  by  catechin,  ECG  and 
EGC.  EC  was  identified  to  have  the  overall  lowest  phenol  content  with  only 
68.5  mg/L  of  total  phenols  present. 
4.3.2.2  Total  catechin  content 
The  total  catechin  colorimetric  assay  is  a  specific  test  which  identifies 
the  presence  of  1,3-dihydroxy-benzene  structures.  Catechins  react  with  the 
DMACA  solution  (previously  discussed,  Chapter  2)  to  form  highly  specific 
colour  condensation  products,  ranging  from  pale  yellow  to  dark  blue  with 
increasing  catechin  content  (Kivitis  et  aL,  1997).  All  results  are  expressed  as 
total  catechins  present  in  each  sample  (g/L).  EGC  was  had  the  highest  total 
catechin  content  (197  g/L),  followed  closely  by  EGCG  (160  g/L).  EC  and  CG Jennifer  McGinn  2001  Chapter  4,162 
had  the  overall  lowest  catechin  levels,  66  g/L  and  64  g/L  total  catechins 
respectively  (Graph  32,  Table  19). 
4.3.2.3  Ferric  reducing  ability  (FRAP) 
Antioxidant  capacity  of  each  of  the  green  tea  epicatechin  derivatives  has 
been  determined  by  the  ferric  reducing  ability  or  "antioxidant  power"  of  each 
derivative.  Results  are  expressed  as  the  concentration  of  Fe(II)  produced  by 
each  green  tea  derivative  during  its  reduction  from  Fe(III).  EGCG  was 
identified  to  have  the  greatest  antioxidant  activity  as  compared  to  the  other 
epicatechin  derivatives  (Graph  33),  with  EC  having  the  least  activity.  EGCG 
produced  2.6  mM  Fe(II)  produced  as  compared  to  only  0.65  mM  Fe(II) 
produced  by  EC  (Table  19). 
Graphs  34  and  35  demonstrate  the  relationship  between  the  FRAP-based 
antioxidant  activity,  total  phenolic  and  catechin  content  and  the  vasodilatory 
ability  of  the  green  tea  catechin  and  epicatechin  derivatives.  A  significant 
positive  correlation  (r  =  0.93,  P<0.01,  P=0.01)  between  vasodilator  activity 
and  antioxidant  activity  by  FRAP  analysis  was  determined.  The  high  r  value 
of  this  relationship  indicates  that  the  two  variables  are  truly  related  and 
increase  together.  However,  no  statistically  significant  correlation  was 
demonstrated  between  vasodilatory  activity  of  the  green  tea  derivatives  and 
total  phenol  (r  =  0.67,  P=0.14)  and  catechin  content  (r  =  0.30,  P=0.57). 
4.4  Discussion 
In  terms  of  vasodilation  induced  in  isolated  rabbit  aortic  vessels,  CG 
was  identified  to  be  the  most  potent  derivative  in  vitro  and  EC  to  be  the  least. 
In  all  cases,  vasorelaxation  was  seen  to  occur  via  the  release  of  NO  and  was 
dependent  upon  the  presence  of  intact  functional  endothelium.  Green  tea 
derivatives  were  also  determined  to  be  effective  antioxidants  with  a  potency 
directly  correlated  with  their  overall  vasodilatory  activity. -0 
Q 
"Ci 
"0 
E- 
"0  11-1  ltý  I 
E;  1'.  0  C> 
v 
.0 
E  . Jý  4s 
cq  C'i  Ci  00 
C>  0  C>  0  Cý  C; 
to 
r 
4.  )  z  E  ý;,  -,  +1  +1 
I 
+1  41 
* 
+1  -H  .  0 
10  tn 10  C en  10  C  l  W)  ýo Cf)  m  Q U  ýa  60  0Q 
I 
.2 
C-i 
u 
7a 
CA  =- 
1  5  -a  R.  -  L. 
40 
d 
u 
4  )-  . 
:3  "0 
cl 
cd  Q 
co  C14  r-  tn  10 
; 
ý:  r  00 
4  1  C4  C)  6  el;  -  -  EL  ;ao  A 
U  +1  +1  +1  +1  +1  +1  t0= 
wi  IR  Ci  Ci  I:  0 
0 
ý4 
w 
W  -ý 
0 
ii  r.  2=Z 
Q  0  "o  ýý 
Z o  0 
"0 
1ý 
+1 
C14 
+1 
C14 
+1 
Cý 
+1 
6 
+1 
C5 
+1 
0  U  'D  o 
1ý0  r-  r-  en  Cl% 
cl 
cl, 
rn  0 
m 
C14  C14  C14  C14  N  '. 
0. 
C> 
u 
C::  Ln 
0 
0 
4  -ted 
. 0.  > 
C: 
u 
-C,  --g  -Cý C) 
u  u  u  aj  0  >  3 
.-V  u  u  u  u 
w  u  u 
0 
I-  w Jennifer  McGinn  2001  Chapter  4,164 
4.4.1  Vasodilation  activity 
The  flavan-3-ols  are  a  subclass  of  flavonoids  (Haslam,  1998).  They 
range  from  the  simple  monomers  (+)-catechin  and  its  isomer  (-)-epicatechin, 
to  the  oligomeric  and  polymeric  prOanthocyanidins  (Balentine  et  aL,  1997).  In 
addition  to  forming  complexes  with  other  catechins,  they  maybe  hydroxylated 
to  form  gallocatechins  such  as  EGC,  and  undergo  esterification  with  gallic 
acid  to  form  catechin  gallates  such  as  ECG  and  CG  (Robb  &  Brown,  2001). 
Red  wine,  previously  discussed,  is  also  rich  in  (+)-catechin  and  (-)- 
epicatechin  (Bums  et  aL,  2000).  Catechin  and  epicatechin  derivatives  are 
found  primarily  in  the  seeds  of  red  grapes  (Sato  et  aL,  1999).  This  fact  may 
contribute  to  the  high  antioxidant  and  vasodilatory  capacity  of  the  French 
grape  seed  investigated  in  Chapter  3,  as  compared  to  the  predominately 
anthocyanin  containing  grape  skin  extracts  examined.  Grapes  also  contain 
gallate  esters  and  gallocatechins  but  only  in  low  levels  in  red  wine  (Bums  et 
aL,  2000)  but  may,  according  to  the  present  study  account  for  a  small  degree 
of  vasodilation  induced  by  red  wines.  Green  teas  contain  (+)-catechin,  EC, 
EGCG,  EGC,  ECG  and  CG  (Balentine  et  aL,  1997).  The  major  catechin  in 
green  teas  is  EGCG,  which  accounts  for  -37%  of  the  dry  weight  of  green  tea 
(de  Pascual-Teresa  et  aL,  2000)  and  was  in  this  study  identified  to  be  a  very 
potent  vasodilator  and  antioxidant.  In  the  present  study  EC  and  (+)-catechin 
were  devoid  of  significant  vasodilator  activity  in  the  rabbit  aorta.  This  finding 
is  consistent  with  studies  in  the  rat  aorta  where  catechin  and  EC  had  very  low 
vasodilator  activity  (Andriambeloson  et  aL,  1997;  1998). 
EGCG,  CG,  EGC  and  ECG  all  induced  vasodilator  responses  which 
were  inhibited  by  the  presence  of  the  NO  synthase  inhibitor,  L-NAME  and 
removal  of  the  endothelium,  demonstrating  that  vasorelaxation  with  these 
catechins  and  epicatechins  was  mediated  via  the  release  of  NO  from  vascular 
endotheliurn  and  is  dependent  on  the  presence  of  intact  functional 
endothelium.  These  findings  may  account  for  some  of  the  vasodilator  activity 
of  green  tea  but,  as  discussed  previously  (Chapter  3),  cannot  account  for  all Jennifer  McGinn  2001  Chapter  4,165 
the  dilator  activity  of  the  green  tea,  which  also  involves  non-endothelial 
factors  and  prostaglandin-mediated  effects.  This  study  has  also  shown  CG  to 
be  a  very  potent  vasodilator  in  vitro  but  also  to  have  low  antioxidant  activity 
and  low  overall  phenol  content,  a  pattern  opposite  to  that  identified  for  the 
other  epicatechins  investigated.  The  grape  based  extracts  investigated  in 
Chapter  3  had  comparable  vasodilatory  and  antioxidant  responses  to  that  of 
CG.  CG  is  found  in  low  levels  in  red  wine,  derived  primarily  from  the  grape 
seeds  (Bums  et  aL,  2000)  but  which  has  also  been  identified  in  the  grape  skin. 
CG  may  therefore,  be  in  part  accountable  for  the  potent  vasodilation  induced 
by  both  grape  skin  and  seed  extracts.  Epicatechin  derivatives  have  also  been 
determined  to  be  vasodilators  in  rat  mesenteric  arteries  with  EGCG  being  the 
most  effective  dilator.  Relaxation  occurred  via  endothelium-dependent 
mechanisms  and  was  mediated  via  the  release  of  NO. 
4.4.2  Antioxidant  activity 
The  previous  chapter  demonstrated  that  vasodilation  induced  by  grape 
and  tea  based  extracts  was  inversely  correlated  to  their  overall  antioxidant 
activity,  with  grape  extracts  being  good  vasodilators  but  poor  antioxidants  as 
compared  to  tea  extracts.  This  chapter  on  the  other  hand  has  demonstrated  that 
catechins  and  epicatechins  derived  from  green  tea,  and  which  are  also  present 
to  a  smaller  extent  in  black  tea,  are  vasodilators  and  antioxidants,  a  feature  that 
is  positively  correlated.  A  non-significant  relationship  was  observed  between 
increasing  total  catechin  and  phenolic  content  and  increasing  vasodilatory 
ability. 
The  differences  in  the  statistical  results  presented  between  the 
vasodilatory  and  antioxidant  activities  of  the  grape  and  tea  based  extracts  of 
the  previous  chapter  as  compared  to  that  of  the  green  tea  epicatechin  and 
catechin  derivatives  presented  in  this  study  may  be  due  to  genuine  differences 
in  the  basic  chemical  composition  of  the  compounds  investigated  as  same 
standardised  methodology  was  used  in  both  sets  of  experiments.  The  grape 
and  tea  extracts  investigated  contained  a  range  of  active  components  in Jennifer  McGinn  2001  Chapter  4,166 
varying  concentrations  which  may  have  interacted  together  to  produce 
cumulative  effects  as  compared  to  the  purified  epicatechin  standards  of  a 
known  concentration  which  could  be  directly  compared.  Contamination  of  the 
extracts  is  another  factor  which  may  have  had  an  overall  affect  on  the  results 
and  which  could  not  be  ruled  out. 
This  study  has  also  demonstrated  that  the  antioxidant  activity  of  the 
selected  catechins  and  epicatechins  vasodilatory  and  antioxidant  activities  Of 
the  gape  and  tea  based  extracts  as  compared  to  that  of  the  green  tea 
epicatechin  and  catechin  derivatives  range  in  the  order  magnitude  of 
EGCG>EGC>EM:  Catechin>CG>EC.  EGCG  was  found  to  be  the  most 
significantly  (P<0.01)  effective  antioxidant  of  all  the  derivatives  tested.  EGCG 
was  identified  to  be  the  most  powerful  antioxidant  in  both  aqueous  and 
organic  media  in  similar  studies  (Salah  et  aL,  1995;  Gardner  et  aL,  1998). 
These  studies  did  not  investigate  the  antioxidant  activities  of  CG  and  catechin. 
4.4.3  Conclusion 
In  conclusion,  this  study  has  determined  and  demonstrated  that  a  wide- 
range  of  epicatechins  and  catechins  present  in  green  tea  induce  vasorelaxation 
in  isolated  rabbit  aortic  vessels  and  are  effective  antioxidants,  a  relationship 
that  is  statistically  significant.  Their  overall  total  catechin  and  phenolic 
contents  are  not  significantly  related  to  their  vasodilatory  ability.  It  seems 
likely  that  the  possible  cardio-protective  effects  of  catechins  and  epicatechins 
in  green  tea  are  due  to  the  cumulative  effects  of  these  compounds  and  other 
components  present  which  have  not  yet  been  identified  working  in  synergy. Jennifer  McGinn  2001 
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Chapter  5  Identification  of  the  major  phenolics 
present  in  green  &  black  teas 
5.1  Introduction 
Brewed  tea  and  chocolate  are  two  of  the  few  food  products  known  to  contain 
significant  levels  of  catechins  (Vison,  1998).  Comparable  concentrations  have  not 
been  reported  in  any  other  food  stuffs  (Bronner  &  Beecher,  1998).  As  a  result,  tea 
is  one  of  the  major  dietary  source  for  this  potentially  important  group  of 
compounds.  The  four  main  catechins  or  flavan-3-ols,  +)epicatechin  (EC),  + 
)epicatechin  gallate  (ECG),  +)epigallocatechin  (EGC)  and  +)epigallocatechin 
gallate  (EGCG),  constitute  about  one  third  of  the  dry  weight  of  green  tea 
(Balentine  et  aL,  1997).  Of  the  approximately  2.5  million  metric  tons  of  dried  tea 
manufactured  annually,  only  18%  is  consumed  as  green  tea  but  over  80%  is 
consumed  as  black  tea  (Yang  &  Landau,  2000),  with  black  tea  consumption 
contributing  82%  of  the  flavonols  and  flavones  in  the  diet  (Graham,  1992).  During 
the  fermentation  of  green  tea  to  black  tea,  catechins  are  oxidised  by  polyphenol 
oxidase  to  form  the  reddish-brown  well-characterised  theaflavins  and  thearubigens, 
and  the  poorly  described  theaflagallins,  theasinensins  (bisflavonols)  and  theacitrins; 
(Beecher  et  aL,  1999).  Consequently,  the  catechin  content  of  black  tea  is  low, 
representing  only  30%  of  total  dry  weight,  as  compared  to  that  encountered  in 
green  tea  (90%).  Theaflavins  account  for  about  10-15%  of  the  dry  weight  of  black 
tea  with  the  balance  of  catechins  forming  the  undefined  high  molecular  weight 
thearubigens  (I  -  40  kDa)  (Beecher  et  aL,  1999).  These  are  a  class  of  heterogenous 
polyphenolic  condensation  products  believed  to  be  responsible  for  the  dark  colour 
of  black  tea  (Robb  &  Brown,  2001). 
The  measurement  and  identification  of  polyphenols  in  tea  has  employed  a 
variety  of  analytical  techniques.  For  standard  analysis,  high  performance  liquid 
chromatography  (HPLC)  equipped  with  a  reversed-phase  (RPLC)  column  and  an 
ultraviolet  visible  (UV-Vis)  detector  has  become  the  instrumental  method  of 
choice  for  catechin  detection  and  quantification  (Beecher  et  aL,  1999).  In  1976, Jennifer  McGinn,  2001  Chapter  5,179 
Hoeffler  &  Coggon,  published  the  first  quantitative  analysis  of  catechins  from  tea 
extracts  using  a  C18  HPLC  column  (Robb  &  Brown,  2001).  Since  1976,  several 
chromatographic  techniques  have  been  used  to  separate,  characterize  and  quantify 
the  individual  polyphenols  in  teas.  To  date,  only  a  very  small  number  of  analytical 
techniques  have  been  established  for  the  analysis  of  theaflavins  and  thearubigens 
(Lee  &  Ong,  2000). 
Recent  advances  in  instrumentation  have  permitted  the  characterization  of 
polar  molecules,  such  as  polyphenols  and  catechins  from  tea  via  the  use  the  mass 
spectroscopy  (MS).  Mass  spectroscopy,  includes  the  techniques  of  electrospray 
ionisation  (ESI),  atmospheric  pressure  chemical  ionisation  (APCI)  and 
thermospray  ionisation  (TSI),  are  characterised  by  the  formation  of  ions  from 
solutions  that  are  sprayed  from  a  thin  capillary  at  high  voltages  (Dalluge  &  Nelson, 
2000).  Direct  analysis  of  infusions  of  green  tea  with  ESI  operated  in  the  negative 
ionisation  mode  have  met  with  success  in  terms  of  the  identification  of  prominent 
polyphenols  and  other  minor  components  (Poon,  1998).  However,  following  the 
evaluation  of  several  ionisation  procedures  for  MS  of  the  predominant  catechins  in 
tea  it  was  concluded  that  the  best  results  were  obtained  when  individual 
compounds  were  separated  by  HPLC  prior  to  mass  spectroscopic  analysis 
(Miketova  et  aL,  1998).  This  method  is  seen  to  give  the  most  useful  qualitative 
results  and  the  most  accurate  analytical  data. 
Estimation  of  the  "total"  polyphenol  content  of  teas  has  relied  on 
colorimetric  procedures,  such  as  the  Folin-Denis  or  Prussian  Blue  (Balentine  et  aL, 
1997)  assays,  based  on  "reducing  ability"  or  redox  reactions  mostly  specific  to 
phenolic  groups,  or  to  the  Folin-Ciocalteu  assay  based  on  the  identification  of 
gallic  acid  groups  (Singleton  &  Rossi,  1965).  In  spite  of  the  recent  advances  in 
instrumental  techniques,  these  non-specific  methods  are  still  important  for 
estimating  the  amounts  of  non-characterised  polyphenols  in  tea  and  other  foods 
(Beecher  et  aL,  1999).  Likewise,  another  indirect  approach  to  the  estimation  of  the 
polyphenol  content  of  teas  is  the  measurement  of  the  free  radical  scavenging 
activity,  similar  to  that  of  the  total  phenol  content  as  it  is  also  based  on  redox 
potentials.  Several  techniques  have  been  employed  to  measure  radical  scavenging Jennifer  McGinn,  2001  Chapter  5,180 
activity,  these  include  electron  spin  resonance  (ESR)  (Gardner  et  aL,  1998)  and  the 
ferric  reducing  ability  of  plasma  (FRAP)  (Benzie  &  Strain,  1996,1997).  These 
methods  are  based  on  the  ability  of  tea  extracts  or  individual  compounds  to 
scavenge  or  reduced  free  radicals  in  the  aqueous  phase.  Finally,  total  polyphenols 
in  teas  can  also  be  estimated  by  use  of  the  rapid  and  sensitive  method  for  catechin 
identification  in  plasma  and  aqueous  solutions.  Catechins  form  a  coloured 
complex,  which  can  then  be  quantified  colorimetrically  (Kivitis  et  aL,  1997). 
Previous  work  carried  out  with  red  wine  has  shown  that  by  using  preparatory 
fractionation  HPLC  systems  (Labarbe  et  al.,  1999)  and  small-scale  liquid/liquid 
extraction  (C18  Sep-Pak  cartridge)  fractionation  (Oszmianski  et  al.,  1987;  Ghiselli 
et  al.,  1989;  Sun  et  al.,  1998),  we  are  able  to  exploit  differences  in  the  solubility  of 
different  chemical  components  present  in  wine,  it  is  possible  to  separate  and  collect 
different  fractions  as  they  elute  off  the  column  over  a  pre-set  time-scale,  resulting 
in  each  fraction  having  a  different  composition  (Sun  et  al.,  1998).  This  then  allows 
the  identification  of  the  compounds  present  in  each  fraction  and  the  biological 
activity  of  each  individual  sample  to  be  obtained. 
In  this  final  study,  samples  of  brewed  green  and  black  tea  will  be 
fractionated  by  preparative  HPLC  with  the  polyphenolics,  specifically  catechins, 
present  in  each  sample  being  quantified.  The  identification  of  the  fractions  high  in 
antioxidant  activity  and  total  phenolic  and  catechin  content  will  also  be 
determined.  The  effect  of  green  tea  fractions  on  vascular  tension  in  vitro  is  also 
investigated. 
5.2  Materials  &  Methods 
In  order  to  identify  the  catechins  and  polyphenols  present  in  fractionated 
samples  of  green  and  black  tea  and  their  activities  in  vitro,  several  complementary 
methods  were  employed  in  the  course  of  this  study.  These  methods  are  explained 
in  detail  in  Chapter  2.  In  brief: Jennifer  McGinn,  2001  Chapter  5,181 
5.  Zl  Pre-fractionation  tea  preparation 
An  initial  amount  of  Ig  of  Tetley's  coarse  grain  green  tea  (B-50048)  and 
dry  medium  ground  black  tea  (U-1704)  was  brewed  in  100  mL  of  boiling  water  to 
allow  the  full  infusion  of  the  tea  leaves  into  solution. 
5.  Z2  Fractionation  methodology 
A  preparative  HPLC  system  was  used  for  a  large-scale  fractionation  based 
on  differences  in  polarity  of  the  various  green  and  black  tea  catechins.  The  HPLC 
system  (Figure  12)  used  to  fractionate  both  tea  samples  and  their  aid  their 
identification  using  HPLC  MS-MS  in  explained  in  detail  in  Chapter  2. 
5.2.2.1  Green  Tea 
A  sample  green  tea  was  eluted  by  a7-  30%  gradient  of  acetonitrile  in  2% 
formic  acid  and  held  at  30%  for  5  min.  Operating  at  20  mL  min-',  fifty  successive 
fractions  were  collected  every  30  seconds  from  an  injection  of  10  mL  of  green  tea, 
with  each  fraction  containing  10  mL  of  eluent.  Four  identical  10  mL  injection 
system  runs  were  carried  out,  with  a  total  pool  of  40  mL  of  each  fraction  being 
collected. 
5.2.2.2  Black  Tea 
A  sample  of  black  tea  was  run  over  a5-  15  %  gradient  of  acetonitrile  in 
2%  formic  acid  over  the  initial  20  minutes,  then  15  -  35  %  over  the  remaining  20  - 
30  minutes.  Operating  at  10  mUmin,  sixty  successive  fractions  were  collected 
every  30  seconds  from  an  injection  of  10  mL  of  black  tea,  with  each  fraction 
containing  5  mL  of  eluent. Jennifer  McGinn,  2001  Chapter  5,182 
5.  Z3  Mass  spectroscopy  analysis 
The  phenolic  profile  of  selected  green  and  black  tea  fractions  was  analysed 
by  high  performance  liquid  chromatography  -  mass  spectroscopy  -  mass 
spectroscopy  (HPLC-MS-MS).  The  mobile  phase  was  a5-  30%  linear  gradient 
over  60  min  of  acetonitrile  in  1%  formic  acid  eluted  at  a  flow  rate  of  1  mL  min". 
Short  isocratic  runs  (75%  B)  were  used  to  analyse  the  preparative  HPLC  tea 
fractions.  In  all  cases,  100  pL  of  each  selected  fraction  was  analysed  in  both 
positive  and  negative  ion  mode  (scanning  from  100.0  -  2000.0  amu),  using  data 
dependent  MS/MS.  Column  eluent  was  directed  to  a  LJV-vis  6000  photodiode 
array  detector  operating  at  wavelengths  250  -  700  run. 
5.2.4  Antioxidant  activity 
The  antioxidant  activity  and  phenolic  and  catechin  of  the  green  and  black 
tea  fractions  analysed  in  this  study,  were  determined  using  specific  spectral  and 
colorimetric  assays  discussed  in  detail  in  Chapter  2. 
5.2.4.1  ESR  activity 
Total  antioxidant  activity  of  each  green  tea  fraction  was  detennined  using 
ESR  spectroscopy,  where  the  ability  of  the  extracts  to  reduce  radicals  in  the 
aqueous  phase  was  estimated  by  adding  the  extract  to  an  equal  volume  of  a1  mM 
Fremy's  salt  free  radical.  Results  were  standardised  using  trolox. 
5.2.4.2  FRAP  activity 
Plasma  antioxidant  capacity  was  also  estimated  from  the  green  and  black 
tea  fractions  ferric  reducing  ability  (FRAP)  at  593  mn.  The  development  of  an 
intense  blue  colour  resulting  from  the  conversion  of  a  Fe(IIl)-2,4,6-Tri-2-pyr-idyl)- 
s-triazine  (TPTZ)  complex  to  Fe(II)-TPTZ  being  directly  related  to  the  amount  of 
reductant  present  in  each  tea  fraction.  Results  are  expressed  as  the  concentration  of 
Fe(H)  produced/mM  (Benzie  &  Strain,  1997). Jennifer  McGinn,  2001 
5.2.4.3  Total  phenol  content 
Chapter  5,183 
The  total  phenolic  content  of  each  green  and  black  tea  fraction  was 
determined  and  expressed  as  gallic  acid  equivalents  (GAE)  using  the  Folin- 
Ciocalteu  method  of  Singleton  &  Rossi  (1965).  All  fractions  were  analysed  at  765 
Ilm. 
5.2.4.4  Total  catechin  content 
The  total  catechin  content  of  each  green  and  black  tea  fraction  was 
determined  using  the  method  of  Kivitis  et  al  (1997).  Total  content  is  determined  by 
the  addition  of  a  DMACA  in  a  methanol/perchloric  acid/water  mix  to  the  tea 
fraction.  With  the  addition  of  the  DMACA  solution,  samples  are  seen  to  develop 
highly  specific  colour  complexes  dependent  on  total  catechin  content.  Absorbance 
was  measured  between  604  and  684  mn.  Results  are  expressed  as  total  catechins 
(mg/4 
5.2.5  Vasodilatory  activity:  green  tea  fractions 
Vasodilatory  studies  were  also  carried  out  with  the  green  tea  fractions  to 
investigate  their  vascular  tension  in  vitro.  This  method  is  previously  discussed  in 
detail  in  Chapter  2. 
In  brief,  isolated  rabbit  aortic  vessels  were  suspended  in  standard  10  mL 
organ  baths  (Figure  11),  filled  with  Krebs  buffer  solution,  continuously  oxygenated 
with  16%  02,5%  C02  and  79%  N2  and  maintained  at  370C,  to  mimic  the  internal 
environment.  Vessels  were  placed  under  an  optimal  resting  tension  of  2g.  Vessel 
contraction/relaxation  was  measured  via  an  isometric  force  transducer. 
After  an  equilibration  period,  vessels  were  twice  maximally  contracted  with 
50  mM  KCI  and  washed  out  thoroughly  with  Krebs  solution.  After  washing  and 
returning  to  initial  baseline  tension,  vessels  were  precontracted  submaximally  with 
PE  (10-7  M)  and  relaxed  with  ACh  to  ensure  the  presence  of  functional  and  intact Jennifer  McGinn,  2001  Chapter  5,184 
cndothelium  (see  Figure  13).  Matched  experimental  time  controls  were  run  for  all 
fractions  investigated. 
After  washing  and  returning  to  starting  baseline  tension,  aortic  rings  with 
functional  endothelium.  were  submaximally  precontracted  with  PE  (10-7  M).  Once 
a  stable  plateau  had  been  reached  and  was  maintained,  20  pg  mL"  (twice  10  pg 
mI;  '  aliquots)  of  each  green  tea  fraction  concentrate  were  added  to  the  organ  bath 
to  induce  vasodilation  in  the  aortic  ring  segments.  All  results  were  calculated  and 
expressed  as  the  %  vasorelaxation  induced  by  each  green  tea  fraction  following 
PE-induced  tone  in  2  vessels  (n  =  2). 
5.3  Results 
5.3.1  Green  Tea  Fractionation 
Following  the  large-scale  prep  fractionation  of  green  tea  (B-50048),  the 
antioxidant  activity  of  each  fraction  was  determined  by  ESR  and  FRAP  analysis. 
The  total  phenolic  and  catechin  content  of  each  fraction  was  also  determined. 
Results  are  shown  in  Graphs  36  to  39.  Values  for  each  individual  assay  carried  out 
are  shown  in  Table  20. 
5.3.1.1  Spectral&  colorimetric  assays 
Green  tea  fractions  19,27  and  28  were  all  found  to  be  consistently  higher  in 
their  antioxidant  capacity  analysed  by  ESR,  reducing  94.7,82.5  and  50.1  X  1018 
radicals/L,  respectively  (Graph  36,  Table  20).  The  overall  pattern  of  large-scale 
fractionation  was  seen  to  be  variable  in  activity  throughout  the  50  fractions,  with 
the  main  area  of  antioxidant  activity  being  confined  to  the  middle  band  of  tea 
samples,  fractions  18  to  29.  Poor  antioxidant  activity  was  observed  with  samples  at 
the  end  of  the  fractionation  range,  fractions  40-  to  50. 
Similar  activity  was  recorded  when  samples  were  analysed  using  their 
ferric  reducing  ability  an  as  index  of  their  antioxidant  capacity  (Graph  37,  Table Jennifer  McGinn,  2001  Chapter  5,185 
20).  FRAP  analysis  identified  high  antioxidant  activity  in  green  tea  fractions  8,18, 
19,27  and  28,  with  fraction  27  having  the  overall  highest  activity  recorded. 
As  before,  fractions  19,27  and  28  were  found  to  have  the  highest  total 
phenols  and  catechins  present  (Graphs  38,39).  Fraction  27  was  found  to  have  the 
highest  phenolic  content  followed  by  fraction  19,  with  453  Vg/mL  and  309  ptg/mL 
GAE  (Table  20),  respectively.  On  the  other  hand,  fraction  19  followed  by  fraction 
27  was  found  to  have  the  highest  catechin  content  with  634  mg/L  and  474  mg/L  of 
catechin  present  in  each  sample  (Table  20),  respectively.  Spectrally  the  antioxidant 
assays,  ESR  and  FRAP,  were  positively  related  to  both  total  phenolic  and  total 
catechin  contents,  with  the  same  fractions  being  higher  in  both  colorimetric  assays 
as  compared  to  remaining  samples.  In  all  assays,  the  fractions  at  the  beginning  and 
end  of  the  fraction  range  were  found  to  have  both  poor  antioxidant  activity  and  low 
total  phenolics  and  catechins  present. 
The  antioxidant  assays,  ESR  and  FRAP  were  found  to  be  highly  correlated 
(r  =  0.86,  P<0.0001)  when  analysed  using  Pearson's  correlations.  Both  antioxidant 
tests  produced  very  similar  patterns  of  activity  when  analysing  the  green  tea 
fractions  (Graph  40)  indicating  that  the  two  tests  of  antioxidant  capacity  can 
produce  comparable  results.  The  relationship  between  the  total  phenolic  and 
catechin  contents  and  antioxidant  activities  by  ESR  and  FRAP  are  shown  in  Graph 
41.  ESR-based  antioxidant  activity  was  highly  and  positively  correlated  to  both 
total  phenolic  (r  =  0.88,  P<0.001)  and  catechin  content  (r  =  0.94,  P<0.0001)  by 
multivariate  correlation  analysis.  The  higher  r  value  reported  by  the  total  catechin 
assay  on  analysis  indicates  that  the  catechin  content  of  the  green  tea  fractions  has  a 
greater  effect  on  ESR  determined  antioxidant  activity  than  phenol  content.  On  the 
other  hand,  both  total  phenol  (r  =  0.80,  P<0.0001)  and  total  catechin  (r  =  0.87, 
P<0.001)  contents  were  also  highly  correlated  to  antioxidant  activity  by  the  FRAP 
assay,  with  total  phenol  content  having  a  greater  effect  on  activity  than  catechin 
content.  Overall  total  catechin  and  phenol  contents  of  the  green  tea  fractions  were 
also  highly  correlated  (r  =  0.89). Jennifer  McGinn,  2001 
Table  20  Green  tea  fractionation  assay  mean  values  table 
Chapter  5,186 
1 
29.1  8.6  0.95  -0.15 
2  29.5  -8.6  1.66  -0.05 
3  20.7  -8.6  -0.5  -0.10 
4  43.1  -4.2  7.88  -0.04 
5  36.3  1  -7.5  3.29  0.05 
6  34.84  --7.5  4.25  0.15 
7  33.4  -8.2  6.08  0.68 
8  100.2  -7.8  11.4  2.90 
9  40.2  -6.0  5.74  0.29 
10  28.4  -7.6  3.57  0.21 
11  18.1  -7.5  4.67  0.14 
12  60.2  29.9  23.9  1.66 
13  44.8  5.0  18.0  0.67 
14  38.1  -4.9  7.72  0.23 
15  34.3  -7.2  3.83  0.39 
16  39.5  -3.5  6.02  0.30 
17  54.8  10.3  9.35  1.10 
18  82.8  24.3  33.8  2.39 
19  308.7  634.5  94.6  3.87 
20  42.8  26.3  28.9  0.76 
21  47.5  8.6  11.2  1.47 
22  71.6  22.4  17.9  0.81 
23  71.0  4.1  13.6  0.77 
24  21.3  -8.6  2.11  0.69 
25  39.0  -2.1  11.1  0.56 
26  74.8  20.7  31.6  0.90 
27  452.8  474.6  82.8  4.01 
28  290.7  356.5  50.1  3.20 
29  96.9  41.9  23.6  0.92 
30  47.8  7.0  1.66  0.42 
31  46.1  0.08  12.4  0.38 
32  39.8  -5.6  8.4  0.23 
33  33.7  -6.1  6.7  0.14 
34  41.4  -6.02  7.24  0.11 
35  40.7  1.7  10.22  0.17 
36  41.9  0.11  9.63  0.30 
37  38.4  -5.9  11.0  0.22 
38  229.0  60.6  18.9  1.88 
39  139.2  43.3  17.4  1.84 
40  43.7  0.6  8.56  0.44 
41  44.0  -3.5  9.4  0.27 
42  55.4  -6.2  7.66  0.31 
43  35.7  -7.4  5.10  0.16 
44  41.9  -7.5  4.67  0.19 
45  21.9  -7.9  4.10  0.09 
46  31.1  -5.9  4.45  0.12 
47  33.7  -3.2  4.17  0.18 
48  30.7  -7.3  4.98  0.12 
49  31.9  -7.7  4.79  0.10 
50  28.2  -8.1  8.60  0.16 
'Total  phenol  data  expressed  as  mean  ptg/ml  gallic  acid  equivalents  (GAE).  hTotal 
catechins  expressed  as  mean  mg/L  catechin.  cAntioxidant  (AOX)  activity  by  ESR, 
expressed  as  number  mean  of  radicals  reduced/L  x  1017  . 
Ferric  reducing  ability 
(FRAP)  expressed  as  the  mean  concentration  of  Fell  produced  (mM).  All  samples 
run  in  duplicate  from  pooled  samples  from  4  fractionations. Jennifer  McGinn,  2001 
5.2.1.2  Vasodilatory  activity 
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The  vasodilatory  activity  of  each  green  tea  fraction  in  rabbit  aortic  vessels 
in  vitro  was  determined.  Time  controls  for  each  fraction  run  to  demonstrate  the 
individual  effect  of  each  fraction  on  vascular  tension.  In  general,  fractions  with 
high  antioxidant  activity  were  able  to  relax  preconstrictcd  aortic  vessels  (Graph 
42).  Vasodilation  activity  of  the  fractions  was  found  to  correlate  with  their 
antioxidant  activity  by  ESR  (r  =  0.28,  P>0.05)  by  multivariatc  correlation  analysis. 
Fractions  induced  an  initial  period  of  transient  vasodilation  with  the  first  10  Pg 
m1:  1  aliquot  of  green  tea  fraction  concentrate  added  to  the  bath,  followed  by  period 
of  maintained  vasodilation  with  the  second  10  pg  mI;  '  aliquot  (Figure  17). 
Fraction  8  induced  the  greatest  degree  of  vasodilation  in  vitro  (Graph  42). 
Figure  17  displays  an  exainple  of  a  vasorelaxation  trace  induced  by 
fractions  27  and  28  following  PE-induced  tone.  Fraction  27  induced  a  period  of 
vasodilation  with  the  first  fraction  addition  followed  by  a  period  of  rapid  vessel 
reversal  and  contraction  with  the  second  concentrate  addition.  On  the  other  hand 
on  addition  of  the  second  fraction  concentrate  fraction  28  induced  a  period  of  rapid 
maintained  vasorelaxation  (Figure  17). 
5.2.1.3  Mass  spectrometry  analysis 
Mass  spectrometry  (MS)  detection  has  been  employed  in  this  study  to  aid 
catechin  and  polyphenol  identification.  The  phenolics  present  were  determined  by 
co-chromatography  with  authentic  standards.  Compounds  were  identified  on  the 
basis  of  their  retention  times,  absorbance  spectra  and  MS-MS  fragmentation 
pattems. 
Figure  18  displays  an  HPLC  chromatographic  traces  for  the  green  tea 
sample,  displaying  absorption  at  280  nm,  the  specific  wavelength  for  identification 
of  catechins  (Finger  et  A,  1992)  and  365  nm  the  specific  wavelength  for 
identification  of  flavonols  (Finger  et  aL,  1992).  Table  21  identifies  each 
component  of  the  green  tea  sample  by  peak  number  from  its  HPLC  trace  retention Jennifer  McGinn,  2001  Chapter  5,188 
time.  These  chromatographic  traces  display  the  complex  nature  and  large  number 
of  compounds  present  in  green  tea.  EGCG,  the  main  epicatechin  in  present  in  green 
tea,  was  the  main  peak  identified  with  absorbance  at  280  run  (peak  6).  A  catechin 
trimer  (4-8  linkage)  was  also  identified  (peak  8)  which  is  composed  of  3  catechin 
units  linked  together.  The  main  flavonol  identified  was  a  quercetin-hexose- 
rhamnose  molecule  (peak  10),  composed  of  a  quercetin  molecule  with  the  addition 
of  a  hexose  sugar  unit  and  a  rhamnose  sugar  unit.  These  compounds  were 
identified  on  the  basis  of  the  molecular  ion  weight,  fragmentation  pattern  and 
absorbance  spectra  for  each  individual  compound. 
Table  21  Identification  of  the  main  phenolics  in  green  tea  by  HPLC  MS-MS 
Peak  No.  Component  Retention  Time  (Rt  mins) 
1  Epigallocatechin  (EGC)  13.05 
2  Catechin  15.17 
3  Chlorogenic  acid  16.75 
4  Caffeine  17.90 
5  Epicatechin  (EC)  20.45 
6  Epigallocatechin  gallate  (EGCG)  21.80 
7  Cyanidin  28.82 
8  Catechin  trimer  31.07 
9  Rutin  32.80 
10  Quercetin-hexose-rhamnose  33.65 
11  Quercetin-3-glucoside  34.93 
12  Kaempferol-3-glucose  40.00 
13  Quercetin  53.88 
Sample  run  on  a  5-30%  acetonitrile/1%  formic  acid  gradient  over  60  mins  in 
positive  ion  mode. 
On  analysis  of  the  results  fraction  27  displayed  high  antioxidant  activity, 
high  phenolic  and  catechin  content  levels  and  subsequent  low  vasodilatory  activity, 
the  opposite  pattern  to  the  results  in  Chapter  4  for  green  tea  catechins  and 
epicatechins. Jennifer  McGinn,  2001  Chapter  5,189 
Fraction  27  was  therefore  investigated  by  HPLC  MS-MS  to  detennine  the 
phenolics  present.  The  presence  of  caffeine  and  EGCG  were  identified  in  this 
fraction  by  their  MS-MS  fragmentation  patterns  and  co-chromatography  with 
standards  (Figure  19  &  20).  On  calculating  peak  area,  both  EGCG  and  caffeine 
were  found  to  be  equal  in  size. 
The  positive  identification  of  EGCG  was  made  by  its  MS-MS  of  its  M- 
molecular  ion  nilz  459.0  amu,  with  fragments  at  nVz  289.0,  representative  of  a 
catechin/epicatechin  unit,  and  the  neutral  loss  of  170.0,  representative  of  a  gallate 
unit  (Figure  19).  EGCG  had  a  lamba  maximum  (k  ..  )  of  272  run  (Table  22) 
identified  by  its  PDA  spectra. 
The  positive  identification  of  caffeine  was  made  by  its  MS-MS  of  nilz 
195.0  amu,  with  molecular  ion  fragment  at  138.0  (Figure  20)  and  PDA  spectra 
with  aX..  ..  of  261  mn  (Table  22). 
The  confinned  positive  identification  of  EGCG  and  caffeine  in  green  tea 
fraction  27  was  carried  out  using  authentic  standards  of  both  compounds. 
Table  22  MS-MS  of  the  molecular  ions  in  green  tea  fraction  27 
Component  Rt  (min)  M+  (IWZ)  MS2  fragment  (nVz)  %  Mal 
EGCG  21.80  459.0  289,151,139  272 
Caffeine  17.90  195.0  138  261 
Sample  run  on  a  5-30%  acetonitrile  in  1%  formic  acid  gradient  over  60  mins  in 
positive  ion  mode. 
Due  to  time  limitations,  the  MS-MS  analysis  of  other  green  tea  fractions  of 
interest  was  not  carried  out. 0) 
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Figure  18  Green  tea  HPLC  chromatographic  traces 
(For  peak  identities  see  Table  21) 
Chapter  5,198 
nm 
i5  nm 
05  10  15  20  25  30  35  40  45  50  55  60 
Time  (min) Jennifer  McGinn,  2001  Chapter  5,199 
288.9 
1. 
MA 
Figure  19  Mass  spectrum  of  EGCG  molecular  ion  M"459.0 
138.0 
I 
MA 
Figure  20  Mass  spectrum  of  caffeine  molecular  ion  M"  195.0 Jennifer  McGinn,  2001  Chapter  5,200 
5.3.3  Black  Tea  Fractionation 
Following  the  large-scale  prep  fractionation  of  black  tea  (U-1704),  the 
antioxidant  activity  of  each  fraction  was  determined  by  FRAP  analysis.  The 
total  phenolic  and  catechin  content  of  each  fraction  was  also  detennined. 
Results  are  shown  in  Graphs  43  to  45.  Values  for  each  individual  assay  carried 
out  are  shown  in  Table  23  &  24. 
5.2.1.4  Spectral&  colorimetric  assays 
The  antioxidant  activity  of  the  black  tea  fractions  showed  little 
variability  across  the  range  of  fractions  (Graph  43)  as  determined  by  their 
ferric  reducing  ability  as  an  index  of  their  antioxidant  capacity  (FRAP 
analysis).  Fractions  3&4,  and  17-21  had  high  antioxidant  activity,  with  an 
overall  decrease  in  activity  thereafter.  Fraction  21  was  found  to  have  the 
highest  overall  activity  producing  0.6  mM  of  Fe(II)  (Table  23).  A  slight 
increase  in  antioxidant  activity  is  evident  with  fractions  at  the  end  of  the 
collection  range,  fractions  57-60.  The  antioxidant  activity  of  the  black  tea 
fractions  was  not  investigated  using  ESR.  Previous  analysis  with  the  green  tea 
fraction  demonstrated  that  ESR  and  FRAP  produce  highly  correlated  and 
equivalent  results. 
The  total  phenolic  content  of  the  black  tea  fractions  produced  a  similar 
content  pattern  as  that  of  the  FRAP  antioxidant  activity.  As  before,  fractions 
18  -  21,  were  found  to  be  consistently  higher  than  surrounding  fractions 
allowing  for  a  peaked  effect  with  a  reduction  in  total  phenolic  content  with 
increasing  fraction  number,  with  the  exception  of  fraction  28  which  had  the 
overall  highest  content  (Graph  44)  containing  68  pg/mL  GAE  as  compared  to 
fraction  18  which  contained  65  [tg/mL  GAE  (Table  23). 
The  catechin  assay  displayed  the  specific  separation  in  catcchin 
content  (Graph  45).  A  gradual  increase  in  content  up  to  fraction  18  was 
evident.  Fractions  18  -22  and  30  -  35  were  found  to  have  a  high  total  catechin 
content  with  a  decrease  in  content  with  surrounding  fractions.  Fraction  21  had Jennifer  McGinn,  2001  Chapter  5,201 
Table  23  Black  tea  fractionation  assay  mean  values  table  (fractions  1-40) 
1  34.6 
I 
-0.5  0.03 
2  47.7  0.44  0.20 
3  55.2  2.07  0.45 
4  52.7  2.64  0.53 
5  43.6  1.37  0.19 
6  40.8  2.20  0.16 
7  45.5  2.28  0.19 
8  44.9  2.93  0.25 
9  44.9  2.12  0.20 
10  52.4  3.13  0.22 
11  44.9  3.68  0.25 
12  44.0  3.60  0.23 
13  47.7  6.61  0.32 
14  51.1  6.74  0.37 
15  52.1  4.59  0.35 
16  55.5  5.31  0.40 
17  54.6  8.60  0.44 
18  67.7  13.5  0.55 
19  65.8  11.6  0.51 
20  60.5  8.26  0.47 
21  64.9  14.3  0.60 
22  59.0  12.5  0.59 
23  56.1  6.94  0.44 
24  48.3  3.34  0.35 
25  46.8  2.82  0.33 
26  46.8  4.07  0.34 
27  50.8  3.29  0.35 
28  68.3  3.83  0.36 
29  48.6  3.99  0.40 
30  37.6  7.54  0.46 
31  39.1  12.1  0.39 
32  28.8  11.3  0.38 
33  33.5  8.31  0.36 
34  36.3  13.2  0.46 
35  30.7  11.3  0.39 
36  30.1  5.48  0.32 
37  30.7  4.23  0.27 
38  27.6  2.39  0.26 
39  34.5  2.60  0.27 
40  31.0  2.98  0.32 
'Total  phenol  data  expressed  as  mean  pg/mL  gallic  acid,  b  Total  catechins 
expressed  as  mean  g/L  catechin,  cFerric  reducing  ability  expressed  as  the  mean 
concentration  of  Fe(ll)  produced  (mM).  All  samples  run  in  duplicate. Jennifer  McGinn,  2001  Chapter  5,202 
Table  24  Black  tea  fractionation  assay  mean  values  table  (fractions  41-60) 
41  38.2  3.15  0.34 
42  31.3  2.77  0.31 
43  30.7  2.28  0.28 
44  31.0  3.64  0.31 
45  31.3  2.55  0.34 
46  33.5  2.44  0.27 
47  27.3  2.22  0.24 
48  25.7  4.56  0.23 
49  28.5  4.78  0.25 
50  28.5  3.91  0.22 
51  30.1  4.45  0.27 
52  27.9  4.61  0.28 
53  30.4  4.61  0.27 
54  24.5  3.53  0.28 
55  23.8  3.36  0.26 
56  35.4  3.80  0.29 
57  29.1  6.52  0.35 
58  29.8  6.63  0.37 
59  32.3  6.52  0.39 
60  25.4  6.14  0.35 
'Total  phenol  data  expressed  as  mean  ýtg/ml-  gallic  acid,  b  Total  catechins 
expressed  as  mean  g/L  catechin,  Terric  reducing  ability  expressed  as  the  mean 
concentration  of  Fe(ll)  produced  (mM).  All  samples  run  in  duplicate. Jennifer  McGinn,  2001  Chapter  5,203 
the  highest  overall  catechin  content,  with  14.3  g/L  of  catechin  present  (Table 
23).  As  with  the  FRAP  analysis,  an  increase  in  total  catechin  content  is  evident 
with  fractions  57-60. 
The  relationship  between  the  total  phenolic  and  catechin  contents  and 
antioxidant  activities  by  FRAP  of  the  black  tea  fractions  is  shown  in  Graph  46. 
FRAP-based  antioxidant  activity  was  highly  and  significantly  correlated  with 
both  total  phenolic  (r  =  0.50,  P<0.001)  and  total  catechin  content  (r  =  0.75, 
P<0.0001)  by  Pearson's  correlation  analysis.  The  higher  r  value  reported  by 
the  total  catechin  assay  on  analysis  indicates  that  the  catechin  content  of  the 
black  tea  fractions  has  a  greater  effect  on  overall  on  antioxidant  activity  than 
phenol  content,  and  has  a  stronger  relationship  with  the  FRAP  assay.  Total 
catechin  and  phenol  contents  of  the  black  tea  fractions  were  also  positively 
correlated  (r  =  0.26,  P<0.05). 
5.2.1.5  Vasodilatory  activity 
Vasodilation  studies  with  the  black  tea  fractions  were  not  carried  out. 
5.2.1.6  Mass  spectrometry  analysis 
Catechin  and  polyphenol  identification  with  the  black  tea  fractions  was 
determined  by  HPLC  MS-MS.  The  phenolics  present  in  the  tea  sample  were 
determined  by  co-chromatography  with  authentic  standards.  Compounds  were 
identified  on  the  basis  of  their  retention  times,  absorbance  spectra  and  MS-MS 
fragmentation  patterns.  Figure  21  displays  the  HPLC  chromatographic  trace 
for  the  black  tea  sample,  displaying  absorption  at  280  rim  and  365  run. 
A  number  of  compounds  were  identified  in  the  black  tea  sample 
following  co-chromatography  with  standards.  Table  25  identifies  each 
component  of  the  black  tea  sample  by  peak  number  from  the  HPLC  traces  by 
retention  time.  These  chromatographic  traces  display  the  complex  nature  and 
large  number  of  compounds  present  in  black  tea.  The  small  number  of  peaks 
not  identified  with  retention  times  between  40  to  45  minutes  in  present  in  both Jennifer  McGinn,  2001  Chapter  5,204 
HPLC  traces  (Figure  21),  are  thought  to  correspond  to  the  presence  of 
theaflavins  which  are  known  to  elute  after  the  flavonols  (Lee  &  Ong,  2000). 
The  poor  HPLC  baseline  with  the  black  tea  chromatography  is  attributed  to  the 
presence  of  the  high  molecular  weight  thearubigens  being  present  throughout 
the  tea  sample  which  do  not  separate  or  chromatograph  well. 
Table  25  Identification  of  the  main  phenolics  in  black  tea  by  HPLC  MS-MS 
Peak  No.  Component 
, 
Retention  Time 
1  Epigallocatechin  (EGC)  13.62 
2  Chlorogenic  acid  16.52 
3  Epicatechin  (EC)  19.83 
4  Epigallocatechin  gallate  (EGCG)  21.43 
5  Catechin  trimer  25.85 
6  Myricetin  glucoside  27.28 
7  Cyanidin  28.72 
8  Rutin  32.50 
Black  tea  sample  run  on  a  5-30%  acetonitrile/1%  formic  acid  gradient  over  60 
mins  in  positive  ion  mode. 
Additional  work  with  other  tea  samples  using  co-chromatography  with 
a  standard  tea  extract  of  theaflavins  (Sigma-Aldrich,  Dorset,  England), 
retention  times  and  elution  order  identified  the  presence  of  the  4  main 
theaflavins  in  black  tea  (Figure  22,  Table  26)  using  MS-MS  their  molecular 
ions  and  fragmentation  patterns  (Figures  23  -  26). 
Table  26  Identification  by  HPLC  MS-MS  of  the  theaflavins  in  black  tea 
Peak  No.  Component  Rt  (min)  M+  (nvz) 
1  Theaflavin  50.88  563 
2  Theaflavin-3-gallate  53.55  715 
3  Theaflavin-Y-gallate  55.17  715 
4  Theaflavin-3,3-digallate  55.83  867 
Peak  I  had  a  M'  of  m/z  563  amu,  the  molecular  ions  of  peaks  2  and  3 
were  152  amu  greater,  an  increase  which  corresponds  to  the  addition  of  a 
gallate  group.  The  molecular  ion  of  peak  4  was  304  amu  greater  than  peak  1, 
twice  152  amu,  corresponding  to  the  addition  2  gallate  groups. LO 
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Figure  22  HPLC  chromatographic  trace  of  the  theaflavins  present  in  black  tea 
(For  peak  identities  see  Table  26) Jennifer  McGinn,  2001 
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Figure  23  Mass  spectrum  of  theaflavin  molecular  ion  M'563.0 Jennifer  McGinn,  2001 
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Figure  24  Mass  spectrum  of  theaflavin-3-gallate  molecular  ion  M'715.1 Jennifer  McGinn,  2001 
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Figure  25  Mass  spectrum  of  theaflavin-3'-gallate  molecular  ion  M-  715.1 Jennifer  McGinn,  2001 
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Figure  26  Mass  spectrum  of  theaflavin-3-3'-digallate  molecular  ion  M*  867.0 Jennifer  McGinn,  2001  Chapter  5,215 
5.3.5  Comparison  of  the  fractionation  of  green  &  black 
teas 
In  order  to  investigate  differences  between  the  2  types  of  tea  which 
were  previously  fractionated,  comparisons  of  the  fractionation  results  from  the 
FRAP  antioxidant  assays  and  total  phenolic  and  catechin  contents  were  carried 
out.  Comparison  results  for  the  green  and  black  teas  are  shown  in  Graphs  47  to 
49. 
Green  tea  fractions  are  found  to  be  consistently  higher  in  both  activity 
and  content  than  the  black  tea  fractions.  Green  tea  fractions  were  found  to  be 
significantly  (P<0.001)  more  effective  antioxidants  than  corresponding  black 
tea  fractions,  being  in  general  about  five  times  for  effective  free  radical 
scavengers  (Graph  46).  The  concentration  of  both  phenols  and  catechins 
present  in  the  black  tea  fractions  were  significantly  lower  (P<0.0001)  (5  to  10 
times  lower)  than  that  recorded  for  the  green  tea  fractions  (Graphs  48,49). 
Differences  in  overall  content  and  activity  of  the  tea  fraction  may  account  for 
the  differences  in  the  effects  of  green  and  black  tea  in  vivo,  with  green  tea 
having  a  consistently  higher  in  vivo  effect. 
The  use  of  mass  spectrometry  also  identified  differences  between  the 
chemical  composition  of  each  tea  type. L6 
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5.4  Discussion 
Chapter  5,219 
The  present  study  has  demonstrated  the  pattern  of  separation,  based  on 
differences  in  polarity  and  identification  using  MS-MS,  of  the  main  catechins 
and  polyphenols  present  in  green  and  black  teas  following  large-scale 
preparatory  fractionation.  This  study  has  further  determined  by  the  use  of 
complementary  methods,  the  antioxidant  activity,  total  phenolic  and  catechin 
content  of  each  fraction,  highlighting  a  significant  positive  association  of 
increasing  antioxidant  capacity  with  increasing  phenol  and  catechin  content. 
Likewise,  in  the  case  of  the  green  tea  fractions,  indicating  a  general  correlation 
between  increasing  antioxidant  capacity  and  vasodilator  activity  in  vitro. 
Phenols  in  tea  are  believed  to  be  responsible  for  its  subsequent 
antioxidant  activity.  The  pure  catechins  and  phenolics  found  in  tea  are  more 
powerfid  than  the  antioxidant  vitamins  C,  E  and  P-carotene  in  an  in  vitro 
lipoprotein  oxidation  model  (Vinson  et  aL,  1995).  Comparison  of  the  tea 
fractions  in  this  study  indicate  that  the  catechins  and  theaflavins  contribute  to 
the  teas'  antioxidant  characteristics  (Vinson  &  Dabbagh,  1998).  Green  and 
black  tea  extracts  have  also  been  reported  to  have  3.5  times  greater  antioxidant 
activity  than  the  traditional  vitamins  (Langley-Evans,  2000).  Data  on  the 
levels  of  total  phenolics  in  this  study  were  obtained  by  the  relatively  non- 
specific  Folin-Ciocalteu  method  calibrated  with  gallic  acid  (Singleton  & 
Rossi,  1965).  Green  tea  was  found  to  have  a  higher  total  phenol  content  as 
compared  to  black  tea  fractions,  which  may  account  for  the  lower  antioxidant 
capacity  of  the  black  tea  fractions  determined  using  the  FRAP  assay.  In  all  3 
assays  investigating  black  tea  fractionation,  fractions  57-60  at  the  end  of  the 
collection  range  increased  in  both  activity  and  content.  This  feature  of  the 
fractionation  corresponds  to  the  presence  of  theaflavins,  the  high  molecular 
weight  products  with  previously  described  comparable  antioxidant  potency  to 
green  tea  catechins  (Leung  et  aL,  2001)  which  are  generally  considered  to  be 
more  effective  components  for  the  inhibition  of  carcinogenesis  (Lee  &  Ong, 
2000).  0. Jennifer  McGinn,  2001  Chapter  5,220 
The  antioxidant  properties  of  polyphenols  have  been  proposed  to 
underlie  their  apparent  health  benefit.  The  results  displayed  in  this  study  show 
the  antioxidant  effectiveness  of  green  and  black  tea  fractions.  Green  tea 
fractions  were  found  to  be  about  5  times  more  active  as  antioxidants  as 
compared  to  black  tea  fractions.  A  large  number  of  in  vitro  studies  have  shown 
that  tea  catechins  are  absorbed  by  humans.  Studies  have  shown  that  both  green 
(He  &  Kies,  1994;  Serafini  et  A,  1996;  Benzie  et  A,  1999;  Sung  et  aL,  2000) 
and  black  (Langley-Evans,  2000)  tea  consumption  may  lead  to  subsequent 
increases  in  plasma  antioxidant  capacity. 
HPLC  is  extensively  used  for  the  identification  and  quantification  of 
polyphenols.  The  main  catechins  and  epicatechins  can  be  routinely  detected  in 
green  tea  using  UV  at  280  mn  (Finger  et  A,  1992),  with  catechin  and 
epicatechin  known  to  be  naturally  fluorescent  with  excitation  at  280  ran  and 
emission  at  3  10  mn.  In  black  tea,  catechin  and  epicatechin  are  present  at  much 
lower  levels  and  due  to  UV  sensitivity,  fluorescence  detection  is  preferred 
(Blacklock,  personal  communication).  The  use  of  both  isocratic  and  gradient 
solvent  systems  have  been  used  for  the  analysis  of  catechins  from  teas.  Mobile 
phases  are  generally  based  on  methanol  or  acetonitrile  and  contain  acid  (Robb 
&  Brown,  2001).  The  presence  of  acid  is  necessary  not  only  for  complete 
separation  of  the  catechins  but  also  for  optimal  separation  efficiency. 
Although  catechins  are  extremely  stable  at  pH  <4,  stability  is  pH  dependent  in 
the  range  of  pH  4-8:  the  lower  the  pH,  the  greater  the  stability.  Catechins 
instantly  degrade  at  pH  levels  above  8  (Finget  et  aL,  1992).  Column 
temperature  can  affect  catechin  separations.  Temperatures  ranging  from  20- 
50"C  have  been  employed  to  get  good  separations  (Beecher  el  aL,  1999).  The 
HPLC  system  used  in  this  study  was  run  using  acetonitrile  and  formic  acid  as 
the  mobile  phase,  with  a  of  pH  5  and  a  column  temperature  of  40*C,  to  endure 
the  optimal  conditions  for  resolution  and  sensitivity  of  detection  for  the 
effective  separation  of  the  catechins  present  in  each  sample.  This  study  has 
shown  the  distinct  composition  of  green  and  black  teas  and  the  differences 
between  them.  EGCG  was  identified  in  both  tea  samples,  being  the  main  peak 
identified  in  green  tea  and  being  present  in  lower  levels  in  black  tea. Jennifer  McGinn,  2001  Chapter  5,221 
MS  detection  has  also  been  employed  for  improved  catechin 
identification  and  quantification.  Thermospray,  electrospray  and  plasmaspray 
interfaces  to  the  liquid  chromatograph  have  all  been  used  (Dalluge  &  Nelson, 
2000).  Using  MS,  the  flow  rate  and  temperature  of  the  inlet  tube  have  all  to  be 
optimised  for  each  class  of  compounds.  Good  sensitivity  is  obtained  for 
compounds  which  ionise  efficiently  (Dalluge  &  Nelson,  2000).  However,  in  a 
tea  extracts,  a  large  number  of  compounds  are  present,  which  ionise  at 
different  efficiencies,  thus  optimisation  is  more  difficult  (Miketova  et  aL, 
1998).  Two  recent  studies  of  the  mass  spectrometric  characteristics  of  the 
polyphenolic  extract  of  green  tea  have  shown  that  liquid 
chromatography/electrospray  ionisation  mass  spectrometry  (LC/ESI-MS)  is  a 
powerful  tool  for  the  identification  of  the  components  present  in  the  tea 
mixture  (Miketova  et  al.,  1998;  Dalluge  &  Nelson,  2000).  The  phenolic 
content  of  the  teas  in  this  study  was  determined  by  LC-MS-MS  and  co- 
chromatography  with  authentic  standards  and  standard  tea  mixtures.  It  must 
however  be  noted  that  very  few  of  the  teas  are  commercially  available  in  a 
purified  form.  The  present  study  has  identified  the  presence  of  3  of  the  4  main 
epicatechins  present  in  green  tea,  EC,  EGC  and  EGCG  in  our  fractionated 
green  tea  sample,  with  additional  catechin  trimers  also  identified.  The 
presence  of  large  amounts  of  caffeine  was  also  identified.  This  may  account 
for  the  poor  vasodilator  ability  of  green  tea  fraction  27,  which  was  found  to 
have  potent  antioxidant  capabilities  and  high  phenolic  and  catechin  content. 
The  identification  of  caffeine  in  green  tea  may  also  account  for  the  contractile 
effects  of  green  tea  shown  in  previous  chapters. 
Theaflavins  are  catechin-based  trimers  (Robb  &  Brown,  2001). 
Individual  theaflavin  standards  are  not  commercially  available  and  additional 
work  with  a  tea  standard  theaflavin  mixture  allowed  the  identification  of 
theaflavins  on  the  basis  of  elution  order,  retention  time,  MS-MS  data  and 
current  related  literature  (Lewis  et  aL,  1998,  Lee  &  Ong,  2000).  The 
theaflavins  are  known  to  elute  after  the  flavonols  (Finger  et  aL,  1992;  Lee  & 
Ong,  2000)  in  black  tea  and  are  absent  in  green  tea  due  to  chemical  changes 
which  take  place  during  the  fermentation  stage  of  the  manufacturing  process. Jennifer  McGinn,  2001  Chapter  5,222 
Individual  thearubigens,  the  high  molecular  weight  fermentation  condensation 
products  were  not  identified  using  HPLC.  The  peaked  baseline  effect  shown  in 
the  black  tea  chromatographic  trace  is  thought  to  correspond  to  the  presence  of 
thearubigens  in  the  tea  sample.  Previous  work  has  shown  that  they  do  not 
chromatograph  well  due  to  their  high  molecular  weight,  and  to  date  have  not 
been  identified  using  mass  spectrometry  (Lee  &  Ong,  2000). 
5.4.1  Conclusion 
Catechins  are  the  most  common  type  of  polyphenol  found  in  tea.  The 
consumption  of  catechins  may  have  a  beneficial  effect  on  some  aspects  of 
health.  The  phenolic  profile  of  tea  is  dependent  upon  a  number  of  influences 
including  leaf  variety  and  extent  of  processing.  HPLC  is  by  far  the  most 
common  method  of  catechin  analysis,  the  improvement  of  existing 
technologies  and  the  development  of  new  assays  may  contribute  to  an  increase 
in  the  alleged  health  benefits  of  tea  compounds. Jennifer  McGinn,  2001  Chapter  6,223 
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Chapter  6  General  Discussion 
This  thesis  has  reported  on  a  series  of  investigations  undertaken  to 
examine  the  relationship  between  the  vasodilatory  activity  and  antioxidant 
capacity  of  polyphenolic  compounds,  namely  extracts  of  grape  and  tea  and 
green  tea  epicatechin  derivatives.  By  detennining  the  effect  of  such 
compounds  on  vascular  tension  in  vitro  and  their  related  antioxidant  activity 
this  provides  additional  information  on  the  alleged  beneficial  effects  of  such 
beverages.  In  addition  the  main  components  present  in  samples  of  green  and 
black  tea  were  determined  identifying  the  main  components  of  each  tea  type 
and  the  chemical  differences  between  green  and  black  tea. 
6.1  Vasodilatory  &  antioxidant  activity  of  grape 
and  tea  extracts 
The  possible  beneficial  health  effects  of  red  wine  and  tea  have  mainly 
focused  on  their  role  as  potent  antioxidants  and  their  ability  to  scavenge  free 
radicals,  but  the  ability  of  polyphenols  present  in  these  beverages  to  induce 
vessel  relaxation  is  also  important  in  their  alleged  protection  of  the 
cardiovascular  system.  Natural  dietary  phenolics  and  polyphenols  from  grape 
derived  products  can  induce  endothelium-dcpendent  vasodilation  in  both 
human  and  rodent  vessels  (Andriambeloson  et  aL,  1998;  Flesch  et  aL,  1998), 
with  the  mechanism  of  this  vasodilation  being  via  the  release  of  nitric  oxide 
(NO)  and  subsequent  increases  in  cGMP  (Fitzpatrick  et  aL,  1993; 
Andriambeloson  et  aL,  1997;  Flesch  et  aL,  1998).  Green  tea  has  also  been 
shown  in  small  number  of  studies  to  induce  vasodilation  in  isolated  vascular 
vessels.  The  vasodilator  activity  of  green  tea  has  been  attributed  to  its  (-)- 
cpicatechin  (EQ  content,  to  the  release  of  NO  from  vascular  endothelial  cells, 
and  to  the  inhibition  of  calcium  influx  (Huang  et  aL,  1998,1999). 
Vasodilation  induced  in  vitro  by  grape  and  tea  based  extracts  were 
detcnnined  and  related  to  their  antioxidant  activity  and  phenolic  content. Jennifer  McGinn,  2001  Chapter  6,225 
Mechanisms  and  pathways  of  action  in  the  vascular  system  were  also 
determined. 
The  vasodilatory  activity  of  each  individual  extract  was  determined 
using  organ  bath  pharmacology,  a  standard,  reliable  and  repeatable 
experimental  pharmacology  technique.  This  study  has  demonstrated  that  grape 
and  tea  based  extracts  can  induce  vasodilation  in  isolated  aortic  vessels 
(Chapter  3).  A  dried  extract  of  French  grape  seed  was  identified  to  be  the  most 
potent  extract  investigated  and  the  black  tea  theaflavin  extract  to  be  the  least, 
inducing  vasorelaxation  at  the  lowest  extract  concentration  and  inducing 
vasorelaxation  with  the  lowest  maximum  value  respectively.  Grape  based 
extracts  consistently  induced  greater  maximum  vasodilation  than  the  tea  based 
extracts.  All  extracts  produced  biphasic  concentration-dependent 
vasorelaxation  in  rabbit  aortic  isolated  vessels. 
An  extract  of  red  grape  skin  induced  vasodilation  by  complex 
mechanisms.  These  included  endothelium-independent  mechanisms,  via 
vasodilating  prostaglandins,  and  via  prostacyclin  and  endothclial  NO 
production.  Vasodilation  induced  by  a  grape  powder  extract,  a  dried  extract  of 
the  whole  grape,  indicated  that  the  both  the  flesh  and  the  seeds  of  the  grape 
have  the  potential  for  relaxation.  It  is  evident  therefore  that  not  all  vaso-active 
components  in  grapes  are  derived  from  the  grape  skin.  The  French  grape  skin 
and  seed  extracts  induced  vasorelaxation  via  NO-endothelium-dependent 
mechanisms.  Vasorelaxation  induced  by  green  and  black  tea  extracts  were  due 
to  the  combined  interactions  between  vasodilating,  endothelium-depcndent 
prostaglandins,  and  other  undetermined  mechanisms. 
The  antioxidant  capacity  of  the  extracts  consistently  showed  the  tea 
extracts  to  be  better  antioxidants  than  the  grape  based  extracts.  The  French 
grape  seed  extract  was  the  exception  as  it  was  identified  a  potent  vasodilator 
and  a  poor  antioxidant.  This  extract  was  identified  to  have  comparable 
antioxidant  activity  to  the  green  and  black  tea  and  was  consistently  higher  in 
all  spectral  and  colorimetric  assays  than  other  grape  based  extracts.  Grape Jennifer  McGinn,  2001  Chapter  6.226 
seeds  contain  flavan-3-ols  or  catechins  (Fitzpatrick  ct  A,  1997),  similar  to  that 
of  green  tea.  On  the  other  hand,  the  composition  of  the  grape  skin  extract  is 
predominately  composed  of  anthocyanins  accounting  for  their  dccp  red  colour. 
Red  wine  extracts  have  previously  been  shown  to  induce  vasorclaxation  in 
rabbit  aortic  vessels  with  a  potency  directly  correlated  to  their  antioxidant 
activity  and  total  phenolic  content  (Bums  ct  aL,  2000).  This  study  on  the  other 
hand,  has  demonstrated  a  significant  inverse  correlation  bctwccn  the 
vasodilatory  and  antioxidant  activity  of  the  extracts,  indicating  that  the  highcr 
the  antioxidant  activity  of  the  extracts,  the  less  active  they  are  as  vasodilators. 
It  is  also  evident  that  the  compounds  responsible  for  inducing  antioxidant 
activity  are  distinct  from  those  responsible  for  their  vasodilator  activity  of  the 
extracts  in  vitro. 
The  opposite  nature  of  the  results  published  by  Bums  ct  A.  (2000)  as 
compared  to  the  present  study  may  be  due  to  genuine  differences  in  the  initial 
starting  products  rather  than  differences  in  experimental  methodology.  Red 
wine  extracts  were  investigated  for  their  antioxidant  and  vasodilatory  activity 
as  compared  to  various  dried  grape  based  extracts  in  this  study.  The  full  wine 
extracts  may  therefore  have  contained  a  wider  range  of  active  compounds 
other  than  grape  derived  products  which  may  have  enhanced  their  vasodilatory 
and  antioxidant  capabilities.  Red  wines  will  also  have  a  difTercrit  composition 
to  that  of  grape  extracts  because  of  the  chemical  changes  that  occur  during 
extraction,  vinification  and  maturation  of  the  finished  wine. 
6.2  Vasodilatory  &  antioxidant  activity  of  green 
tea  epicatechins 
Catcchins  arc  a  group  of  natural  polyplicnols  found  in  grccn  tcas  usually 
accounting  for  30  -  42%  of  the  dry  wcight  of  the  solids  in  brcwcd  tca  (Yang, 
1999).  Thcy  also  arc  prcscnt  in  black  tca  but  to  a  much  smallcr  cxtcnt. 
Catcchins  are  oxidiscd.  to  forrn  the  distinctivc  thcaflavins  of  black  tca.  Grccn 
tca  contains  the  charactcristic  polyplicnolic  compounds,  (+)-catcchin  and  its Jennifer  McGinn,  2001  Chapter  6,227 
isomer  EC,  (-)-epicatcchin  gallatc  (ECG),  cpigallocatccilin  (EGQ,  (-)-catcchin 
gallate  (CG)  and  (-)-cpigallocatcchin  gallatc  (EGCG)  (Baicntinc  ct  aL,  1997). 
Green  tea  was  previously  showed  in  this  study  (Chaptcr  3)  to  be  a 
vasodilator  in  isolatcd  aortic  vcsscls.  To  dctcrrninc  the  vasoactivc  componcrits 
of  green  tea  a  selection  of  the  main  catcchins  and  cpicatccliins  prcscnt  wcrc 
investigated  for  their  vasodilatory  activity  using  standard  organ  bath 
pharmacology,  and  related  to  their  antioxidant  activity  (Chapter  4).  Their 
mechanisms  and  pathways  of  action  in  vitro  were  also  dctcrmincd. 
CG  was  identificd  to  bc  the  most  potcnt  dcrivativc  in  vitro  and  EC  to 
be  the  least,  inducing  vasorclaxation  at  the  lowest  derivative  concentration 
added  to  the  organ  bath  and  inducing  the  lowest  maximum  relaxation  value 
respectively.  Vasorclaxation  occurred  via  the  release  of  NO  and  was 
dependent  upon  the  presence  of  intact  functional  vascular  cndothclium.  EC 
and  (+)-catcchin  were  devoid  of  significant  vasodilator  activity  in  the  rabbit 
aorta,  consistent  with  studies  in  the  rat  aorta  where  catcchin  and  EC  had  very 
low  vasodilator  activity  (Andriambcloson  a  aL,  1997;  1998).  The  results  of 
this  study  may  account  for  a  degree  of  the  vasodilator  activity  of  green  tca  but, 
as  discussed  previously  (Chapter  3),  cannot  account  for  all  the  dilator  activity 
which  also  involved  non-endotliclial  factors  and  prostaglandin-mcdiatcd 
cffects. 
Grccn  tca  epicatcchins  and  catcchins  wcrc  also  Wntified  to  bc 
cffcctivc  antioxidants,  with  ovcrall  activity  ranging  in  the  ordcr  niagnitudc  of 
EGCG>EGC>ECG2:  Catccliin>CG>EC.  Antioxidant  activity  was  positivcly 
and  highly  significantly  corrclatcd  with  vasodilatory  activity. 
Catechin  and  epicatcchin  derivatives  arc  found  primarily  in  the  seeds 
of  grapes  (Sato  et  aL,  1999).  This  may  contribute  to  the  high  antioxidant,  and 
vasodilatory  capacity  of  the  French  grape  seed  extract  investigated  in  Chaptcr 
3,  as  compared  to  the  predominately  anthocyanin  containing  grapc  skin 
extracts.  Grapes  also  contain  gallatc  esters  and  gallocatcchins  but  thcsc  arc Jennifer  McGinn,  2001  Chapter  6,228 
found  in  only  low  levels  in  red  wine  (Bums  et  aL,  2000)  but  may,  according  to 
the  this  study  account  for  a  small  degree  of  vasodilation  induced  by  red  wines. 
This  study  has  shown  CG  to  be  a  potent  vasodilator  in  vitro  but  to  be  a  poor 
antioxidant  with  low  overall  phenol  content.  The  red  grape  based  extracts 
investigated  in  Chapter  3  had  similar  vasodilatory  and  antioxidant  responses  to 
that  of  CG,  which  is  found  in  low  levels  in  red  wine,  and  is  derived  primarily 
from  the  grape  seed  (Bums  et  aL,  2000)  but  which  has  also  been  idcntiricd  in 
the  grape  skin.  CG  may  therefore,  be  in  part  accountable  for  tile  vasodilation 
induced  by  grape  skin  and  seed  extracts. 
Differences  in  the  statistical  results  presented  for  the  vasodilatory  and 
antioxidant  activities  of  the  grape  and  tea  based  extracts  (Chapter  3)  as 
compared  to  that  of  the  green  tea  epicatechin  and  catcchin  derivatives 
(Chapter  4),  may  be  due  to  genuine  differences  in  the  basic  chemical 
composition  of  the  compounds  investigated  as  standard  experimental 
methodology  was  used  in  both  studies.  The  grape  and  tea  extracts  invcstigatcd 
contained  a  range  of  active  components  in  varying  concentrations  which  may 
have  interacted  together  to  produce  cumulative  antioxidant  and  vasodilatory 
effects  as  compared  to  the  purificd  single  epicatcchin  standards  of  a 
predetermined  concentration.  Contamination  of  the  grape  and  tea  cxtracts  is 
another  factor  which  may  have  had  an  affect  on  the  results  prcscntcd  and 
which  could  not  be  ruled  out. 
This  study  has  demonstrated  that  cpicatcchins  dcrivcd  from  grccn  tca 
and  which  are  also  present  to  a  smallcr  extent  in  black  tca,  can  be  both 
vasodilators  and  antioxidants.  Tile  possible  health  cffccts  of  such  compounds 
are  likely  due  to  the  cumulative  effects  of  these  catcchins  and  cpicatcchins  and 
other  components  present  not  yet  idcntiricd  working  in  synergy. 
6.3  Fractionation  of  green  &  black  tea 
Further  investigations  into  the  naturc  of  the  polyphcnols  prcscnt  in  tca 
and  their  related  antioxidant  activity  was  dcmonstratcd.  SampIcs  of  grccn  and Jennifer  McGinn,  2001  Chapter  6,229 
black  tea  were  separated  into  fractions  on  the  basis  of  tlicir  polarity  using  a 
preparative  HPLC  system. 
This  study  has  demonstrated  the  pattcm  of  scparation  and  idcntirication 
using  mass  spectrometry  of  the  main  catechins  and  polyphcnols  prcscnt  in 
green  and  black  teas  following  large-scale  fractionation  (Chapter  5).  This 
study  has  further  determined  by  the  use  of  complementary  methods,  the 
antioxidant  activity,  total  phenolic  and  catcchin  content  of  cach  tca  fraction. 
Increasing  antioxidant  capacity  was  highly  corrclatcd  with  increasing  total 
phenol  and  catechin  content.  The  effect  of  each  green  tea  fraction  on  vascular 
tension  in  vitro  was  also  determined.  A  positive  association  bctwccn 
increasing  antioxidant  capacity  and  vasodilator  activity  was  shown. 
Mass  spectrometry  (MS)  detection  was  also  been  cmploycd  for 
improved  catechin  identification.  The  phenolic  content  of  the  tcas  in  this  study 
were  determined  by  LC-MS-MS  and  co-chromatography  with  authentic 
standards.  The  present  study  identified  the  presence  of  3  of  thc  4  main 
catechins  present  in  green  tea,  EC,  EGC  and  EGCG  with  additional  catcchin 
trimers  and  large  amounts  of  caffeine  also  evident.  This  may  account  for  the 
poor  vasodilator  ability  of  green  tea  fraction  27  which  was  idcntirlcd  to  havc 
high  antioxidant  capabilities  and  a  high  phenolic  and  catcchin  contcnt.  The 
identification  of  caffeine  in  green  tea  may  account  for  the  contractilc  cffccts  of 
green  tea  shown  in  Chapter  3.  The  theaflavins  and  tlicarubigcns  from  black  tca 
were  also  putatively  identified  in  the  fractionated  sampic. 
6.4  Conclusions 
The  consumption  of  red  wine  and  tca  as  part  of  a  healthy  dict  maybe 
associatcd  with  a  reduced  incidcncc  of  CIID  and  cancers.  This  protection  is 
bclicvcd  to  be  confcrrcd  by  the  high  polyplicnol  content  of  both  beverages. 
This  study  has  clearly  dcmonstratcd  that  grape  and  tca  based  extracts  and 
grccn  tca  cpicatcchin  derivatives  can  induce  vasorclaxation  in  vascular  tissue 
and  has  spccificd  the  mcchanisms  of  action  for  cach  individual  cxtract  and Jennifer  McGinn,  2001  Chapter  6,230 
green  tea  derivative.  A  number  of  thesc  compounds  are  also  cffcctivc 
antioxidants,  both  mechanisms  which  may  contribute  to  the  alleged  protcctivc 
effects  of  red  wine  and  tea.  This  study  has  also  demonstrated  that  tile 
anthocyanins  present  in  red  wine  account  for  tile  vasodilatory  activity  of  grapc 
based  extracts,  and  catechins  to  be  responsible  for  the  antioxidant  activity 
conferred  by  tea  extracts  and  catechin  and  epicatcchin  dcrivativcs. 
Consumption  of  red  wine  and  tea  may  therefore  play  a  role  in  helping 
maintain  optimal  vascular  function  in  vivo  via  antioxidant  and  vasodilatory 
mechanisms,  contributing  to  improved  cardiovascular  health. 
6.5  Future  work 
There  has  been  an  explosion  of  interest  in  the  possible  bencricial  cffccts 
of  dietary  components  on  human  health  over  the  past  few  years.  The 
publications  arising  from  this  research  field  appear  to  be  increasing 
exponentially.  Possibilities  for  continuing  research  in  this  field  arc 
innumerable. 
The  isolation  and  identification  of  the  vaso-activc  substances  present  in 
the  extracts  examined  in  this  study  and  their  possible  cffccts  in  Wvo,  continues 
and  are  yet  to  be  fully  detcrinined.  It  seems  likely  that  the  bcncricial  cffccts  of 
red  wine  and  tea  are  due  to  the  cumulative  cffccts  of  several  polyplicnols 
working  in  synergy  rather  than  one  individual  compound  present. 
Wine  and  tea  contain  a  huge  number  of  compounds,  plicnolics, 
polyphenols  and  a  large  number  of  which  at  present  rcmain  uncharactcriscd. 
Work  is  required  to  understand  the  structure  of  these  compounds,  particularly 
the  large  complex  tannins,  thcaflavins  and  thcarubigens. 
Vasodilation,  induced  by  the  individual  phenolics,  especially  the 
anthocyanins,  prcscnt  in  red  wine  has  not  yet  been  investigated.  Although  in 
vitro  studies  have  shown  the  possible  beneficial  cfTccts  of  rcd  wine,  more  In 
vivo  studies  are  required  to  give  a  clearer  picture  or  the  compounds  that  are Jennifer  McGinn,  2001  Chapter  6,231 
responsible  for  maintaining  optimal  vascular  blood  flow.  Similar  studies  are 
also  required  to  investigate  the  cardiovascular  effects  of  green  and  black  tea  in 
vivo. 
Extensive  trials  with  human  subjects  are  required  to  determine  the 
nature  and  extent  of  red  wine  derived  phenolic  and  tea  catechin  absorption, 
bioavailability  and  metabolism.  The  work  in  this  field  to  date  relies  heavily  on 
the  use  of  animal  models  and  the  use  of  pure  compounds  or  plant  extracts 
rather  than  whole  beverages.  Such  trials  may  enable  the  major  phenolics  and 
polyphenols  that  are  absorbed  and  their  active  metabolites,  to  be  isolated  and 
characterised.  This  may  then  allow  the  production  of  wines  and  tea  enriched 
with  these  active  components. Jennifer  McGinn,  2001  Chapter  7,232 
Chapter  7  List  of  References 
Aherne,  S.  A.,  and  O'Brien,  N.  A  (2002).  Dietary  flavonols:  chemistry,  food 
content  and  metabolism.  Nutrition  18,75-81 
Ahmad,  N.,  and  Mukhtar,  H.  (1999).  Green  tea  polyphenols  and  cancer: 
biological  mechanisms  and  practical  implications.  Nutrition  Reviews  57,78-83 
Andriambeloson,  E.,  Kleschyov,  A.  L.,  Muller,  B.,  Beretz,  A.,  Stoclet,  J.  C., 
and  Andriantsitohaina,  R.  (1997).  Nitric  oxide  production  and  endothelium- 
dependent  vasorelaxation  induced  by  wine  polyphenols  in  rat  aorta.  British 
Journal  ofPharmacology  120,1053-1058. 
Andriambeloson,  E.,  Magnier,  C.,  Haan-Archipoff,  G.,  Lobstein,  A.,  Anton, 
R.,  Beretz,  A.,  Stoclet,  J.  C.,  and  Andriantsitohaina,  R.  (1998).  Natural  dietary 
polyphenolic  compounds  cause  endothelium-dependent  vasorelaxation  in  rat 
thoracic  aorta.  Journal  offutrition  128,2324-2333. 
Andriambeloson,  E.,  Stoclet,  J.  C.,  and  Andriantsitohaina,  R.  (1999). 
Mechanism  of  endothelium  nitric  oxide-dependent  vasorelaxation  induced  by 
wine  polyphenols  in  rat  thoracic  aorta.  Journal  of  Cardiovascular 
Pharmacology  33,248-254. 
Antiplatelet  Trialists'  Collaboration  (1988).  Secondary  prevention  of  vascular 
disease  by  prolonged  antiplatelet  treatment.  British  Medical  Journal  296,320- 
331 
Ascherio,  A.,  Rimm,  E.  B.,  Hernan,  M.  A.,  Giovannucci,  E.,  Kawachi,  I., 
Stampfer,  M.  J.,  and  Willet,  W.  C.  (1999).  Relation  of  consumption  of  vitamin 
E,  vitamin  C  and  carotenoids  to  risk  for  stroke  among  men  in  the  United 
States.  Annuals  ofInternal  Medicine  130,963-970 
Aziz,  A.  A.,  Edwards,  C.  A.,  Lean,  M.  E.  J.,  and  Crozier,  A.  (1998). 
Absorption  and  excretion  of  conjugated  flavonols,  including  quercetin-4'-O-P- Jennifer  McGinn,  2001  Chapter  7,233 
glucoside  and  isorhamnetin-4'-O-P-glucoside  by  human  volunteers  after 
consumption  of  onions.  Free  Radical  Research  29,257-269 
Balentine,  D.  A.,  Wiseman,  S.  A.,  and  Bouwens,  L.  C.  M.  (1997).  The 
chemistry  of  tea  flavonoids.  Critical  Reviews  in  Food  Science  and  Nutrition 
37,693-704 
Barra,  S.,  Franceschi,  S.,  Negri,  E.,  Talarnini,  R.,  and  La  Vecchia,  C.  (1990). 
Type  of  alcoholic  beverage  and  cancer  of  the  oral  cavity,  pharynx  and 
oesophagus  in  an  Italian  area  with  high  wine  consumption.  International 
Journal  of  Cancer  46,1017-1020 
Beecher,  G.  R.,  Warden,  B.  A.,  and  Merken,  H.  (1999).  Analysis  of  tea 
polyphenols.  Proceedings  of  the  Society  of  Experimental  Biology  and 
Medicine  220,267-270. 
Benito,  S.,  Lopez,  D.,  Saiz,  M.  P.,  Buxaderas,  S.,  Sanchez,  J.,  Puig-Parellada, 
P.,  and  Mitjavila,  M.  T.  (2002).  A  flavonoid-rich  diet  increases  nitric  oxide 
production  in  rat  aorta.  British  Journal  ofPharmacology  135,910-916 
Benzie,  I.  F.  F.  and  Strain,  J.  J.  (1996).  The  ferric  reducing  ability  of  plasma 
(FRAP)  as  a  measure  of  "Antioxidant  Power":  The  FRAP  assay.  Analytical 
Biochemistry  239,70-76. 
Benzie,  I.  F.  F.  and  Strain,  J.  1  (1997).  Simultaneous  automated  measurement 
of  total  "antioxidant"  (reducing)  capacity  and  ascorbic  acid  concentration. 
Redox  report  3,233  -23  8. 
Benzie,  1.  F. F.  and  Szeto.  Y.  T.  (1999).  Total  antioxidant  capacity  of  teas  by 
the  Fcrric  Reducing/Antioxidant  Powcr  Assay.  Journal  of  Agricultural  and 
Food  Chemistry  47,633-636. 
Blot,  W.  J.,  Li,  J.  Y.,  Taylor,  P.  R.,  Guo,  W.,  Dawsey,  S.,  Wang,  G,  Q,  Yang, 
C.  S.,  Zheng,  S,  F.,  Gail,  M.,  Li,  G.  Y.,  Yu,  Y.,  Lui,  B.  Q.,  Tangrea,  J.,  Sun,  Y. 
H.,  Lui,  G.  Y.,  Fraumeni,  J.  F.,  Zhang,  Y.  H.,  and  Li,  B.  (1993).  Nutritional 
intervention  trials  in  Linxian,  China:  supplementation  with  specific Jennifer  McGinn,  2001  Chapter  7,234 
vitamin/mineral  combinations,  cancer  incidence  and  disease  specific  mortality 
in  the  general  population.  Journal  of  the  National  Cancer  Incidence  85,1483- 
1492 
Bokuchava,  M.  A.  and  Skobeleva,  N.  1.  (1980).  The  biochemistry  and 
technology  of  tea  manufacture.  Critical  Reviews  in  Food  Science  and 
Nutrition  12,303-370. 
Bravo,  L.  (1998).  Polyphenols:  Chemistry,  dietary  sources,  metabolism  and 
nutritional  significance.  Nutrition  Reviews  56,317-333. 
Bums,  J.,  Gardner,  P.  T.,  O'Neil,  J.,  Crawford,  S.,  Morecroft,  I.,  McPhail,  D. 
B.,  Lister,  C.,  Matthews,  D.,  MacLean,  M.  R.,  Lean,  M.  E.  J.,  Duthie,  G.  G., 
and  Crozier,  A.  (2000).  Relationship  arnong  antioxidant  activity,  vasodilation 
capacity,  and  phenolic  content  of  red  wines.  Journal  ofAgricultural  and  Food 
Chemistry  48,220-230. 
Bums,  J.,  Crozier,  A.,  and  Lean,  M.  E.  J.  (2001).  Alcohol  consumption  and 
mortality:  is  red  wine  different  to  other  alcoholic  beverages.  Nutrition, 
Metabolism  and  Cardiovascular  Diseases  11,249-25  8 
Bushman,  J.  L.  (1998).  Green  tea  and  cancer  in  humans:  a  review  of  the 
literature.  Nutrition  and  Cancer  31,151-159. 
Caccetta,  R.  A.  A.,  Croft,  K.  D.,  Beilin,  L.  J.,  and  Puddey,  I.  B.  (2000). 
Ingestion  of  red  wine  significantly  increases  plasma  phenolic  acid 
concentration  but  does  not  affect  ex  vivo  lipoprotein  oxidizability.  American 
Journal  of  Clinical  Nutrition  71,67-74 
Cishek,  M.  B.,  Galloway,  M.  T.,  Karim,  M.,  German,  J.  B.,  and  Kappagoda,  C. 
T.  (1997).  Effects  of  red  wine  on  endothelium-dependent  relaxation  in  rabbits. 
Clinical  Science  93,507-511. 
Clifford,  A.  J.,  Ebeler,  S.  E.,  Ebcler,  J.  D.,  Bills,  N.  B.,  Hinrichs,  S.  H., 
Teissedre,  P.  L.,  and  Waterhouse,  A.  L.  (1996).  Delayed  turnour  onset  in Jennifer  McGinn,  2001  Chapter  7,235 
transgenic  mice  fed  with  an  amino-acid  based  diet  supplemented  with  red 
wine  solids.  American  Journal  of  Clinical  Nutrition  64,748-756. 
Cook,  N.  C.,  and  Samman,  S.  (1996).  Flavonoids-chemistry,  metabolism, 
cardio-protective  effects  and  dietary  sources.  Nutritional  Biochemistry  7,66- 
76 
Criqui,  A  H.,  and  Ringel,  B.  L.  (1994).  Does  diet  or  alcohol  explain  the 
French  Paradox?  Lancet  344,1719-1723 
Criqui,  M.  H.  (1998).  Do  known  cardiovascular  risk  factors  mediate  the  effect 
of  alcohol  on  cardiovascular  disease?  Novartis  Foundation  Symposium  216, 
159-167 
Crozier,  A.,  Jensen,  E.,  Lean,  M.  E.  J.,  and  McDonald,  M.  S.  (1997). 
Quantitative  analysis  of  flavonoids  by  reversed-phase  high  performance  liquid 
chromatogaphy.  Journal  of  Chromatography  A  761,315-32  1. 
Crozier,  A.,  Lean,  M.  E.  J.,  McDonald,  M.  S.,  and  Black,  C.  (1997). 
Quantitative  analysis  of  the  flavonol  content  of  commercial  tomatoes,  onions, 
lettuce  and  celery.  Journal  ofAgricultural  and  Food  Chemistry  43,590-595. 
Crozier,  A.,  Bums,  J.,  Aziz,  A.  A.,  Stewart,  A.  J.,  Rabiasz,  H.  A.,  Jenkins,  G. 
I.,  Edwards,  C.  A.,  and  Lean,  M.  E.  J.  (2000).  Antioxidant  flavonols  from 
fruit,  vegetables  and  beverages:  measurements  and  bioavailability.  Biological 
Research  33,79-88. 
Cullen,  K.  J.,  Knuiman,  M.  W.,  and  Ward,  N.  J.  (1993).  Alcohol  and  mortality 
in  Busselton,  Western  Australia.  American  Journal  of  Epidemiology  137,242- 
248 
Dalluge,  J  and  Nelson,  B.  C.  (2000).  Determination  of  tea  catechins.  Journal 
of  Chromatography  881,411-424 
Damianaki,  A.,  Bokogeorrgou,  E.,  Kampa,  M.,  Notas,  G.,  Hatzoglou,  A., 
Panagiotou,  S.,  Gemetzi,  C.,  Kouroumalis,  E.,  Martin,  P.  M.,  and  Castanas,  E. Jennifer  McGinn,  2001  Chapter  7,236 
(2000).  Potent  inhibitory  action  of  red  wine  polyphenols  on  human  breast 
cancer  cells.  Journal  of  Cellular  Biochemistry  78,429-441. 
Das,  D.  K.,  Sato,  M.,  Ray,  P.  S.,  Maulik,  N.,  Englernan,  R.  M.,  Bertelli,  A.  A. 
E.,  and  Bertelli,  A.  (1999).  Cardio-protection  of  red  wine:  role  of  polyphenolic 
antioxidants.  Drugs  Experimental  and  Clinical  Research  25,115-120. 
Daviglus.  -  A  L.,  Orencis,  A.  J.,  Dyer,  A.  R.,  Lui,  K.,  Morris,  D.  K.,  Persky, 
V.,  Chavez,  N.,  Goldberg,  J.,  Drum,  M.,  Shekelle,  R.  B.,  and  Samler,  J. 
(1997).  Dietary  vitamin  C,  P-carotene  and  30  year  risk  of  stroke:  results  from 
thte  Western  Electric  Study.  Neuroepidemiology  16,69-77 
Day,  A.  P.,  Kemp,  H.  J.,  Bolton,  C.,  Hertog,  M.,  and  Stansbie,  D.  (1997). 
Effect  of  concentrated  red  grape  juice  on  serum  antioxidant  capacity  and  low- 
density  lipoprotein  oxidation.  Annuals  of  Nutrition  and  Metabolism  41,353- 
357 
Demrow,  H.,  Slane,  P.  R.,  and  Folts,  J.  D.  (1995).  Administration  of  wine  and 
grape  juice  inhibits  in  vivo  platelet  activity  and  thrombosis  in  stenosed  canine 
coronary  arteries.  Circulation  91,1182-1188. 
De  Pascual-Teresa,  S.,  Santos-Buelga,  C.,  and  Rivas-Gonzalo,  J.  (2000) 
Quantitative  analysis  of  flavon-3ols  in  Spanish  foodstuffs  and  beverages. 
Journal  ofAgricultural  Food  Chemistry  48,5331-5337 
Doll,  R.,  and  Peto,  R.  (1981).  The  causes  of  cancer.  Journal  of  the  National 
Cancer  Institute  66,1191-1308 
Donovan,  J.  L.,  Bell,  J.  R.,  Kasim-Karakas,  S.,  German,  J.  B.,  Walzem,  R.  L., 
Hansen,  R.  J.,  and  Waterhouse,  A.  L.  (1999).  Catechin  is  present  as 
metabolites  in  human  plasma  after  consumption  of  red  wine.  Journal  of 
Nutrition  129,1662-1668. 
Dufresne,  C.  I  and  Farnworth,  E.  R.  (2001).  A  review  of  latest  research 
findings  on  the  health  promotion  properties  of  tea.  Journal  of  Nutritional 
Biochemistry  12,404-42  1. Jennifer  McGinn,  2001  Chapter  7,237 
Duthie,  G.  G.,  Pedersen,  A  W.,  Gardner,  P.  T.,  Morrice,  P.  C.,  Jenkinson,  A. 
M., McPhail,  D.  B.,  and  Steele,  G.  M.  (1998).  The  effect  of  whiskey  and  wine 
consumption  on  total  phenol  content  and  antioxidant  capacity  of  plasma  from 
healthy  volunteers.  European  Journal  of  Clinical  Nutrition  52,733-736. 
Duthie,  G.  G.  and  Bellizzi,  M.  C.  (1999).  Effects  of  antioxidants  on  vascular 
health.  British  Medical  Bulletin  55,568-577. 
Duthie,  G.  G.,  Duthie,  S.  J.,  and  Kyle,  J.  A.  M.  (2000).  Plant  polyphenols  in 
cancer  and  heart  disease:  implications  as  nutritional  antioxidants.  Nutrition 
Research  Reviews  13,79-106. 
Duthie,  G.  G.,  and  Crozier,  A.  (2002).  Beverages.  In:  Potentially  Protective 
Substances  in  Foods.  Report  of  the  Nutrition  Foundation  Task  Force, 
Blackwell  Press  (in  preparation). 
Finger,  A.,  Kuhr,  S.,  and  Engelhardt,  U.  H.  (1992).  Chromatography  of  tea 
constituents.  Journal  of  Chromatography  624,293-3  IS. 
Fitzpatrick,  D.  F.,  Hirschfield,  S.  L.,  and  Coffey,  R.  G.  (1993).  Endothelium- 
dependent  vasorelaxing  activity  of  wine  and  other  grape  products.  American 
Journal  ofPhysiology  265,  H774-H778. 
Fitzpatrick,  D.  F.,  Hirschfield,  S.  L.,  Ricci,  T.,  Jantzen,  P.,  and  Coffey,  R.  G. 
(1995).  Endothelium-dependent  vasorelaxation  caused  by  various  plant 
cxtracts.  Journal  of  Cardiovascular  Pharmacology  26,90-95. 
Fitzpatrick,  D.  F.,  Maggi,  D.,  Bing,  B.,  and  Coffey,  R.  (1997).  Vasorelaxation, 
endothelium  and  wine.  Biofactors  6,45  5-45  9. 
Fitzpatrick,  D.  F.,  Fleming,  R.  C.,  Bing,  B.,  Maggi,  D.,  and  O'Malley,  R.  M. 
(2000).  Isolation  and  characterisation  of  endothelium-dependent  vasorelaxing 
compounds  from  grape  seeds.  Journal  ofAgricultural  and  Food  Chemistry  48, 
6348-6390. Jennifer  McGinn,  2001  Chapter  7,238 
Flesch,  M.,  Schwarz,  A.,  and  Bohm,  M.  (1998).  Effects  of  red  and  white  wine 
on  endothelium-dependent  vasorelaxation  of  rat  aorta  and  human  coronary 
arteries.  American  Journal  ofPhysiology  275,  H1  183-HI  190. 
Frankel,  E.  N.,  Kanner,  J.,  German,  I  B.,  Parks,  E.,  and  Kinsella,  J.  E.  (1993). 
Inhibition  of  oxidation  of  human  low-density  lipoprotein  by  phenolic 
substances  in  red  wine.  Lancet  341,454-457. 
Frankel,  E.  N.,  Waterhouse,  A.  L.,  and  Teissedre,  P.  L.  (1995).  Principal 
phenolic  phytochernicals  in  selected  Californian  wines  and  their  antioxidant 
activity  in  inhibiting  oxidation  of  human  low-density  lipoproteins.  Journal  of 
Agricultural  and  Food  Chemistry  43,890-894. 
Freedman,  J.  E.,  Parker,  C.,  Li,  L.,  Perlman,  J.  A.,  Frei,  B.,  Ivanov,  V.,  Deak, 
L.  R.,  lafrati,  M.  D.,  and  Folts,  J.  D.  (2001).  Select  flavonoids  and  whole  grape 
juice  from  purple  grapes  inhibit  platelet  function  and  enhance  nitric  oxide 
release.  Circulation  103,2792-2798. 
Friedman,  G.  D.,  and  Klatsky,  A.  L.  (1993).  Is  alcohol  good  for  your  health? 
New  EnglandJournal  ofMedicine  329,1882-1883 
Fuhrman,  B.,  Lavy,  A.,  and  Aviram,  M.  (1995).  Consumption  of  red  wine  with 
meals  reduces  the  susceptibility  of  human  plasma  and  low-density  lipoprotein 
to  lipid  oxidation.  American  Journal  of  Clinical  Nutrition  61,549-554. 
Fujiki,  H.,  Yoshizawa,  S.,  Horiuchi,  T.,  Suganma,  M.,  Yatsumani,  J., 
Nishiwaki,  S.,  Okabe,  S.,  Nishiwaki-Matsushima,  R.,  Okuda,  T.,  and 
Sugimura,  T.  (1992).  Anticarcinogenic  effects  of  (-)-epigallocatechin  gallate. 
Preventative  Medicine  21,503-509 
Furchgott,  R.  F.,  and  Kazawaki,  J.  V.  (1980).  The  obligatory  role  of 
endothelial  cells  in  the  relaxation  of  arterial  smooth  muscle  by  acetylcholine. 
Nature  288,373-376 Jennifer  McGinn,  2001  Chapter  7,239 
Gao,  H.  G.,  McLaughlin,  J.  K.,  Blot,  W.  J.,  Ji,  B.  T.,  Dai,  Q.,  and  Fraurneni,  J. 
F.  (1994)  Reduced  risk  of  oesophageal  cancer  associated  with  green  tea 
consumption.  Journal  ofthe  National  Cancer  Institute  86,855-858 
Gardner,  P.  T.,  McPhail,  D.  B.,  and  Duthie,  G.  G.  (1998).  Electron  spin 
resonance  spectroscopic  assessment  of  the  antioxidant  potential  of  teas  in 
aqueous  and  organic  media.  Journal  of  the  Science  of  Food  and  Agriculture 
76,257-262. 
Geleijinse,  J.  M.,  Launer>  L.  J.,  Hofinan,  A.,  Pols,  H.  A.  P.,  and  Witteman,  J. 
C.  M.  (1999).  Tea  flavonoids  may  protect  against  atherosclerosis  -  The 
Rotterdam  study.  Archives  ofInternal  Medicine  159,2170-2174 
German,  J.  B.  (2000).  The  health  benefits  of  wine.  Annual  Reviews  in 
Nutrition  20,561-593. 
Ghiselli,  A.,  Nardini,  M.,  Baldi,  A.,  and  Scaccini.  C.  (1998).  Antioxidant 
activity  of  different  phenolic  fractions  separated  from  an  Italian  red  wine. 
Journal  ofAgricultural  and  Food  Chemistry  46,361-367. 
Gordon,  M.  H.  (1996).  Dietary  antioxidants  in  disease  prevention.  Natural 
Products  Report  13,265-273. 
Graham,  H.  N.  (1992).  Green  tea  consumption,  composition  and  polyphenol 
chemistry.  Preventive  Medicine  21,334-350. 
Gronbxk,  M.,  Dcis,  A.,  Sorcnsen,  T.  I.  A.,  Bccker,  U.,  Schnohr,  P.,  and 
Jensen,  G.  (1997).  Mortality  associated  with  moderate  intakes  of  wine,  beer  or 
spirits.  British  Medical  JOurnal  310,1165-1169. 
Gronbxk,  M.,  Becker,  I.,  Johansen,  D.,  Tonnesen,  H.,  Jensen,  G.,  and 
Sorensen,  T.  1.  A.  (1998).  Population  based  cohort  study  of  the  association 
between  alcohol  intake  and  cancer  of  the  upper  digestive  tract.  British  Medical 
Journal  317,844-848. Jennifer  McGinn,  2001  Chapter  7,240 
Grylewski,  R.  J.,  Korbut,  R.,  Robak,  J.,  and  Swies,  J.  (1987).  On  the 
mechanism  of  antithrombotic  action  of  flavonoids.  Biochemical 
Phannacology  36,317-322 
Guo,  W.,  Yamauchi,  K.,  Watanabe,  N.,  Usui,  T.,  Luo,  S.,  and  Kantz,  S. 
(1995).  A  primeverosidase  as  a  main  glycosidase  concerned  with  the  alcoholic 
aroma  formation  in  tea  leaves.  Bioscience  Biotechnology  and  Biochemistry  59, 
962-964 
Halliwell,  B.  (1997).  Antioxidants  and  human  disease:  a  general  introduction. 
Nutrition  Reviews  55,  S44-S52- 
Halliwell,  B.,  and  Gutteridge,  J.  M.  C.  (1998).  Free  radicals  in  Biology  and 
Medicine.  Oxford  University  Press:  Oxford 
Harborne,  J.  B.  (1993).  The  flavonoids:  Advances  in  research  since  1986. 
Chapman  &  Hall:  London,  UK,  676  pp 
Hartman,  T.  J.,  Tangrea,  J.  A.,  Pietinen,  P.,  Malila,  P.,  Virtanen,  M.,  Taylor,  P. 
PL,  and  Albanes,  D.  (1998).  Tea  and  coffee  consumption  and  risk  of  colon  and 
rectal  cancer  in  middle-aged  Finnish  men.  Nutrition  and  Cancer  31,41-48 
Haslarn,  E.  (1998).  Practical  Polyphenolics.  From  structure  to  molecular 
recognition  and  physiological  action.  Cambridge  University  Press,  UK,  422  pp 
He,  Y.  H.  and  Kies,  C.  (1994).  Green  and  black  tea  consumption  by  humans: 
Impact  on  polyphenol  concentrations  in  faeces,  blood  and  urine.  Plant  Foods 
for  Human  Nutrition  46,221-229. 
Hennekens,  C.  H.,  Willet,  W.,  Rosner,  B.,  Cole,  D.  S.,  and  Mayrent,  S.  L. 
(1979).  Effects  of  beer,  wine  and  liquor  in  coronary  deaths.  Journal  of  the 
American  Medical  Association  242,1973-1974 
Herrmann,  K.  (1976).  Flavonols  and  flavones  in  food  plants:  a  review.  Journal 
ofFood  Technology  11,433-448. Jennifer  McGinn,  2001  Chapter  7,241 
Hertog,  M.  G.  L.,  Holtman,  P.  C.  H.,  and  Katan,  M.  B.  (1992).  Content  of 
potentially  anticarcinogenic  flavonoids  of  28  vegetables  and  9  fruits 
commonly  consumed  in  The  Netherlands.  Journal  of  Agricultural  and  Food 
Chemistry  40,2379-2383. 
Hertog,  M.  G.  L.,  Feskens,  E.  J.  M.,  Hollman,  P.  C.  H.,  Katan,  M.  B.,  and 
Kromhout,  D.  (1993).  Dietary  antioxidant  flavonoids  and  the  risk  of  coronary 
heart  disease:  The  Zutphen  elderly  study.  Lancet  342,1007-1011. 
Hertog,  M.  G.  L.,  Hollman,  P.  C.  H.,  Katan,  M.  B.,  and  Kromhout,  D.  (1993). 
Intake  of  potentially  anticarcinogenic  flavonoids  and  their  determinants  in 
adults  in  The  Netherlands.  Nutrition  and  Cancer  -  An  International  Journal 
20,21-29. 
Hertog,  M.  G.  L.,  Hollman,  P.  C.  H.,  and  van  de  Putte,  B.  (1993).  Content  of 
potentially  anticarcinogenic  flavonoids  of  tea  infusions,  wines  and  fruit  juices. 
Journal  ofAgricultural  and  Food  Chemistry  41,1242-1246. 
Heinonen,  0.  P.,  Albanes,  D.,  Virtamo,  J.,  Taylor,  P.  R.,  Huttunen,  J.  K. 
Hartman,  A.  M.,  Haapakoski,  J.,  Malila,  N.,  Rautalathi,  M.,  Maenpaa,  H., 
Teerenhovi,  L.,  Koss,  L.,  Virolainen,  M.,  and  Edwards,  B.  K.  (1998).  Prostate 
cancer  and  supplemental  with  alpha-tocopherol  and  beta-carotene:  incidence 
and  mortality  in  a  controlled  trial.  Journal  of  the  National  Cancer  Institute  90, 
440-446 
Hirvonen,  T.,  Virtarno,  J.,  Korhonen,  P.,  and  Albanes,  D.  (2000).  Intake  of 
flavonoids,  carotenoids,  vitamins  C  and  E  and  risk of  stroke  in  male  smokers. 
Stroke  31,2301-2306 
Hirvonen,  T.,  Virtamo,  J.,  Korhonen,  P.,  Albanes,  D.,  and  Pietinen,  P.  (2001). 
Flavonol  and  flavone  intake  and  the  risk  of  cancer  in  male  smokers.  Cancer 
Causes  Control  12,789-796 
Hollman,  P.  C.  H.,  de  Vries,  J.  H.  M.,  van  Leeuwen,  S.  D.,  Mengelers,  M.  J. 
B.,  and  Katan,  M.  B.  (1995).  Absorption  of  dietary  quercetin  glycosides  and Jennifer  McGinn,  2001  Chapter  7,242 
quercetin  in  healthly  ileostorny  volunteers.  American  Journal  of  Clinical 
Medicine  62,1276-12  82 
Hollman,  P.  C.  H.,  Feskens,  E.  J.  M.,  and  Katan,  M.  B.  (1999).  Tea  flavonols 
in  cardiovascular  disease  and  cancer  epidemiology.  Proceedings  of  the  Society 
ofExperimental  Biology  andMedicine  220,198-202. 
Huang,  Y.,  Zhang,  A.,  Lau,  C.  W.,  and  Chen,  Z.  Y.  (1998).  Vasorelaxant 
effects  of  purified  green  tea  epicatechin  derivatives  in  rat  mesenteric  artery. 
Life  Sciences  63,275-283. 
Huang,  Y.,  Chan,  N.  W.  K.,  Lau,  C.  W.,  Yao,  X.  Q.,  Chan,  F.  L.,  and  Chen,  Z. 
Y.  (1999).  Involvement  of  endothelium/nitric  oxide  in  vasorelaxation  induced 
by  purified  green  tea  (-)-epicatechin.  Biochimica  et  Biophysica  Acta  1427, 
322-328. 
Jackson,  R.,  Scragg,  R.,  and  Beaglehole,  R.  (1991).  Alcohol  consumption  and 
risk  of  coronary  heart  disease.  British  Medical  Journal  303,211-216 
Kanner,  J.,  Frankel,  E.  N.,  Granit,  R.,  Gennan,  J.  B.,  and  Kinsella,  J.  E. 
(1994).  Natural  antioxidants  in  grapes  and  wines.  Journal  ofAgricultural  and 
Food  Chemistry  42,64-69. 
Karim,  M.,  McCormick,  K.,  and  Kappagoda,  C.  T.  (2000).  Effects  of  cocoa 
extracts  on  endothelium-dependent  relaxation.  Journal  of  Nutrition  130, 
2105S-2108S. 
Kaufinan,  D.  W.,  Rosenberg,  L.,  Helmrich,  S.  P.,  and  Shapiro,  S.  (1985). 
Alcoholic  beverages  and  myocardial  infarction  in  young  men.  American 
Journal  of  Epidemiology  121,548-554 
Keli,  S.  0.,  Hertog,  M.  G.  L.,  Feskens,  E.  M.  J.,  and  Kromhout,  D.  (1996). 
Dietry  flavonoids,  antioxidant  vitamins,  and  incidence  of  stroke.  Archives  of 
Internal  Medicine  156,637-642 Jennifer  McGinn,  2001  Chapter  7.243 
Kerry,  N.  L.,  and  Abbey,  M.  (1997).  Red  wine  and  fractionated  phenolic 
compounds  prepared  from  red  wine  inhibit  low-density  lipoprotein  oxidation 
in  vitro.  Atherosclerosis  135,93-102 
Kinsella,  J.,  Frankel,  E.,  and  German,  J.  (1993).  Possible  mechanisms  for  the 
protective  role  of  antioxidants  in  wine  and  plant  foods.  Food  Technology  47, 
85-89 
Kivitis,  G.  A.  A.,  Can  der  Sman,  F.  J.  P.,  and  Tijburg,  L.  B.  M.  (1997). 
Analysis  of  catcchins  from  green  and  black  tea  in  humans:  a  specific  and 
sensitive  colorimetric  assay  of  total  catechins  in  biological  fluids. 
International  Journal  offood  Science  and  Nutrition  48,387-392 
Klatsky,  A.  L.,  Armstrong,  M.  A.,  Friedman,  G.  D.,  and  Hiatt,  R.  A.  (1989). 
The  relations  of  alcoholic  beverage  use  to  colon  and  rectal  cancer.  American 
Journal  ofEpidemiology  126,1007-1013 
Klatsky,  A.  L.,  Armstrong,  M.  A.,  and  Friedman,  G.  D.  (1990).  Risk  of 
cardiovascular  mortality  in  drinkers,  ex-drinkers  and  non-drinkers.  American 
Journal  of  Cardiology  66,1237-1242 
Klatsky,  A.  L.  (2001).  Diet,  alcohol  and  health:  a  story  of  connections, 
confounders  and  cofactors.  American  Journal  of  Clinical  Nutrition  74,279- 
280 
Kohlmeier,  L.,  Weterings,  K.  G.  C.,  Steck,  S.,  and  Kok,  F.  J.  (1997).  Tea  and 
cancer  prevention:  an  evaluation  of  the  epidemiological  literature.  Nutrition 
and  Cancer  27,1-13. 
Kopp,  P.  (1998).  Resveratrol,  a  phytoestrogen  found  in  red  wine.  A  possible 
explanation  for  the  conumdrum  of  the  'French  Paradox'?  European  Journal  of 
Endocrinology  138,619-620 
Knekt,  P.,  Jarinen,  R.,  Reunanen,  A.,  and  Maatela,  J.  (1996).  Flavonoid  intakc 
and  coronary  mortality  in  Finland:  a  cohort  study.  British  Medical  Journal 
312,478-481 Jennifer  McGinn,  2001  Chapter  7,244 
Kuhnau,  J.  (1976).  The  flavonoids:  a  class  of  semi-essential  food  components 
-  their  role  in  human  nutrition.  World  Review  of  Nutrition  and  Dietetics  24, 
117-191 
Kwok,  L.,  Su,  Y.,  Chen,  R.,  Zhang,  Z.,  Huang,  Y.,  and  Chen,  Z.  Y.  (2001). 
Theaflavins  in  black  tea  and  catechins  in  green  tea  are  equally  effective 
antioxidants.  Journal  ofNutrition  131,2248-2251 
Lalarbe,  B.,  Cheynier,  V.,  Brossaud,  F.,  Souquet,  J.  M.,  and  Moutounet,  M. 
(1999).  Quantitative  fractionation  of  grape  proanthocyanidins  according  to 
their  degree  of  polymerization.  Journal  of  Agricultural  and  Food  Chemistry 
47,2719-2723. 
Langley-Evans,  S.  C.  (2000).  Antioxidant  potential  of  green  and  black  tea 
determined  using  the  ferric  reducing  power  (FRAP)  assay.  International 
Journal  offood  Sciences  and  Nutrition  51,181-188. 
Lee,  B.  L.,  and  Ong,  C.  N.  (2000).  Comparative  analysis  of  tea  catechins  and 
theaflavins  by  high-performance  liquid  chromatography  and  capillary 
electrophoresis.  Journal  of  Chromatography  A  881,439-447 
Lewis,  J.  R.,  Davis,  A.  L.,  Cai,  Y.,  Davies,  A.  P.,  Wilkins,  J.  P.  G.,  and 
Pennington,  M.  (1998).  Theaflavate  B,  isotheaflavin-3-0-gallate  and 
neotheaflavin-3-0-gallate:  three  polyphenolic  pigments  from  black  tea. 
Phytochemistry  49,2511-2519. 
Leung,  L.  K.,  Su,  R.,  Chen,  R.,  Zhang,  Z.,  Huang,  Y.,  and  Chen,  Z.  Y.  (2001). 
Theaflavins  in  black  tea  and  catechins  in  green  tea  are  equally  effective 
antioxidants.  Journal  offutrition  31,2248-225  1. 
Liao,  S.,  Hsi-Kao,  Y.,  and  Hiipakka,  R.  A.  (2001).  Green  tea:  Biochemical  and 
biological  basis  for  health  benefits.  Vitamins  and  Hormones  62,1-94. 
Luo,  D.,  Nakazawa,  M.,  Yohida,  Y.,  Cai,  M.,  and  Imai,  S.  (2001).  Effects  of  3 
different  C2+  ATPase  inhibitors  on  evoked  contractions  in  rabbit  aorta  and Jennifer  McGinn,  2001  Chapter  7,245 
activities  of  C2+  ATPases  in  porcine  aorta.  General  Pharmacology  34,211  - 
220. 
MacLean,  M.  R.,  Alexander,  D.,  Crozier,  A.,  and  Starling,  L.  J.  (1997). 
Dietary  flavonoids  cause  relaxation  of  rat  pulmonary  arteries.  Thorax  52, 
P123. 
Markhmn,  K.  R.  (1989).  Flavones,  flavonols  and  their  glycosides.  Methods  in 
Plant  Biochemistry  1,197-235 
Marin,  J.,  and  Rodriguez-Martinez,  A.  (1995).  Endothelium  and  free  radicals. 
Journal  ofAutonomic  Pharmacology  15,279-307 
Marmot,  M.  G.,  Rose,  G.,  Shipely,  M.  J.,  and  Thomas,  B.  J.  (1981).  Alcohol 
and  mortality  -A  U-shaped  curve.  Lancet  1,580-583 
Marmot,  M.,  and  Brunner,  E.  (1991).  Alcohol  and  cardiovascular  disease:  the 
status  of  the  U-shaped  curve.  British  Medical  Journal  303,565-568 
Martin,  S.,  Andrambeloson,  E.,  Takeda,  K.,  and  Andriantsitohania,  R.  (2002). 
Red  wine  polyphenols  increase  calcium  in  bovine  aortic  endothelial  cells:  a 
basis  to  elucidate  signalling  pathways  leading  to  nitric  oxide  production. 
British  Journal  ofPharmacology  135,1579-1587 
Maxwell,  S.  R.  J.,  Cruickshank,  A.,  and  Thorpe,  G.  H.  G.  (1994).  Red  wine 
and  antioxidant  activity  in  serum.  Lancet  344,193-194. 
Maxwell,  S.  R.  J.  (1997).  Wine  antioxidants  and  their  impact  on  antioxidant 
function  in  vivo.  In  'Wine:  nutritional  and  therapeutic  benefits.  (Ed  T.  R. 
Watkins.  )  (American  Chemical  Society:  Washington,  D.  C.  ) 
McDonald,  M.  S.,  Hughes,  M.,  Bums,  J.,  Lean,  M.  E.  J.,  Matthews,  D.,  and 
Crozier,  A.  (1998).  Survey  of  the  free  and  conjugated  myricetin  and  Quercetin 
content  of  different  red  wines  of  different  geographical  origins.  Journal  of 
Agricultural  and  Food  Chemistry  46,368-375 Jennifer  McGinn,  2001  Chapter  7,246 
McElduff,  P.,  and  Dobson,  A.  J.  (1997).  How  much  alcohol  and  how  often? 
Population  based  case-control  study  of  alcohol  consumption  and  risk  of  a 
major  coronary  event.  British  Medical  Journal  314,115  9-1164 
Middleton,  E.,  Kandaswami,  C.,  and  Theoharides,  T.  C.  (2000).  The  effects  of 
plant  flavonoids  on  mammalian  cells:  Implications  for  inflammation,  heart 
disease  and  cancer.  Pharmacological  Reviews  52,673-751 
Miketova,  P.,  Schram,  K.  H.,  Whitney,  L.  J.,  Kerns,  E.  H.,  Valcic,  S., 
Timmermann,  B.  N.,  and  Volk,  K.  1  (1998).  Mass  spectrometry  of  selected 
components  of  biological  interest  in  green  tea  extracts.  Journal  of  Natural 
Products  61,461-467 
Mizutani,  K.,  Ikeda,  K.,  Kawai,  Y.,  and  Yamori,  Y.  (1999).  Extracts  of  wine 
phenolics  improves  aortic  biomechanical  properties  in  Stroke-Prone 
Spontaneously  Hypertensive  rats  (SHRSP).  Journal  of  Nutrition,  Science  and 
Vitaminology  45,95-106. 
Morton,  L.  W.,  Caccetta,  R.  A.  A.,  Puddey,  I.  B.,  and  Croft,  K.  D.  (2000). 
Chemistry  and  biological  effects  of  dietary  phenolic  compounds:  relevance  to 
cardiovascular  disease.  Clinical  and  Experimental  Pharmacology  and 
Physiology  27,152-159. 
Mukhtar,  H.,  Wang,  Z.  Y.,  Kayitar,  S.  K.,  and  Agarwal,  R.  (1992).  Tea 
components:  antimutagenic  and  anticarcinogenic  effects.  Preventative 
Medicine  21,351-360 
Mukhtar,  H.,  Kayitar,  S.  K.,  and  Agarwal,  R.  (1994).  Green  tea  and  skin  - 
anticarcinogenic  effects.  Journal  ofInvestigations  in  Dermatology  102,3-7 
Mukhtar,  H.  and  Ahmad,  A.  (2000).  Tea  polyphenols:  prevention  of  cancer 
and  optimising  health.  American  Journal  of  Clinical  Nutrition  71,1698S- 
1702S. 
National  Drinks  Survey  1996.  Marketsearch  Data  (1997)  Vol  26a Jennifer  McGinn,  2001  Chapter  7,247 
Nakachi,  K.,  Suemasu,  K.,  Suga,  K.,  Takeo,  T.,  Imai,  K.,  and  Higashi,  Y. 
(1998).  Influence  of  drinking  green  tea  on  breast  cancer  malignancy  among 
Japanese  patients.  Japanese  Journal  of  Cancer  Research  89,254-26  1. 
Nakachi,  K.,  Matsuyama,  S.,  Miyake,  S.,  Suganuma,  M.,  and  Imai,  K.  (2000). 
Preventative  effects  of  drinking  green  tea  on  cancer  and  cardiovascular 
disease:  Epidemiological  evidence  for  multiple  targeting  prevention. 
Biofactors  13,49-54. 
National  Research  Council  (US)  (1989).  Committee  on  Diet  and  Health, 
National  Academy  of  Sciences.  Diet  and  Health;  National  Academy  Press; 
Washington,  DC. 
Nigdikar,  S.  V.,  Williams,  N.  R.,  Griffin,  B.  A.,  and  Howard,  A.  N.  (1998). 
Consumption  of  red  wine  polyphenols  reduces  the  susceptibility  of  low- 
density  lipoproteins  to  oxidation  in  vivo.  American  Journal  of  Clinical 
Nutrition  68,258-265. 
Noroozi,  M.,  Bums,  J.,  Crozier,  A.,  Kelly,  I.  E.,  and  Lean,  M.  E.  J.  (2000). 
Prediction  of  dietary  flavonol  consumption  from  fasting  plasma  concentration 
or  urinary  excretion.  European  Journal  of  Clinical  Nutrition  54,143  -149 
Osman,  H.  E.,  Maalej,  N.,  Shanmuganayagarn,  D.,  and  Folts,  J.  D.  (1998). 
Grape  juice  but  not  orange  juice  inhibits  platelet  activity  in  dogs  and  monkeys. 
Journal  offutrition  128,2307-2312. 
Oszmianski,  J.,  Ramos,  T.,  and  Bourzeix,  M.  (1988).  Fractionation  of  phenolic 
compounds  in  red  wine.  American  Journal  ofEnology  and  Viticulture  39,259- 
262. 
Pace-Asciak,  C.  R.,  Rounova,  0.,  Hahn,  S.  E.,  Diamandis,  E.  P.,  and 
Goldberg,  D.  M.  (1996).  Wines  and  grape  juices  as  modulators  of  platelet 
aggregation  in  healthy  human  subjects.  Clinica  Chimica  Acta  246,1634  82. Jennifer  McGinn,  2001  Chapter  7,248 
Paganga,  G.,  Miller,  N.,  and  Rice-Evans,  C.  A.  (1999).  The  polyphenolic 
content  of  fruit  and  vegetables  and  their  antioxidant  activities.  What  does  a 
serving  constitute?  Free  Radical  Research  30,153-162 
Palmer,  R.  M.  J.,  Ferrige,  A.,  and  Monacada,  S.  (1987).  Nitric  oxide  release 
accounts  for  the  biological  activity  of  endothelium-derived  relaxing  factor. 
Nature  327,524-526 
Pearson,  D.  A.,  Frankel,  E.  N.,  Aeschbach,  R.,  and  German,  J.  B.  (1998). 
Inhibition  of  endothelial  cell  mediated  low-density  lipoprotein  oxidation  by 
green  tea  extracts.  Journal  of  Agricultural  and  Food  Chemistry  46,1445- 
1449. 
Peterson,  J.  and  Dwyer,  J.  (1998).  Flavonoids:  dietary  occurrence  and 
biochemical  activity.  Nutrition  Research  18,1995-2018. 
Pietta,  P.  G.  (2000).  Flavonoids  as  antioxidants.  Journal  of  Natural  Products 
63,1035-1042 
Poon,  G.  K.  (1998).  Analysis  of  catechins  in  tea  extracts  by  liquid- 
chromatography-electrospray  ionisation  mass  spectrometry.  Journal  of 
Chromatography  A  794,63-74 
Prescott,  E.,  Gronbxk,  M.,  Becker,  U.,  and  Sorensen,  T. I.  A.  (1999).  Alcohol 
intake  and  the  risk  of  lung  cancer:  influence  of  type  of  alcoholic  beverage. 
American  Journal  ofEpidemiology  149,463-470. 
Price,  K.  R.,  Rhodes,  M.  J.  C.,  and  Barnes,  K.  A.  (1998).  Flavonol  glycoside 
content  and  composition  of  tea  infusions  made  from  commercially  available 
teas  and  tea  products.  Journal  of  Agricultural  and  Food  Chemistry  46,2517- 
2522. 
Pryor,  W.  A.,  Stahl,  W.,  and  Rock,  C.  L.  (2000).  Beta  carotene:  from 
biochemistry  to  clinical  trials.  Nutrition  Reviews  58,39-53 Jennifer  McGinn,  2001  Chapter  7,249 
Rakhit,  R.  D.,  and  Marber,  M.  S.  (2001).  Nitric  oxide:  an  emerging  role  in 
cardioprotection?  Heart  86,368-372 
Renaud,  S.  and  de  Logeril,  M.  (1992).  Wine,  alcohol,  platelets,  and  the  French 
paradox  for  coronary  heart  disease.  Lancet  339,1523-1526. 
Renaud,  S.  and  Ruf,  J.  C.  (1996).  Effects  of  alcohol  on  platelet  functions. 
Clinica  Chimica  Acta  246,77-89. 
Rice-Evans,  C.  A.,  Miller,  N.  J.,  Bolwell,  P.  G.,  Bramley,  P.  M.,  and  Pridham, 
J.  B.  (1995).  The  relative  antioxidant  activities  of  plant-derived  polyphenolic 
flavonoids.  Free  Radical  Research  22,375-3  83. 
Rice-Evans,  C.  A.  (1999).  Wake  up  to  flavonoids.  International  Congess  and 
Symposium  Series.  The  Royal  Society  of  Medicine  Press. 
Rice-Evans,  C.  A.  (1999).  Implications  of  the  mechanisms  of  action  of  tea 
polyphenols  as  antioxidants  in  vitro  for  chemoprevention  in  humans. 
Proceedings  of  the  Society  of  Experimental  Biology  and  Medicine  220,262- 
266. 
Rice-Evans,  C.  A.  (2001).  Flavonoid  antioxidants.  Current  Medicinal 
Chemistry  8,797-807. 
Rimm,  E.  B.,  Giovannucci,  E.  L.,  Willett,  W.,  Colditz,  G.  A.,  Aschezio,  A., 
Rosner,  B.,  and  Stampfer,  M.  J.  (1991).  Prospective  study  of  alcohol 
consumption  and  risk  of  coronary  disease  in  men.  Lancet  338,464-468. 
Rimm,  E.  B.,  Klatsky,  A.  L.,  Grobbee,  D.,  and  Stampfer,  M.  J.  (1996).  Review 
of  moderate  alcohol  consumption  and  reduced  risk  of  coronary  heart  disease: 
is  the  effect  due  to  wine,  beer  or  spirits?  British  Medical  Journal  312,713- 
736. 
Rimm,  E.  B.,  Katan,  M.  B.,  Ascherio,  A.,  Stampfcr,  M.  J.,  and  Willctt,  W. 
(1996).  Relation  between  intake  of  flavonoids  and  risk  for  coronary  heart Jennifer  McGinn,  2001  Chapter  7,250 
disease  in  male  health  professionals.  Archives  of  Internal  Medicine  125,384- 
389. 
Robb,  C.  S.  and  Brown,  P.  R.  (2001).  Catechins  in  tea:  chemistry  and  analysis. 
Advances  in  Chromatography  41,379-410. 
Rosenberg,  L.,  Slone,  D.,  Shapiro,  S.,  Kaufman,  S.  W.,  Miettinen,  0.  S.,  and 
Stolley,  P.  D.  (1981).  Alcoholic  beverages  and  myocardial  infarction  in  young 
women.  American  Journal  ofPublic  Health  71,82-85 
Rotondo,  S.,  and  de  Gaetano,  G.  (2000).  Protection  from  cardiovascular 
disease  by  wine  and  its  derived  products.  World  Review  of  Nutrition  and 
Dietetics  87,90-113 
Salah,  N.,  Miller,  N.  J.,  Paganga,  G.,  Tijburg,  L.  B.  M.,  Bolwell,  P.  G.,  and 
Rice-Evans,  C.  A.  (1995).  Polyphenolic  flavonols  as  scavengers  of  aqueous 
phase  radicals  and  as  chain-breaking  antioxidants.  Archives  of  Biochemistry 
and  Biophysics  322,339-346. 
Sato,  M.,  Ray,  P.  S.,  Maulik,  N.,  Englcman,  R.  M.,  Bcrtelli,  A.  A.  E.,  Bertelli, 
A.,  and  Das,  D.  K.  (1999).  Myocardial  protection  with  red  wine  extract. 
Journal  of  Cardiovascular  Pharmacology  35,263-268. 
Scalbert,  A.  and  Williamson,  G.  (2000).  Dietary  intake  and  bioavaliability  of 
polyphenols.  Journal  offutrition  130,2073S-2085S. 
Serafini,  M.,  Ghiselli,  A.,  and  Ferro-Luzzi,  A.  (1996).  In  vivo  antioxidant 
effect  of  green  and  black  tea  in  man.  European  Journal  of  Clinical  Nutrition 
50,28-32. 
Serafini,  M.,  Maiani,  G.,  and  Ferro-Luzzi,  A.  (1998).  Alcohol  free  red  wine 
enhances  plasma  antioxidant  capacity  in  humans.  Journal  of  Nutrition  128, 
1003-1007. Jennifer  McGinn,  2001  Chapter  7,251 
Sesso,  H.  D.,  Gaziano,  J.  M.,  Buming,  J.  E.,  and  Hennekens,  C.  H.  (1999). 
Coffee  and  tea  intake  and  the  risk  of  myocardial  infarction.  American  Journal 
of  Clinical  Nutrition  149,162-167. 
Shaper,  A.  G.,  Wannamethee,  G.,  and  Walker,  M.  (1988).  Alcohol  and 
mortality  in  British  men:  explaining  the  U-shaped  curve.  Lancet  2,1267-1273 
Shahidi,  F.,  and  Wanasundara,  P.  (1992).  Phenolic  antioxidants.  Critical 
Reviews  ofFood  Science  and  Nutrition  32,67-103 
Singleton,  V.  L.  (1982).  Grape  phenolics:  background  and  prospects.  In 
Proceedings  of  the  University  of  California,  Davis,  Grape  and  wine  centennial 
symposium.  (Ed  A.  D.  Webb.  )  (University  of  California  Press:  California.  ) 
Singleton,  V.  L.  (1995).  Maturation  of  wines  and  spirit  comparisons,  facts  and 
hypotheses.  American  Journal  ofEnology  and  Vitology  46,98-113 
Singleton,  V.  L.  and  Esau,  P.  (1969).  Phenolic  substances  in  grapes  and  wine, 
and  their  significance.  (Academic  Press:  New  York.  ) 
Singleton,  V.  L.,  and  Rossi,  J.  A.  (1965).  Colorimetry  of  total  phenolics  with 
phospornolybdic-phosphotungstic  reagents.  American  Journal  of  Enology  and 
Vitology  16,144-15  8 
Soleas,  G.  J.,  Diamandis,  E.  P.,  and  Goldberg,  D.  M.  (1997).  Wine  as  a 
biological  fluid:  history,  production,  and  its  role  in  disease  prevention.  Journal 
of  Clinical  and  Laboratory  Analysis  11,287-313. 
Solcas,  G.  J.,  Diamandis,  E.  P.,  and  Goldberg,  D.  M.  (1997).  Rcsveratrol:  A 
molecule  whose  time  has  come  and  gone?  Clinical  Biochemistry  30,91-113 
Stanley,  L.  L.,  and  Mazier,  M.  J.  P.  (1999).  Potential  explanations  for  the 
French  Paradox.  Nutrition  Research  19,3-15 
Stensvold,  I.,  Tverdal,  A.,  Solvoll,  K.,  and  per  Foss,  0.  (1992).  Tea 
consumption,  relationship  to  cholesterol,  blood  pressure  and  coronary  and 
total  mortality.  Preventative  Medicine  21,546-553. Jennifer  McGinn,  2001  Chapter  7,252 
St  Leger,  A,  S.,  Cochrane,  A,  L.,  and  Moore,  F.  (1979).  Factors  associated 
with  cardiac  mortality  in  developed  countries  with  particular  reference  to  the 
consumption  of  wine.  Lancet  1,1017-1020 
Stoclet,  J.  C.,  Kleschyov,  A.  L.,  Muller,  B.,  and  Lugnier,  C.  (1997).  New 
insights  into  the  role  of  nitric  oxide  in  cardiovascular  protection.  Experimental 
and  Clinical  Cardiology  2,93-97 
Stoclet,  J.  C.,  Kleschyov,  A.  L.,  Andriambeloson,  E.,  Diebolt,  M.,  and 
Andriantsitohaina,  R.  (1999).  Endothelial  NO  release  caused  by  red  wine 
polyphenols.  Journal  ofPhysiology  and  Pharmacology  50,535-540. 
Sun,  B.,  Leandro,  C.,  Ricardo  de  Silva,  J.,  and  Spranger,  1.  (1998).  Separation 
of  grape  and  wine  proanthocyanidins  according  to  their  degree  of 
polymerization.  Journal  ofAgricultural  and  Food  Chemistry  46,1390-1396. 
Sung,  H.,  Nah,  J.,  Chun,  S.,  Park,  H.,  Yang,  S.  E.,  and  Min,  W.  K.  (2000).  In 
vivo  antioxidant  effect  of  green  tea.  European  Journal  of  Clinical  Nutrition 
54,527-527 
Tea  Council  (2000).  http:  //www.  teahealth.  co.  uk 
Teissedre,  P.  L.,  Frankel,  E.  N.,  Waterhouse,  A.  L.,  Peleg,  H.,  and  German,  J. 
B.  (1996).  Inhibition  of  in  vitro  human  LDL  oxidation  by  phenolic 
antioxidants  from  grapes  and  wines.  Journal  of  Science  Food  and  Agriculture 
70,55-61 
The  Alpha-Tocopherol  Beta  Carotene  Cancer  Prevention  Study  Group.  (1994). 
The  effect  of  vitamin  E  and  beta  carotene  on  the  incidence  of  lung  cancer  and 
other  cancers  in  male  smokers.  New  England  Journal  ofMedicine  330,1029- 
1035 
Thun,  M.  J.,  Peto,  R.,  Lopez,  A.  D.,  Monaco,  I  H.,  Henley,  S.  J.,  Heath,  C. 
W.,  and  Doll,  R.  (1997).  Alcohol  consumption  and  mortality  among  middle- 
aged  and  elderly  U.  S.  adults.  New  England  Journal  of  Medicine  337,1705- 
1714 Jennifer  McGinn,  2001  Chapter  7,253 
Tijburg,  L.  B.  M.,  Mattem,  T.,  Folts,  J.  D.,  Weisgerber,  U.  M.,  and  Katan,  M. 
B.  (1997).  Tea  flavonoids  and  cardiovascular  diseases:  a  review.  Critical 
Reviews  in  Food  Science  and  Nutrition  37,771-785 
Tsuda,  T.,  Horio,  F.,  and  Osawa,  T.  (1999).  Absorption  and  metabolism  of 
cyanidin  3-0-B-D-glucoside  in  rats.  FEBS  Letters  449,179-182. 
van  het  Hof,  K.  H.,  de  Boer,  H.  S.,  Wiseman,  S.  A.,  Lien,  N.,  Westrate,  J.  A., 
and  Tijburg,  L.  B.  M.  (1997).  Consumption  of  green  and  black  tea  does  not 
increase  resistance  of  low-density  lipoprotein  to  oxidation  in  humans. 
American  Journal  of  Clinical  Nutrition  66,1125-1132 
van  het  Hof,  K.  H.,  Kivitis,  G.  A.  A.  Weststrate,  J.  A.  and  Tijburg,  L.  B.  M. 
(1998).  Bioavailability  of  catechins  from  tea:  the  effect  of  milk.  European 
Journal  of  Clinical  Nutrition  52,356-359 
van  het  Hof,  K.  H.,  Wiseman,  S.  A.,  and  Tijburg,  L.  B.  M.  (1999).  Plasma  and 
lipoprotein  levels  of  tea  catechins  following  repeated  tea  consumption. 
Proceedings  of  the  Society  of  Experimental  Biology  and  Medicine  220,203- 
209. 
Vanhoutte,  P.  M.  (1989).  Endothelium  and  control  of  vascular  function. 
Hypertension  13,65  8-667 
Virtarno,  J.,  Rapola,  J.  M.,  Ripatti,  S.,  Heinonen,  0.  P.,  Taylor,  P.  R.,  Albanes, 
D.,  and  Huttunen,  J.  K.  (1998).  Effect  of  vitarnin  E  and  beta  carotene  on  the 
incidence  of  primary  nonfatal  myocardial  infarction  and  fatal  coronary  heart 
disease.  Archives  ofInternal  Medicine  158,668-675 
Virtaino,  J.,  Edwards,  B.  K.,  Virtanen,  M.,  Taylor,  P.  R.,  Malila,  N.,  Albanes, 
D.,  Huttunen,  J.  K.  Hietanen,  P.,  Maenpaa,  H.,  Koss,  L.,  Nordling,  S.,  and 
Heinonen,  0.  P.  (2000).  Effects  of  supplemental  alpha-tocophcrol  and  beta- 
carotene  on  urinary  tract  cancer:  incidence  and  mortality  in  a  controlled  trial 
(Finland).  Cancer  Causes  Control  11,933-999 Jennifer  McGinn,  2001  Chapter  7,254 
Vison,  J.  A.,  Dabbagh,  Y.  A.,  Serry,  M.  M.,  and  Jang,  J.  (1995).  Plant 
flavonoids,  especially  tea  flavonols,  are  powerful  antioxidants  using  an  in  vitro 
oxidation  model  for  heart  disease.  Journal  of  Agricultural  and  Food 
Chemistry  43,2800-2802. 
Vison,  J.  A.  and  Dabbagh,  Y.  A.  (1998).  Tea  phenols:  antioxidant 
effectiveness  of  teas,  tea  components,  tea  fractions  and  their  binding  with 
lipoproteins.  Nutrition  Research  18,1067-1075. 
Vison,  J.  A.  and  Dabbagh,  Y.  A.  (1998).  Effect  of  green  and  black  tea 
supplementation  on  lipids,  lipid  oxidation  and  fibrinogen  in  the  hamster: 
mechanisms  for  the  epidemiological  benefits  of  tea  drinking.  FEBS  Letters 
433,44-46. 
Vison,  J.  A.,  Proch,  J.,  and  Zubik,  L.  (1999).  Phenol  antioxidant  quantity  and 
quality  in  foods:  cocoa,  dark  chocolate  and  milk  chocolate.  Journal  of 
Agricultural  and  Food  Chemistry  47,4821-4824. 
Vison,  J.  A.  (2000).  Black  and  green  tea  and  heart  disease:  a  review. 
Biofactors  13,127-132. 
Vison,  J.  A.,  Proch,  J.,  and  Bose,  P.  (2001).  Determination  of  quantity  and 
quality  of  polyphenol  antioxidants  in  foods  and  beverages.  Methods  in 
Enzymology  335,103-114. 
Weisburger,  J.  H.  (2000).  Eat  to  live,  not  live  to  eat.  Nutrition  16,767-773 
Wiseman,  S,  A.,  Balentine,  D.  A.,  and  Frei,  B.  (1997).  Antioxidants  in  tea. 
Critical Reviews  in  Food  Science  and  Nutrition  37,705-718 
Wollgast,  J.  and  Anklam,  E.  (2000).  Polyphenols  in  chocolate:  is  there  a 
contribution  to  human  health?  Food  Research  International  33,449-45  9. 
Wollny,  T.,  Aiello,  L.,  Di  Tommaso,  D.,  Bellavia,  V.,  Rotilio,  D.,  Donati,  M. 
D.,  de  Gaetano,  G.,  and  Iacoviello,  L.  (1999).  Modulation  of  haemostatic 
function  and  prevention  of  experimental  thrombosis  by  red  wine  in  rats:  a  role Jennifer  McGinn,  2001  Chapter  7.255 
for  increased  nitric  oxide  production.  British  Journal  of  Pharmacology  127, 
747-755. 
Woodward,  M.,  and  Tunstall-Pedoe,  H.  (1995).  Alcohol  consumption,  diet, 
coronary  risk  factors  and  prevalent  coronary  heart  disease  in  men  and  women 
in  the  Scottish  Heart  Health  Study.  Journal  of  Epidemiology  and  Community 
Health  49,354-362. 
Woodward,  A  and  Tunstall-Pedoe,  H.  (1999).  Coffee  and  tea  consumption  in 
the  Scottish  Heart  Health  Study  follow-up:  conflicting  relations  with  coronary 
risk  factors,  coronary  disease,  and  all  cause  mortality.  Journal  of 
Epidemiology  and  Community  Health  53,481-487. 
World  Health  Organisation  (1989).  World  Health  Statistics  Annual. 
Xie,  B.,  Shi,  H.,  Chen,  Q.,  and  Ho,  C.  T.  (1993).  Antioxidant  properties  of 
fractions  and  polyphenol  constituents  from  green,  oolong  and  black  teas. 
Proceedings  of  the  National  Science  Council,  ROC  14,77-84. 
Yang,  C.  S.,  and  Wang,  Z.  Y.  (1993)  Tea  and  cancer.  Journal  of  the  National 
CancerInstitute  85,1038-1049 
Yang,  C.  S.,  Chcn,  L.,  Lee,  M.  J.,  Balentine,  D.,  Kuo,  M.  C.,  and  Schantz,  S. 
P.  (1998).  Blood  and  urine  levels  of  tea  catechins  atIcr  ingestion  of  different 
amounts  of  green  tea  by  human  volunteers.  Cancer  Epidemiology  Biomarkers 
Prevention  7,351-354 
Yang,  C.  S.  (1999).  Tea  and  Health.  Nutrition  15,946-949. 
Yang,  C.  S.,  Chung,  J.  Y.,  Yang,  G.,  Chabra,  S.  K.,  and  Lee,  M.  1  (2000).  Tea 
and  tea  polyphenols  in  cancer  prevention.  Journal  of  Nutrition  130,472S- 
478S. 
Yang,  C.  S.,  Chung,  J.  Y.,  Yang,  G.  Y.,  Li,  X.,  Meng,  X.,  and  Lee,  M.  J. 
(2000).  Mechanisms  of  inhibition  of  carcinogenesis  by  tea.  Biofaclors  13,73- 
79. Jennifer  McGinn,  2001  Chapter  7,256 
Yang,  C.  S.,  and  Landau,  J.  M.  (2000).  Effects  of  tea  consumption  on  health. 
Journal  offutrition  13  0,2409-2412 
Yokozawa,  T.,  Oura,  H.,  Sananaka,  S.,  and  Kim,  M.  (1995).  Effects  of  a 
component  of  green  tea  on  the  proliferation  of  vascular  smooth  muscle  cells. 
Bioscience,  Biotechnology  &  Biochemistry  59,2134-2136. 
Yokozawa,  T.,  and  Dong,  E.  (1997).  Influence  of  green  tea  and  its  three  major 
components  upon  low-density  lipoprotein  oxidation.  Experimental  Toxicology 
and  Pathology  49,329-3  35 
Yoshida,  T.,  Hantano,  T.,  and  Ito,  H.  (2000).  Chemistry  and  function  of 
vegetable  polyphenols  with  high  molecular  weights.  Biofactors  13,121-125. 
Yu,  G,  P.,  Hsieh,  C.  C.,  Wang,  L.  Y.,  Yu,  S.  Z.,  Li,  X,  L.,  and  Jin,  T.  H. 
(1995).  Green  tea  consumption  and  risk  of  stomach  cancer:  A  population 
based  case-control  study  in  Shanghai,  China.  Cancer  Causes  and  Control  6, 
532-538 
Zheng,  W.,  Doyle,  T.  J.,  Kushi,  L.  H.,  Sellers,  T.  A.,  Hong,  C.  P.,  and  Folsom, 
A.  R.  (1996).  Tea  consumption  and  cancer  incidence  in  a  prospective  cohort  of 
postmenopausal  women.  American  Journal  ofEpidemiology  144,175-182. 
http:  //www.  tea.  co.  uk 